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The transition from intrauterine to extrauterine life represents a critical phase of physiological 
adaptation in preterm infants. The validation of comprehensive haemodynamic monitoring, aimed at 
the assessment of cardiovascular function and end-organ perfusion throughout this challenging phase, 
would not only improve knowledge of transitional physiology and pathophysiology following 
preterm birth, but would also support the development of an individualized approach to therapeutic 
management. 
The aim of this research project was to add further knowledge to cardiovascular and cerebrovascular 
physiology in preterm infants during postnatal transition. 
To achieve this aim, transitional haemodynamics were explored in preterm infants <32 weeks’ 
gestation or with a birth weight <1500g using a non-invasive system of integrated multiparametric 
monitoring, which included electrical velocimetry, near-infrared spectroscopy, pulse oximetry and  
serial echocardiographic assessments.  
Sixty-four preterm infants with a mean (standard deviation) gestational age of 29.6 (2.7) weeks were 
included in the research analysis. The results are divided into 3 sections:  
1. In the first section, the time trends of cardiovascular and cerebrovascular haemodynamics 
during the transitional period were evaluated, demonstrating a progressive improvement in 
overall cardiovascular function and cerebrovascular reactivity. The presence of a 
haemodynamically significant patent ductus arteriosus (hsPDA) was associated with 
significantly different patterns of cardiac output (CO), stroke volume (SV), heart rate (HR), 
cardiac contractility and with a greater impairment of cerebral autoregulation.  The association 
between cardiovascular and cerebrovascular parameters and a pool of antenatal, perinatal and 
postnatal factors was also evaluated, revealing characteristic haemodynamic profiles in 
relation to gestational age, antenatal Doppler status, ductal status during the transitional 
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period. In particular, more preterm infants showed significantly increased systemic vascular 
resistance (SVR) and HR, reduced SV and cardiac contractility, lower cerebral oxygenation 
and higher cerebral oxygen extraction. Infants with an abnormal umbilical Doppler had 
significantly higher SVR. Of these, those with antenatal brain sparing also showed an altered 
cerebral autoregulation, whereas a significant CO reduction was observed in the subgroup 
with no evidence of cerebral blood flow redistribution. The presence of a hsPDA significantly 
affected cerebral autoregulation and was also associated with significantly higher CO, SV, 
HR values, an enhanced cardiac contractility and decreased SVR.  
2. In the second part, the relationship existing between CO and its two main determinants, HR 
and SV, was evaluated. The correlation between CO and HR was not perfectly linear and was 
significantly influenced by HR ranges, the ductal status and ongoing cardiovascular drugs. A 
strong relationship between SV and CO was also demonstrated, supporting the role for SV in 
CO determination even in preterm infants. 
3. In the third part, the cardiovascular and cerebrovascular response to brief cardio-respiratory 
events, which are particularly common during the transitional period, was evaluated. The 
haemodynamic impact of these events on both cardiovascular and cerebral sides was 
modulated not only by the event characteristics – with events characterized by combined 
desaturation and bradycardia <80 bpm showing the greatest effects – but also by the individual 
neonatal features, namely gestational age, antenatal Doppler status and ductal status. 
The results of this project demonstrate how multifaceted the transitional haemodynamic status is in 
such a heterogenic population as preterm infants and provide valuable hints in support of the 
development of an individualized haemodynamic management of preterm infants during this delicate 




LIST OF ABBREVIATIONS 
ACA: anterior cerebral artery IB: isolated bradycardia 
AREDF: umbilical absent or reversed end-diastolic flow  ICON: index of cardiac contractility 
BP: blood pressure ID: isolated desaturation 
CBF: cerebral blood flow IUGR: intrauterine growth restriction 
cFTOE: cerebral fraction of tissue oxygen extraction IVH: intraventricular haemorrhage 
CO: cardiac output LA:Ao: left atrium to aortic root ratio 
COECHO: cardiac output, measured by echocardiography LF: low frequency 
COEV: cardiac output, measured by electrical velocimetry LVO: left ventricular output 
CPAP: continuous positive airway pressure LMM: linear mixed-effects model 
CPP: cerebral perfusion pressure  MABP: mean arterial blood pressure 
CRE: cardio-respiratory events MCA: middle cerebral artery 
CrUSS: cranial ultrasounds MPE: mean percentage error 
cTOI: cerebral tissue oxygenation index MRI: magnetic resonance imaging 
CW: continuous wave NICU: neonatal intensive care unit 
DA: ductus arteriosus NIRS: near-infrared spectroscopy 
DAo: descending aorta PDA: patent ductus arteriosus 
DB: combined desaturation and bradycardia PFO: patent foramen ovale 
EV: electrical velocimetry PHI: parenchymal haemorrhagic infarction 
FO: foramen ovale PVL: periventricular leukomalacia 
FTOE: fraction of tissue oxygen extraction PVR: pulmonary vascular resistance 
GA: gestational age PW: pulsed-wave 
GEE: generalized estimating equation RVO: right ventricular output 
GLMM: generalized linear mixed-effects model SpO2: peripheral arterial oxygen saturation 
HF: high frequency SV: stroke volume 
HR: heart rate SVIA: self-ventilating in air 
HREV: heart rate, detected by electrical velocimetry SVR: systemic vascular resistance 
HRPO: heart rate, detected by pulse oximeter TOHRx: correlation index between cTOI and HR 
hsPDA: haemodynamically significant patent ductus 
arteriosus 





1.1. Transitional haemodynamics of preterm infants  
The transition from intrauterine to extrauterine life represents a critical phase of physiological 
adaptation which has an important impact on many organs and systems, most notably the 
cardiovascular system and the lungs. The functional and anatomical immaturity that characterizes 
premature infants poses a major challenge to their postnatal adaptation. As a result, the 
haemodynamic status of this population during the transitional phase is typically unstable, with 
clinically relevant implications. Knowledge of transitional physiology and pathophysiology 
following preterm birth is core to appropriate interpretation of the haemodynamic changes occurring 
during this period and to the establishment of optimal therapeutic management.  
 
1.1.1.  Transition of the fetal circulation at birth 
The development of an adequate placental circulation, providing a low-resistance vascular bed for 
efficient exchange of gases and nutrients between maternal and fetal blood, is vital for fetal 
development. During antenatal life, oxygenated blood enters the fetal circulation through the 
umbilical vein. Between 50-60% of this blood flow bypasses the hepatic circulation via the ductus 
venosus and enters the inferior vena cava, where it tends to stream separately from the desaturated 
systemic return of the lower portions of the body. At the junction between the inferior vena cava and 
the right atrium, a tissue flap known as the Eustachian valve directs this blood across the foramen 
ovale into the left atrium, from which it enters the left ventricle and is ejected into the ascending aorta. 
The majority of this blood is then delivered to the brain and coronary circulation, to ensure the 
delivery of better oxygenated blood to these vital structures. Desaturated blood from the superior vena 
cava, the coronary sinus and the inferior vena cava, which comprises the venous return from lower 
body and hepatic circulation, is collected in the right atrium and then directed into the right ventricle 
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across the tricuspid valve. This deoxygenated blood is then ejected into the pulmonary artery. 
However, due to the high pulmonary vascular resistance (PVR) that characterizes the antenatal period, 
only a small proportion of blood reaches the pulmonary circulation, while 80-90% of this flow is 
shunted across the ductus arteriosus (DA) into the descending aorta toward the lower half of the body, 
which is thus supplied with relatively desaturated blood. At the level of the iliac arteries, this 
deoxygenated blood enters the umbilical arteries and flows back to the low-resistance vascular bed 
of the placenta for gas and nutrient exchanges. The gradients of oxygen saturation in the fetal 
circulation gives a picture of the distribution and blending of flows: the highest saturation is found in 
the umbilical vein, whereas the lowest is observed in the abdominal tract of the inferior vena cava, 
before its connection with the ductus venous [1]. 
During pregnancy several pathological conditions may compromise placental circulation, with 
significant implications on fetal haemodynamics [2]. The placental trophoblast invasion, which 
begins around 10-12 weeks of gestational age, is responsible for the development of a low-resistance 
placental circulation. This process is regulated by several biochemical modulators, among which 
blood oxygen, growth factors, cytokines, and other angiogenic substances [3]. Poor trophoblast 
invasion or maternal ischaemia increases placental impedance and is associated with a hypoxia-driven 
cardiovascular fetal adaptation to ensure an adequate oxygen delivery to vital organs, such as the 
brain. This adaptation, which is characterized by an increase in systemic vascular resistance (SVR) 
in splanchnic and peripheral vascular beds and by vasodilatation of cerebral vessels [4], results in a 
raised ventricular afterload, which is also exacerbated by abnormal retrograde diastolic flow in the 
aortic isthmus secondary to cerebral vasodilatation, with potential failure of coronary perfusion and 
ensuing myocardial damage [5]. Moreover, the decreased fetal perfusion ensuing from the altered 
placental circulation and the blood flow redistribution towards the brain further worsen the low blood 
oxygenation of splanchnic fetal organs, which are thus more prone to hypoxic-ischemic complications 
after birth [6].  
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At delivery, clamping the umbilical cord triggers a cascade of major cardiovascular changes that 
occur within seconds to hours. Disconnection from the low-resistance placental bed results in an 
instantaneous increase in SVR, whereas the onset of ventilation is followed by a rapid fall in PVR, 
which drastically increases pulmonary blood flow. Due to the subsequent increase in pulmonary 
venous return, the left atrial pressure rises rapidly and leads to the functional closure of the septal 
layers of the foramen ovale [7]. At the same time the shunt across the DA shifts from predominantly 
right-to-left to predominantly left-to-right; in term neonates, this usually occurs within 10 min after 
birth, as a consequence of the rapid PVR drop [8]. The increase in arterial oxygen saturation from 60-
70% at 1 minute to above 90% within 10 minutes after birth reflects the effective establishment of 
pulmonary gas exchange resulting from these physiological changes [9]. While the ductus venosus 
can remain patent for several days with no circulatory consequences [10], the DA usually undergoes 
a functional closure by 48-72 hours of life in the majority of healthy term neonates [11]. This event 
cascade is illustrated in Figure 1.1. 
 
Figure 1.1. Cascade of events during transition from a fetal to a neonatal circulation. Abbreviations: 
DA, ductus arteriosus; FO, foramen ovale; LA, left atrium; PaO2, arterial O2 pressure; PBF, 
pulmonary blood flow; PVR, pulmonary vascular resistance. 
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The closure of the fetal shunts completes the transition from a parallel into a serial circulation (Figure 




Figure 1.2. Blood flow circulation before (A) and after birth (B). The paths of oxygenated blood are 
shown in orange. Antenatal circulation is a parallel circuit, whereas postnatal circulation is a serial 





1.1.2. Cardiovascular adaptation in the transitional period  
The heterogeneity of the preterm population in terms of gestational and postnatal ages results in 
different levels of maturation of the cardiovascular system, with different degrees of functional 
impairment of preload, diastolic filling, intra-cardiac flow patterns, contractility and afterload [5,13].  
The ability of the cardiac muscle fibers to change their force of contraction in response to changes in 
the volume of venous return is defined as preload. According to the Frank-Starling mechanism 
(Figure 1.3), as preload increases, sarcomeres stretch and the number of formed actin‒myosin bridges 
augments, thus enhancing cardiac contractile force [5].  
 
 
Figure 1.3. Representation of Frank-Starling curve according to the adult (1) and the neonatal 
cardiac function (2). Adapted from Vrancken et al. Frontiers in Pediatrics (2018) [13] 
 
A reduction in preload, resulting from a decreased blood volume from acute blood loss, or extensive 
insensible water loss or capillary leak associated with sepsis, will result in ventricular dysfunction. 
However, as shown in Figure 1.3, the functional curve of the Frank-Starling mechanism is different 
in neonates, with similar changes in preload resulting in a smaller increase in cardiac output compared 
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to older children and adults. As a result, excessive fluid administration will shift neonatal cardiac 
function towards the flat part of the curve resulting in impaired ventricular function [13]. 
Volume changes in response to a change in pressure define compliance. Cardiac compliance depends 
on the structural properties of the cardiac muscle, with particular reference to connectin, a protein 
that links the z-disk region of the thin filament to the myosin thick filament. Early studies suggested 
that fetal cardiac compliance is poor and undergoes a developmental increase during gestation [14]. 
More recently, however, it has been shown that, due to the presence of specific fetal connectin 
isoforms with high elastic properties that contribute to reduce myocardial stiffness and passive 
tension, suggesting the fetal heart actually has a higher compliance compared to the adult heart [15].  
Ventricular filling is characterized by an early passive phase followed by an active phase, secondary 
to atrial contraction. Due to its enhanced elastic properties, however, the force that the fetal connectin 
isoform generates when restoring its resting length after systolic contraction or diastolic distention is 
decreased [16]. This, in turn, may alter the rotational patterns of intracardiac flow [17], resulting in 
lower passive filling when the ventricle untwists. As a consequence, neonatal ventricular filling is 
more dependent on atrial contraction [5,18]. 
Cardiac contractility is defined by the ability of sarcomeres to change their contractile force. 
Intracellular calcium is a principal determinant of cardiac contractility; when calcium levels increase, 
some bind to troponin and alter its shape, allowing the formation of actin‒myosin cross-bridges that 
lead to cardiac contraction, whereas the removal of calcium from troponin restores the tropomyosin 
blocking action, with subsequent muscle relaxation [19]. The sympathetic autonomic nervous system 
and catecholamines also play a relevant role on cardiac contractility by regulating the calcium influx 
within the cardiac myocyte [20]. 
Due to structural and functional immaturity of the preterm myocardium, which is characterized by a 
relatively low number of myofibrils with a simplified internal organization, immaturity of the 
sarcoplasmatic reticulum and T tubules resulting in altered calcium release, lower troponin C levels 
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and higher troponin T levels, the cardiac contractile function of premature neonates is often reduced 
[13,14]. Nevertheless, a significant improvement in cardiac contractility has been observed in very-
low-birth-weight infants from day 1 to 5 after birth [21], suggesting the occurrence of adaptive 
mechanisms, such as a progressive improvement of the intracellular calcium influx in the early 
postnatal period [13]. 
The ability of the heart to increase its contractile function with increasing heart rates is defined as the 
Bowditch effect [5]. However, in in-vitro experiments, it has been shown that the force-frequency 
relationship in the newborn human ventricle is flat and tends to increase with age, possibly because 
of developmental changes in calcium handling (Figure 1.4) [22]. Furthermore, the sympathetic 
innervation and the number of β-adrenergic receptors in the immature myocardium are decreased 
[23]; as a consequence, administration of inotropes has been shown to result in smaller increases of 
myocardial contractility in a neonatal animal model, compared to adult controls [24].  
 
 
Figure 1.4. Force developed from a newborn and an infant at different cycle lengths, indicating 




While it had long been assumed that neonates can only increase their cardiac output by increasing 
their heart rate, with stroke volume remaining relatively fixed [13], more recent evidence has 
indicated that, in preterm infants, cardiac output changes mainly result from stroke volume changes 
rather than heart rate increases [25,26]. The preterm circulation is characterized by high resting heart 
rates, which subsequently reduce the time available for the end-diastolic ventricular filling and may 
further exacerbate the consequences of the intrinsic diastolic dysfunction previously described. 
Moreover, the chronotropic effects of the vasopressor-inotropes that are commonly used to support 
the cardiovascular function in this population may contribute further to shorten the diastolic 
ventricular filling [20], with potential therapeutic implications. 
Afterload is defined as the force against which the heart must work to pump the stroke volume and 
depends upon ventricular dimensions, SVR, blood pressure (BP) and vascular compliance [5]. 
Ventricular wall stress and afterload are intrinsically related: with increasing afterload, the ventricular 
wall stress increases and the velocity of circumferential fiber shortening decreases, resulting in a 
reduced stroke volume [13]. Echocardiographic data have shown an age-dependent relationship 
between circumferential fiber shortening and end-systolic wall stress, suggesting that the performance 
of the neonatal myocardium is more sensitive to afterload [27]. 
The complex interactions existing between BP, SVR, cardiac output and end-target organ blood flow 
in the preterm population and their regulating factors are summarized in Figure 1.5. In premature 
infants, a high resting a-adrenergic tone in the peripheral vasculature maintains the constriction of 
the capacitance arterioles in many vascular beds, leading to increased SVR [5]. Echocardiographic 
studies in preterm neonates have shown that the immature myocardium not only has reduced 
contractility, but also a poor tolerance to high SVR that contributes to increased afterload [21,28]. 
Among the factors that contribute to further increase afterload in this population are ductal ligation, 
or the presence of conditions characterized by low cardiac output and increased SVR, such as cold 
shock. On the other hand, low afterload results from reduced SVR, as in warm shock [13]. Given the 
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substantial difference in the pathophysiological mechanisms of shock presentation, an adequate 
diagnosis is fundamental in order to undertake the appropriate therapeutic approach (i.e., inotropes 
versus vasopressors) [29,30]. 
 
Figure 1.5. Modulatory interactions between blood flow, systemic vascular resistance and blood 
pressure and related influencing factors. Abbreviations: BP, blood pressure; CO, cardiac output; 
CVP, central venous pressure; GA, gestational age; OBF, organ blood flow; PFO, patent foramen 
ovale; PNA, postnatal age; PDA, patent ductus arteriosus. Adapted from Noori et al. Neonatology 
questions and controversies: haemodynamics and cardiology (2012) [31]. 
 
The postnatal persistence of the fetal shunt pathways also provides a significant challenge to 
transitional cardiovascular physiology. The persistence of patent ductus arteriosus (PDA) will be 
addressed in detail in section 1.1.3. Unlike in term infants, transitional circulation of preterm infants 
is characterized by the exposure to a unrestrictive PDA in most of the cases [32]. In the vast majority 
of preterm neonates, PVR drops below systemic levels within a few hours after birth and, as a 
consequence, the shunting direction of transductal blood reverses to left to right [7]. This causes 
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significant pulmonary overflow at the expenses of systemic perfusion. The foramen ovale tends to 
remain patent in many premature infants; in the absence of a PDA, the haemodynamic consequences 
of this are trivial. However, the large amount of blood returning to the left atrium due to the pulmonary 
overcirculation caused by the ductal patency may reverse the direction of shunting via the foramen 
ovale, thus further worsening pulmonary hyperperfusion and low systemic blood flow. 
Finally, it should be taken into account that the heart and the lungs are intrinsically connected by 
complex dynamic physiological interactions. Due to their immaturity, preterm infants have weak 
thoracic musculature with a high thoracic compliance, while lung compliance is poor and the 
respiratory drive insufficient. For these reasons, positive pressure ventilation is often needed in the 
early postnatal phases. While positive pressure ventilation is obviously beneficial to improve alveolar 
gas exchanges and to reduce the work of breathing, the use of high tidal volumes, peak and end-
expiratory pressures can alter the neonatal haemodynamics in several ways [33]. An increased airway 
pressure decreases the transmural pressure gradient of the alveolar/capillary interface, thus 
contributing to squeeze blood out of the intra-alveolar capillaries [13]; the ensuing PVR increase 
results in a reduction of pulmonary perfusion and venous return, decreasing systemic cardiac output. 
If increased PVR persists, a reversion of the transductal shunt to right-to-left may occur. Furthermore, 
the reduction in cardiac output observed in association with increased airway pressure can also be 
ascribed to a direct compressive effect on left ventricular filling [13]. At an end-target organ level, 
inappropriate ventilation strategies might also affect cerebral blood flow according with several 
mechanisms. High positive end-expiratory pressures can significantly reduce superior vena cava 
blood flow, which represents the blood return from the head, neck and upper limbs; moreover, the 
use of high tidal volumes during the transitional period, when cerebral autoregulation is often 
impaired, may cause detrimental fluctuations in cerebral blood flow, thus increasing the risk of short- 
and long-term neurodevelopmental sequelae.  
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1.1.3. Patent ductus arteriosus: the protagonist of transitional pathophysiology 
The role of the DA during postnatal circulatory transition has been object of much research and 
discussion especially because of its known association with specific prematurity-related 
complications. 
Postnatal DA closure is regulated by the exposure to oxygen and vasodilators. Oxygen induces the 
release of the potent vasoconstrictor endothelin-1 at the ductal level, whereas vasodilators substances 
such as prostaglandin E2, prostacyclin and nitric oxide contribute to DA patency [34]. The immature 
DA is characterized by a thinner muscular wall compared to the term ductus, with smooth muscle 
cells that are less sensitive to oxygen-related vasoconstriction and more sensitive to the prostaglandin 
E2 and prostacyclin-related vasodilative effects. The increased circulating levels of systemic 
inflammatory mediators and prostaglandins that are observed in the preterm population further 
contribute to the failure of spontaneous DA closure in this population [35]. Moreover, it has been 
observed that platelets are recruited into the DA lumen during closure, probably promoting a 
thrombotic sealing of the constricted DA [34]. Hence, thrombocytopenia [36], or an impaired platelet 
function [37] may also play a role in the persistence of the DA. 
It has been largely established that PDA prevalence increases with decreasing gestational age (GA). 
Even when spontaneous closure is achieved, however, it may take up to several days to occur: in a 
large retrospective study on preterm infants who did not receive active medical or surgical treatment 
for PDA closure, the median closing time ranged from 6 days in infants ≥30 weeks of gestation to 71 
days in those <26 weeks [38]. This observation suggests that, in the absence of targeted interventions, 
a significant proportion of extremely preterm neonates may be exposed to a prolonged transductal 
shunting with potential pathophysiological implications [32]. 
The shunt volume and direction across the PDA strictly depends on PVR, and so do the ensuing 




Figure 1.6. Event cascade associated with different directions of transductal shunt (scenario A and 
B), depending upon pulmonary vascular resistance (PVR). Abbreviations: BP; blood pressure; DA, 
ductus arteriosus, LV, left ventricle; L, left; PBF, pulmonary blood flow; R, right; RV, right ventricle.  
 
In preterm infants, the decrease in PVR may be slower than in term infants, due to the immaturity of 
the lung parenchyma, respiratory distress and metabolic acidosis frequently seen in the early postnatal 
phase (Figure 1.6 A). The persistence of high PVR prolongs the right-to-left or bidirectional shunting 
across the PDA, with subsequent reduction of pulmonary perfusion, low oxygen saturation levels and 
increased need for supplemental oxygen and invasive respiratory support. If pulmonary blood flow 
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decreases, the venous return to the left atrium is also decreased, and so are the left ventricle preload 
and cardiac output, leading to decreased perfusion and oxygenation in end-target organs. As a 
consequence, a raise in lactate and acidosis, which contribute to increasing PVR, may occur, feeding 
a detrimental vicious cycle that eventually leads to the development of persistent pulmonary 
hypertension [39]. Persistently elevated PVR increase the afterload of the right ventricle, which 
gradually becomes hypertrophic and/or dilated. The resulting bowing of the interventricular septum 
toward the left ventricle further compromises left ventricular output, leading to biventricular 
dysfunction. Systemic hypotension requiring cardiovascular support often coexists during these 
phases. 
Conversely, if PVR gradually decreases during the transitional period (Figure 1.6 B), a left-to-right 
shunt across the PDA may become haemodynamically significant. Pulmonary hyperperfusion, 
increases pulmonary venous return with volume overload of the left ventricle and systemic 
hypoperfusion below the ductal level. The increased venous return to the left atrium may raise the 
left atrial pressure and reverse the direction of shunting through the foramen ovale, thus further 
worsening pulmonary hyperperfusion and low systemic blood flow. Moreover, due to the diastolic 
dysfunction that characterizes the preterm myocardium, which has been previously discussed [5], the 
left ventricle may struggle to adapt to the increased stroke volume, eventually progressing to left 
ventricular failure in case of wide or prolonged left-to-right transductal shunting.  
Hence, the signs and symptoms of PDA depend not only upon the characteristics, the magnitude and 
the duration of the transductal shunt, but also on the individual adaptive ability of the immature 
myocardium as well as additional concomitant factors (e.g., fluid intakes, metabolic and ventilatory 
status). 
Persistence of the PDA in preterm neonates has been reported to be associated with increased 
mortality and several major complications [40–44]; among these, the most relevant that typically 
occur during the transitional period are intraventricular haemorrhage (IVH) and pulmonary 
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haemorrhage . Currently available physiological studies, conducted with sequential echocardiography 
investigations, have provided invaluable insights to better understand the causality and the 
mechanisms through which the PDA may contribute to these complications [43–47]. 
A strong association between low superior vena cava flow, considered as a proxy for cerebral blood 
flow (CBF), during the early hours after preterm birth and subsequent development or progress to 
higher grade IVH has been reported by Kluckow and Evans [46]. The prevalence of a 
haemodynamically significant PDA (hsPDA) was significantly higher in infants with this low-flow 
state. Another prospective physiological study reported lower cardiac output, ventricular function and 
CBF during the first 12 hours of age in extreme preterm neonates who later developed high-grade 
IVH [47]. These observations are consistent with the recognized ischaemia–reperfusion theory for 
the occurrence of IVH and suggest a link with the left-to-right shunt across the DA. 
Deshpande et al. [32] have proposed two potential pathophysiological models in which the interaction 
between the immature preterm myocardium and the exposure to an unrestrictive transductal shunt 
during postnatal transition are important aetiological contributors to the development of both 
pulmonary haemorrhage and IVH in preterm neonates with a PDA. In particular, the delayed 
adaptation of the myocardial function to the volume overload resulting from transductal left-to-right 
may increase left atrial pressure and pulmonary venous hypertension, placing the infant at risk of 
pulmonary haemorrhage. The temporal association between this functional disturbance and the 
typical timing of pulmonary haemorrhage onset (usually at 48 hours after birth) is noteworthy [43]. 
On the other hand, the myocardial adaptation to the loading changes, which usually occurs within the 
first 48 hours of life, may result in a sudden increase of CBF, triggering the reperfusion phase of 
ischaemia-reperfusion predisposing to IVH [47]. The ischaemia-reperfusion theory may be an 
oversimplification of a complex set of events which challenge the idea of a simple causative 
relationship between these haemodynamic changes and clinical outcome [32]. As an example, the 
extent of the transductal shunt may itself be high enough to supersede the autoregulatory capacity of 
 22 
 
CBF, and sicker infants may exhibit more prolonged periods of impaired cerebral autoregulation, thus 
increasing their risk of IVH development in the presence of predisposing conditions [48].  
On the above basis, a thorough and integrated clinical and echocardiographic assessment in preterm 
neonates presenting with a PDA is essential, and the subsequent haemodynamic management should 
be adapted according to the underlying cardiovascular physiology and the clinical context of each 
individual patient, with the ultimate goal of preventing unfavourable outcomes and of defining the 




1.2.  Cerebral autoregulation 
Given the multiple haemodynamic, metabolic and neurogenic factors that influence CBF and the high 
metabolic demands of the brain tissue, the regulation of cerebral perfusion is of fundamental 
importance to prevent hypoxic-ischemic brain injury. However, the anatomical and physiological 
immaturity of the cerebral vasculature that characterizes preterm infants results in incomplete and 
underdeveloped mechanisms of cerebral autoregulation which, together with the haemodynamic 
instability often observed during the transition from a fetal to a neonatal circulation, puts this 
population at high risk of developing noxious CBF fluctuations. The present section will address in 
detail the several mechanisms involved in the regulation of CBF in infants and neonates, along with 
the methods currently available for the assessment of cerebral autoregulation. An overview on the 
characteristics of cerebral autoregulation in preterm infants and its association with the development 
of neonatal brain injury will be reviewed. 
 
1.2.1. Regulation of cerebral blood flow in infants and neonates 
Cerebral blood flow is regulated by several integrated metabolic, biochemical, autonomic and 
myogenic factors [50]. The main physiological mechanisms that contribute to the regulation of CBF 
should therefore be taken into consideration when assessing cerebral haemodynamics of preterm 
infants; these mechanisms are described below.  
• Partial arterial pressure of oxygen (PaO2) and carbon dioxide (PaCO2): both low PaO2 
(hypoxia) and high PaCO2 (hypercapnia) exert a vasodilatory effect on cerebral circulation, 
leading to an increase in CBF, whereas hypocapnia leads to cerebral vasoconstriction. The 
mechanisms through which CBF reactivity to PaCO2 is achieved involve H+/K+ homeostasis: 
the hypercapnia-induced increase in H+ concentration of the perivascular space increases K+ 
outflow from smooth muscles cells of cerebral arteries and arterioles, leading to their 
relaxation and subsequent vasodilatation, whereas the hypocapnia-induced decrease in H+ 
 24 
 
concentration leads to vasoconstriction [51]. The molecular mechanisms underlying O2-
mediated CBF regulation include the nitric oxide pathways and thus require an intact 
endothelium for its production. By increasing H+ concentration, the tissue lactic acidosis 
induced by hypoxia can also provide a link between CO2- and O2-mediated regulation of CBF. 
There is evidence that CBF reactivity to PaCO2 and PaO2 changes is present in preterm 
neonates: at 34 weeks of gestation, CBF reactivity to 1 kPa of CO2 is between 10 and 100% 
with an average of 60%, while the administration of 100% O2 reduces CBF by approximately 
15% [52]. Of interest, it has been observed that the CBF response to increased CO2 might be 
absent under certain circumstances, such as in preterm infants who subsequently developed 
intracranial haemorrhage [53,54], whereas those with normal cerebral ultrasounds showed a 
gradual increase of PaCO2-CBF reactivity over the first 48 hours of life [53]. Under normal 
conditions, there is a functional interaction between the reactivity of CBF to PaCO2 and blood 
pressure: the vasoconstriction occurring with hypocapnia enables the autoregulatory plateau 
to extend towards higher pressures whereas, conversely, hypercapnia shortens the plateau and 
increases the slope of the autoregulatory curve. However, PaCO2-CBF reactivity seems to be 
more robust compared to pressure-flow reactivity: after severe birth asphyxia the first may be 
preserved while the latter is lost [55]. 
• Neurovascular coupling: this regulatory mechanism links neuronal activity to subsequent 
changes in CBF. This occurs through a neuronal glutamate signalling pathway upon neuronal 
activation, with the release of vasoactive substances, such as prostaglandins, nitric oxide and 
adenosine, from both neurons and the astrocyte glial cells that lead to the relaxation of 
vascular smooth muscle. This is also known as functional hyperaemia [56]. Although it has 
long been assumed this regulatory mechanism was associated only with vasodilatory effects, 
a more complex balance of vasodilation and vasoconstriction, driven by chemical mediators 
that control CBF in a direct way, has emerged from recent studies [57]. In addition, a role for 
the pericytes that surround neurons in the local regulation of CBF has also been described 
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[58]. To date, there is some evidence on CBF fluctuations in response to seizures in the 
neonatal population [59,60], reporting a significant increase in CBF; however, from an 
electrical perspective, seizures represent an extreme event and may well result in disturbances 
of physiological neurovascular coupling. Data on spontaneous neural activity and related 
changes in cerebral haemodynamics, especially in the preterm population, are few and mainly 
aimed at exploring new methodologies for neurovascular coupling investigation [57,61]. 
• Metabolic coupling: glucose is the major brain substrate of the neonate, although alternative 
metabolites may in part support cerebral metabolism. In newborn infants, CBF appears to be 
actively coupled to the cerebral fuel demands: it has been previously shown that, in preterm 
infants, the occurrence of hypoglycaemia within 2 hours after birth was found to be associated 
with a 2.5 fold increase in CBF, as a result of cerebral vasodilation in response to decreased 
substrate availability [62]. Following the restoration of adequate blood glucose levels, CBF 
gradually decreased, reaching a steady state after approximately 3 minutes after the end of 
glucose infusion [63]. Individual reductions in cerebral blood volume were inversely related 
to the pre-treatment concentration of glucose, while no relation was observed between 
changes in CBF, mean arterial blood pressure (MABP) and blood gases, suggest the existence 
of a cerebral glucose sensor that may induce capillary recruitment to maintain the glucose 
transport to the neural tissue under hypoglycaemic conditions. The evidence of increased 
plasma epinephrine values during the hypoglycaemic episodes supports the role of the 
sympathetic nervous system in the observed cerebral hyperperfusion, consistent with evidence 
from animal studies [64], but a possible effect of vasoactive aminoacids released during 
hypoglycaemia has also been proposed [65]. 
• Autonomic nervous system: due to its abundance in a1-adrenergic receptors, the cerebral 
vasculature is a target of the autonomic control. The autonomic system may also influence 
cerebrovascular responses by counterbalancing release of nitric oxide and catecholamines in 
response to sympathetic and parasympathetic stimulation [66,67]. By activating a- and b-
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receptors, catecholamines modulate the arterial tone. The sympathetic activation shifts the 
autoregulatory plateau toward higher pressures, thereby protecting the brain against BP 
increases [68]. In an animal model, the ablation of relevant sympathetic ganglia was 
associated with a left-shift of the upper limit of the autoregulation range, with subsequent poor 
adaptation to increased BP [69]. The autonomic regulation of cerebral vasculature is 
intrinsically integrated with other regulating mechanisms of CBF. As an example, evidence 
from a neonatal animal model has demonstrated an interaction between the effect of 
sympathetic activation and PaCO2 reactivity, with sympathetic activation reducing blood flow 
to specific brain regions during hyperaemic conditions, such as hypercapnia [70]. A role for 
the sympathetic system has also been proposed for the CBF changes in response to the 
fluctuations in blood glucose levels described above [62]. Moreover, the sympathetic system 
plays an important role in the perinatal period during hypoxic-ischemic events, as it favours 
a diversion of cardiac output to the brain, heart and adrenals [71]. 
• Myogenic mechanisms: the regulation of the vascular tone in relation to changes in 
intraluminal pressure is a leading mechanism of CBF regulation. This mechanism results from 
a primitive reflex mediated by smooth muscle cells lining the cerebral arteries. In response to 
increased intraluminal pressure, depolarization of smooth muscle cell membranes and 
calcium-dependent vasoconstriction occur with the aim of preventing cerebral 
hyperperfusion, while the opposite occurs at low intraluminal pressure, resulting in 
vasodilation and increased cerebral perfusion [72]. In addition to calcium, endothelium-
derived nitric oxide is also involved in the vasodilation response of this mechanism; however, 
since the contribution of endothelial nitric oxide increases with age, it may be less efficient in 
the preterm infant, where other factors may possibly dominate [73]. The myogenic mechanism 




1.2.2. Cerebral autoregulation: definition and methods of assessment 
The ability of cerebral vasculature to maintain stable brain perfusion across a broad range of cerebral 
perfusion pressure (CPP) is defined as cerebral autoregulation. This mechanism results from the 
myogenic reflex described in the previous paragraph, which, in response to changes in intravascular 
pressure, determines either vasoconstriction or vasodilation to preserve a stable cerebral perfusion. 
CPP is the product of MABP and intracranial pressure. Since the latter is assumed to be relatively 
constant in the neonatal population and in healthy adults, MABP is thus the main determinant of CPP. 
The classic depiction of this system is a sigmoidal curve (Figure 1.7) with stable CBF over a range 
of normal MABP and unstable CBF when MABP is outside of this range. 
 
Figure 1.7. The cerebral autoregulatory curve. Circles represent the schematic arterial diameter. 
Vertical dotted lines indicate the lower and the upper pressure-dependent limit of the autoregulatory 
range. Modified from Kooi and Richter, Clin Perinatol (2020) [74]. 
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If MABP falls below the lower limit of autoregulatory capacity, arteries tend to collapse and CBF 
decreases, whereas if MABP rises above the upper limit, arteries are forcedly dilated and may snap, 
causing haemorrhagic complications [74]. The failure of the preterm cerebral vasculature to maintain 
uniform cerebral perfusion over a range of systemic blood pressures results in the so-called pressure-
passive circulation [75]. 
A complementary view of blood flow regulation was initially proposed in the nineteenth century by 
the physiologist Siegmund Mayer, who observed spontaneous rhythmic oscillations in the blood 
vessel diameter, with a periodicity of 10 s (0.1 Hz), in the wings of bats. Based on their periodicity, 
BP oscillations can be divided into three groups: high frequency (HF, >0.5 Hz), driven by the 
respiratory cycle and therefore relatively fixed, low frequency (LF, 0.05–0.5 Hz) and very-low 
frequency (<0.05 Hz), which are regulated by neurogenic, myogenic and metabolic mechanisms 
[67,76,77]. The development of advanced computational techniques has allowed greater exploration 
of cerebral autoregulation, with data suggesting that this autoregulatory mechanism attenuates the 
effects of LF fluctuations of BP, functioning as a high-pass filter [78,79]. 
It is possible to assess the function of the autoregulatory system by measuring how an input signal 
(i.e., MABP) is shaped and altered into the output (i.e., CBF) [75,80]. However, CBF cannot be 
measured directly in the newborn population, therefore, non-invasive methods for CBF estimation 
and for quantifying the state of cerebral autoregulation have evolved over time in conjunction with 
advances in technology. 
The methods aimed at assessing cerebral autoregulation can be classified according two different 
approaches: static and dynamic. Quantitative methods that measure CBF over a minute or more ignore 
the time course of blood flow fluctuations in response to dynamic MABP changes, therefore the 
pressure-flow reactivity described by these methods is static. The earliest approaches for CBF 
measurement that used 133Xe clearance had a static approach to CBF estimation. In fact, these 
methods provide only semiquantitative information about ongoing autoregulation, and their clinical 
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application is not feasible for longitudinal monitoring due to concerns about the use of invasive 
delivery of radioactive isotopes [75]. Conversely, by monitoring CBF and MABP with sampling 
frequencies of less than few seconds, the dynamic approach allows to describe how MABP 
fluctuations are followed immediately by parallel changes in CBF. 
Positron emission tomography has been previously used to evaluate dynamic cerebral autoregulation 
in human studies. However, the exposure to radiation that this technique entails makes its use 
unsuitable in neonatal settings. 
Transcranial Doppler sonography measures the blood flow velocity within a specific vessel. It is 
commonly assumed that the perfusion of a given cerebral territory can be inferred from blood flow 
velocity measurements in the corresponding stem artery. Hence, upon the calculation of the diameter 
of the insonated vessel, this technique can be used to obtain a non-invasive estimation of CBF and to 
evaluate the immediate effect of MABP changes on cerebral haemodynamics [81]. Since the 
estimation of absolute CBF values would require the knowledge of the brain mass perfused by the 
sampled artery, transcranial Doppler provides a relative index of CBF [80]. While in adults 
transcranial Doppler monitoring is largely used for the continuous estimation of CBF by measuring 
the flow velocities in large cerebral arteries, the application of this monitoring technique in the 
neonatal population, and especially in preterm infants, is hindered by specific technical issues. The 
small size of the neonatal vessels hinders an accurate assessment of their diameter, which is required 
to estimate CBF from Doppler measurements of blood flow velocity. Furthermore, due to the small 
vessel dimension, signal loss is very frequent unless the probe is manually hold in position for the 
whole monitoring time. Eventually, ultrasound is associated with a time-dependent heating effect, 
therefore a prolonged transcranial Doppler monitoring may induce a temperature increase within such 
a delicate target tissue as the developing brain [82]. For these reasons, transcranial Doppler evaluation 
in neonatal studies aimed at assessing the dynamic features of cerebral autoregulation are often 
intermittent and performed over limited time periods [60,83,84]. Computerized coherent averaging 
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of Doppler flow velocity in the middle cerebral arteries in response to spontaneous MABP 
fluctuations has proved to provide a reliable non-invasive assessment of non-stationary cerebral 
autoregulation in neonates undergoing intensive care [84]. 
Cerebral tissue oxygenation, measured continuously and non-invasively using near-infrared 
spectroscopy (NIRS), can be used as a surrogate for cerebral perfusion and allows a dynamic approach 
to cerebral autoregulation assessment. NIRS technique will be discussed in detail in section 1.3.2. 
Since the vast majority of oxygen in blood is bound to haemoglobin, which is confined to the red 
blood cells, assuming a stable cerebral metabolism, changes in cerebral oxygenation will likely reflect 
changes in CBF. Despite several technical limitations, such as the assumption of a stable haemoglobin 
level and of a fixed arterial–venous volume ratio, or the use of diverse algorithms within the various 
devices and sensors currently available which may hinder the precision of this method for CBF 
assessment, its capability to provide a beside continuous monitoring has made this technique widely 
adopted to study brain haemodynamics in the context of cerebral autoregulation [74,85]. To date, the 
following mathematical models, based on the assumption that autoregulation is a simple linear 
process, have been developed for the dynamic assessment of the autoregulatory system in preterm 
neonates using cerebral NIRS monitoring. These methods can be summarized by the following 
approaches, which are also graphically summarized in Figure 1.8: 
• Time-domain analysis: this approach examines the moving correlation between CBF, derived 
from NIRS parameters, and the measured values of MABP over short segments of data (Figure 
1.8 A). A number of different correlation methods have been proposed. Correlations can be 
examined in predefined time epochs, with or without a predefined threshold [86–89]. The 
method used in the present research for the evaluation of cerebral autoregulation relies on this 
type of analysis. The mean correlation for each possible MABP value is then calculated and 
sorted into bins: the resulting output is reminiscent of the autoregulation curve and allows 
evaluating the MABP range within which this mechanism is effective [90–93]. Some groups 
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have also used linear regression to analyse cerebral autoregulation. Tyszczuk et al. used 
correlation coefficients and multiple linear regression to study CBF, MABP and other 
variables, indicating the MABP range of 23.7 to 39.3 mmHg for the maintenance of an 
adequate cerebral perfusion [94]. Moreover, using linear regression to quantify the 
relationship between MABP and CBF, Munro et al constructed curves for cerebral 
autoregulation and concluded that a breakpoint exists at 30 mmHg [95]. 
• Frequency-domain analysis: this approach examines the correlation between MABP and 
cerebral oxygenation within specific frequency bands (i.e., LF). The advantage of this 
approach is that it allows a dynamic assessment of the autoregulatory system and it takes into 
account the effect of time lag between changes in cerebral oxygenation and BP [75]. However, 
different parameter settings, like the length of the epochs or the frequency band, have an 
important influence on this type of approach [96]. Frequency-domain analyses enables 
calculation of coherence, phase and gain of transfer function. 
The coherence function describes the linear relationship existing between two signals in the 
frequency domain and can be used as a measure to indicate if a linear relationship exists 
between the input and the output signal (i.e., CBF), with resulting values ranging between 0 
(no coherence) and 1 (perfect coherence) (Figure 1.8 B). A threshold of 0.5 has been proposed 
to define an impaired cerebral autoregulation and to calculate the proportion of time spent 
with pressure-passive cerebral perfusion [75]. However, this analysis requires a high degree 
of precision in time synchronization of data capture [97], and may necessitate of several hours 
of monitoring to provide reliably measures. Moreover, in some studies, a high coherence was 
observed when MABP was either below or above the lower limit of autoregulation, and it has 
thus been suggested that coherence may be most useful as a filter to outline adequate slow 





Figure 1.8. Representation of the different analytical models (A-C) currently available for the 




Transfer function analysis examines natural LF fluctuations in both BP and CBF to assess 
how well the autoregulatory system is able to dampen pressure oscillations (Figure 1.8 C). 
This approach entails the computation of the signal power spectral density, which indicates 
how much each particular frequency component contributes to form a given signal [78]. By 
measuring the spectral density ant the cross-power spectral density of MABP and CBF, the 
phase and the gain can be computed. The phase represents the time shift between the two 
signals, while the gain represents the relationship in magnitude between BP and CBF and 
provides a measure of the severity of pressure passivity [78]. A low gain would indicate that, 
even in the presence of a non-intact cerebral autoregulation, the magnitude of changes in CBF 
are small or moderate, whereas in the presence of a high gain even moderate changes in MABP 
are associated with large CBF fluctuations. When using TF phase as a measure for cerebral 
autoregulation effectiveness, a high gain with a reduced phase has been associated to impaired 
autoregulation [99]. 
The evaluation of cerebral autoregulation according to the abovementioned methods requires an 
invasive continuous monitoring of arterial BP, which is usually performed by an indwelling arterial 
catheter in the umbilical artery or in a small peripheral artery. As such, it is not exempt from adverse 
effects, such as thrombosis, vasospasm, air embolism and breaks or transections of the catheter [100], 
and may not be universally feasible or practical. Moreover, in the presence of a hsPDA, post-ductal 
blood pressure may not be representative of that in the carotid arteries, due to the haemodynamic 
effects of trans-ductal shunting [74]. Hence, the moving correlation index between heart rate (HR) 
and cerebral oxygenation has been recently proposed for non-invasive, yet continuous evaluation of 
cerebrovascular reactivity in preterm infants [101], based on the fact that HR is a direct cardiac output 
determinant. When this correlation index turns positive, CBF is dependent on total blood flow, 
indicating an impaired regulation of CBF.  
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A shift towards the validation of non-invasive monitoring models for the estimation of 
cerebrovascular reactivity would support a more extensive evaluation of this physiological parameter 
in neonates at high-risk of haemodynamic instability and brain injury. 
Achieving a reliable evaluation of cerebral autoregulation in the preterm population has proven to be 
a complex task, largely due to the technical challenges associated with capturing data, the lack of a 
clear definition for hypotension and the broad range of immaturity in neurovascular development 
[75]. However, the development of a software able to assess cerebral autoregulation in real time, 
processing multi-monitoring signals at the infants’ cot, would help the clinician to identify infants 
with pressure-passive CBF and to individualize care by finding each infant’s own optimal BP range 
[102], in order to prevent the development of cerebral complications related to the failure of 
autoregulation.  
 
1.2.3. Cerebral autoregulation in preterm infants 
Under healthy conditions, the mechanisms of cerebral autoregulation mature together with arterial 
smooth muscle differentiation, starting before mid-pregnancy [103]. However, due to cardiovascular 
and cerebrovascular immaturity related to premature birth, cerebral autoregulation is often impaired 
in preterm infants [104], especially under conditions that cause loss of contractile capacity in the 
immature cerebral arteries, such as hypoxia-ischaemia.  
It has been observed that cerebral autoregulation is positively correlated with GA [105,106], 
suggesting an increased efficacy of this mechanism with advancing functional and anatomical 
maturation. Moreover, a paradoxical drop of cerebral oxygen extraction has been reported by 
Vesoulis et al. in preterm neonates ≤25 weeks’ gestation during low BP states, which imply a drop in 
CBF, compared to a physiological increase of this parameter observed in infants aged 26-28 weeks’ 
gestation, suggesting a GA-dependent maturation of the autoregulatory response [107].  
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Intrauterine growth restriction (IUGR) due to placental insufficiency is a common cause of preterm 
birth. This condition results from a chronic state of fetal hypoxia which, in turn, determines 
cardiovascular remodelling aimed preserving cerebral perfusion and oxygenation at the expenses of 
the splanchnic circulation, characterized by left ventricular predominance, peripheral 
vasoconstriction and cerebral vasodilation. Recent studies have described altered cerebral 
autoregulation and an increased cerebral oxygenation in IUGR infants within the first 72-96 hours 
after birth [108–110], suggesting the postnatal persistence of this vascular redistribution. In addition 
to GA and IUGR, several conditions and complications that are typically associated with preterm 
birth further contribute to affect cerebral autoregulation in this delicate population. 
Hypotension is common in preterm neonates, especially in  the most preterm infants and during the 
transition from a fetal to a postnatal circulation, which is characterized by a significant haemodynamic 
instability. By reducing MABP below the lower limit of cerebral autoregulation, hypotension 
significantly affects this physiological mechanism [93]. Of interest, da Costa et al. aimed to determine 
the individual optimal MABP at which cerebral autoregulation is most effective using the same 
software adopted in the present research. They observed that the optimal MABP threshold increased 
with increasing GA and that a deviation by 4 mmHg or more below the optimal value was associated 
with higher mortality, whereas an analogous deviation above this value was associated with severe 
IVH [102].  
Dopamine is widely used for the treatment of neonatal hypotension due to its vasopressor properties 
resulting from the stimulation of the a- and b-adrenergic and dopaminergic receptors. Although a 
possible role of this medication on cerebral autoregulation has been hypothesized, due to its effects 
on the vascular tone, current evidence is controversial. Recently, increased time periods with impaired 
cerebral autoregulation have been observed during the first 96 hours of life in preterm infants exposed 
to dopamine, in a dose-dependent fashion peaking at a concentration of 11-15 μg/kg/min [111]. A 
higher correlation between MABP and cerebral oxygenation was reported by Eriksen in preterm 
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neonates treated with dopamine compared to controls [91], thus suggesting a steeper slope of the 
autoregulation curve in association with the dopamine-related a-adrenergic vasoconstriction. 
However, when the same group investigated dopamine effects in newborn piglets during BP 
fluctuations, they observed a dose-related improvement of cerebral autoregulation at low BP in 
association with this treatment [112], although an increased dopamine plasma clearance during 
continuous infusion in piglets compared with neonates may have played a role in these conflicting 
results [113]. Furthermore, it should be considered that the indication for dopamine treatment is 
hypotension itself, therefore establishing the individual role of each of these two factors on cerebral 
autoregulation is a challenging issue. 
The association between cerebral autoregulation and the presence of a hsPDA, which may result in a 
diastolic run-off flow in the cerebral vessels, has been previously investigated in small studies. Chock 
et al. described a higher, although not significant, burden of pressure-passive cerebral oxygenation in 
infants with a hsPDA compared to controls. Moreover, comparing infants who had undergone 
pharmacological PDA closure with those requiring surgical PDA ligation the latter had a transient 
increase in pressure passivity brain perfusion up to 6 hours after surgical intervention, which resulted 
in a sudden increase in CBF [88].  
A possible correlation between impaired cerebral autoregulation and respiratory distress syndrome 
has been reported by Lemmers and colleagues [114]. Although PaCO2 levels were similar in infants 
with respiratory distress syndrome and controls, the former had significantly lower MABP with 
increased requirement of inotropic drug; therefore, it may be that the observed results were not 
directly linked to respiratory distress itself, but rather represented an expression of illness severity.  
Endotracheal surfactant administration is a first-line treatment in infants with respiratory distress 
syndrome. Both brief intubation and a less-invasive procedure for surfactant administration (i.e., use 
of a thinner catheter) have shown transient effects on cerebral autoregulation in preterm infants: the 
latter was associated with a milder impairment and a quicker recovery compared with brief intubation, 
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suggesting that autoregulation is affected by the method of surfactant administration [115]. However, 
the use of a different sedation protocol in association with the two techniques and acute PaCO2 
changes associated with the intubation procedure rather than blood pressure changes may have 
primarily contributed to the observed transient CBF changes [116,117].  
In summary, several interrelated conditions may contribute to alter the effectiveness of cerebral 
autoregulation in preterm neonates; as a result of this constellation of factors, maintaining a stable 
CBF in this vulnerable population is tenuous, with subsequent clinical implications in terms of brain 
injury.  
 
1.2.4. Role of cerebral autoregulation in neonatal brain injury 
The failure of the cerebrovascular autoregulatory system results in unstable CBF which, by 
determining repeated cycles of hypoxia–ischaemia–reperfusion, drives the pathogenesis of preterm 
brain injury, characterized by the development of IVH or of white matter injury.  
IVH is a major complication of prematurity, with a highest prevalence during the first 72 hours after 
preterm birth, suggesting that brain circulation is especially vulnerable in this period [118]. Its 
aetiology is multifactorial, but primarily lies in the intrinsic fragility of the germinal matrix 
vasculature and in the disturbances of CBF. In particular, the microvasculature of the germinal matrix 
is characterized by an abundance of angiogenic blood vessels with an immature basal lamina, 
decreased pericytes, and deficient glial fibrillary acidic protein in the ensheathing astrocytes endfeet 
[119]. The exposure of this frail tissue to hypoxia-ischaemia induces a surge in vascular endothelial 
growth factor and angiopoietin-2 levels, activating rapid angiogenesis within the germinal matrix. In 
this context, the repeated episodes of ischaemia and reperfusion that often occur as a consequence of 
CBF fluctuations in the early postnatal period likely contribute to the rupture of the fragile germinal 
matrix vessels, which represents the primum movens for IVH development. Accordingly, CBF 
fluctuations characterized by a transient phase of hyperperfusion [47,120] and a greater burden of 
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impaired autoregulation, detected using different techniques [48,104,121–123], have been 
documented in preterm infants who developed IVH during the transitional period. Moreover, it has 
also been observed that, in mechanically ventilated neonates, severe IVH was preceded by a global 
abolishment of CBF reactivity to both PaCO2 and BP, whereas milder IVH did not [54]. As such, the 
maintenance of a stable CBF since the early postnatal period and the prevention of hypoxic and 
hypotensive states represent fundamental neuroprotective strategies in the preterm population. 
The bleeding in the germinal matrix may disrupt the ependymal lining and extend into the ventricles, 
causing progressing degrees of IVH, detailed in Table 1.1. Although the Papile criteria [124] are still 
largely used in clinical and research settings, a more descriptive and precise nomenclature has been 
proposed by Volpe [125].  
 
Table 1.1. Grading of intraventricular haemorrhage (IVH) according to Papile and Volpe. 
Papile’s grading Volpe’s grading 
Grade 1: subependymal haemorrhage  Grade 1: IVH confined to the germinal matrix region 
Grade 2: IVH without ventricular dilatation  Grade 2: IVH filling ≤ 50% of the lateral ventricle 
and/or without ventricular dilatation 
Grade 3: IVH causing ventricular distension and 
dilatation  
Grade 3: IVH filling >50% of the lateral ventricle 
and/or resulting in ventricular dilatation 
Grade 4: IVH with parenchymal haemorrhage  IVH with periventricular haemorrhagic infarction 
(PHI) in the surrounding parenchyma 
 
The destruction of the germinal matrix resulting from IVH and the damage to the glial precursors 
located in this area may lead to long-term neurodevelopmental sequelae. Moreover, as shown in 
Figure 1.9 A, severe IVH may be complicated by the development of a parenchymal haemorrhagic 
infarction (PHI) in the periventricular white matter. PHI was formerly believed to represent a 
parenchymal extension of the IVH; however, evidence from microscopic studies has revealed that 
perivascular haemorrhage follows the distribution of the medullary veins in the periventricular white 
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matter and tend to be concentrated near the ventricular angle, where these veins become confluent, 
leading to a venous infarction.  
PHI frequently results in a large porencephalic cyst that can be isolated or accompanied by smaller 
cysts. An additional common complication of severe IVH is post-haemorrhagic ventricular dilatation, 
a consequence of obstruction of cerebrospinal fluid flow caused by the formation of a clot at any level 





Figure 1.9. Coronal sections of a premature brain. The dorsal cerebral subventricular zone (SVZ), 
the germinative epithelium of the ganglionic eminence (GE), thalamus (T), putamen (P) and globus 
pallidus (GP) are shown. A: a bleeding into the GE results in germinal matrix haemorrhage (GMH), 
which could burst through the ependyma to cause an intraventricular haemorrhage (IVH) and further 
progress to periventricular haemorrhagic infarction (PHI). B: cystic and non-cystic periventricular 
leukomalacia (PVL). The focal necrotic lesions in cystic PVL (small circles) are macroscopic and 
evolve to cysts, whereas in non-cystic PVL (black dots) are microscopic and evolve to glial scars. 
The diffuse component is characterised by microscopic cellular changes. Adapted from Volpe J. 
Lancet Neurology (2009) [125]. 
 40 
 
The typical patterns of white matter injury observed in preterm infants mainly consist in periventricular 
leukomalacia (PVL) and diffuse white matter gliosis. 
PVL is a form of white matter injury characterised by loss of pre-myelinating oligodendrocytes and 
determines a high risk of neurodevelopmental impairment. The principal initiating pathogenetic factors 
in PVL appear to be cerebral ischaemia-reperfusion and systemic inflammation which, by activating 
excitotoxicity and free radical damage, lead to death of the vulnerable pre-oligodendrocytes. The 
cerebrovascular anatomy and physiology of premature infants, namely the presence of arterial border- and 
end-zones and impaired CBF regulation, underlies the peculiar sensitivity of white matter to ischemic 
insults, resulting in PVL. This type of injury typically involves the periventricular white matter and, as 
shown in Figure 1.9 B, can be characterised by macroscopic or microscopic lesions.  
The focal white matter damage observed in PVL is caused by a deep necrosis of the periventricular 
white matter with loss of all cellular elements. The typical areas involved are the arterial watershed 
zones that lay between the penetrating branches of the middle, anterior and posterior cerebral arteries. 
The resulting focal necrotic lesions may be either macroscopic or microscopic in size. While 
macroscopic lesions tend to evolve to the formation of confluent cystic cavities, which are visible on 
cranial ultrasonography, microscopic necrosis alternatively evolves in whit matter scars characterised 
by marked astrogliosis and microgliosis. It has estimated that this latter form accounts for the majority 
of PVL cases; however, it is not easily diagnosed by cranial ultrasound, and only rarely visualized 
with brain magnetic resonance imaging (MRI), and as such it is underdiagnosed [125]. 
Diffuse white matter injury is characterized by a diffuse gliosis of pre-oligodendrocytes without focal 
necroses. The first step leading to this type of injury is a decrease in pre-myelinating 
oligodendrocytes, which is counteracted by an increase in oligodendroglial progenitors. These 
progenitors, however, are unable to undergo an appropriate maturation and are exquisitely vulnerable 
to hypoxic–ischaemic insults. Although it has not yet been conclusively established, it is likely that 
diffuse white matter gliosis represents the mildest form of injury in a spectrum that includes cystic 
PVL as the most severe form [126]. 
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Cerebral autoregulation disturbances play also a relevant role in the development of hypoxic-ischemic 
brain damage following perinatal asphyxia. Experimental studies in newborn animals have shown 
that, during asphyxia, CBF is diverted towards the brainstem, while it decreases or remains constant 
in the cerebral hemispheres; this brainstem-sparing phenomenon is named caudal-to-rostral priority 
and is aimed at protecting the respiratory and vasomotor centres to improve the chances of survival. 
The second pattern is a parasagittal distribution of cortical and subcortical injury that matches the 
watershed areas between the anterior, posterior and middle cerebral arteries, and ensues from MABP 
drops below the regional autoregulatory plateau of these vulnerable areas [71].  
Hypoxia, hypercapnia, acidosis and the depressed myocardial function that are typically associated 
with this condition significantly challenge the mechanisms of cerebral autoregulation [127]. After the 
initial hypoxic-ischemic hit, a diffuse increase in CBF, starting as early as three hours after the insult 
and lasting for several days, has been documented in Doppler and NIRS studies [128,129]. This 
luxury perfusion is the result of an abolishment of the physiological mechanisms of cerebrovascular 
reactivity, ensuing from the vasoparalysis of cerebral arterioles [129]. Using arterial spin labelling 
MRI it has been confirmed that primary low CBF followed by hyperperfusion is true for cortex, white 
matter, central ganglia and is associated with a more severe pattern of brain injury [130,131]. The 
evidence of impaired cerebral autoregulation in neonates with hypoxic-ischemic encephalopathy 
correlates with a poorer neurological and neuroradiological outcome and with increased rates of 
mortality [92,129,132,133]. Hence, the hyperperfusive state that results from the impairment of 
cerebrovascular reactivity after a hypoxic-ischemic insult has a prognostic value, and may serve as a 
point of entry for neuroprotective strategies aimed at blocking the sequence of events that leads to the 
related brain damage [134].  
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1.3.  Non-invasive monitoring of neonatal haemodynamics 
 
1.3.1. Towards comprehensive haemodynamic monitoring 
The significant improvements in neonatal intensive care over the past decades have led to a substantial 
reduction in neonatal mortality, but have also increased the survival of sick neonates, such as 
extremely preterm infants [135]. Due to the immaturity of the cardiovascular system combined with 
impaired compensatory mechanisms, these infants are at high risk for significant multisystem 
complications and haemodynamic instability. Moreover, multiple pathologies may further contribute 
to challenge the cardiovascular function of the preterm population: among these, are encountered 
perinatal asphyxia, necrotizing enterocolitis, sepsis, intrauterine growth retardation and congenital 
heart defects. In addition, it should also be considered that well-intended therapeutic interventions 
could also result in potentially adverse haemodynamic effects. For example, iatrogenic tachycardia 
secondary to chronotropic cardiovascular drugs may limit the cardiac preload, whereas invasive 
ventilation with high mean airway pressure could hinder the venous return, and analgesia, sedation 
and muscle relaxation have been associated with drug-induced systemic vasodilation [49]. 
Clinical assessment of the haemodynamic status relies upon the evaluation of HR, BP, urine output, 
blood gas analysis and capillary refill time [136]; however, it has been demonstrated that, irrespective 
of the experience of the health care professional, even a severe compromise of systemic perfusion 
could remain clinically undetected [137]. Moreover, these clinical parameters may not provide 
enough information to guide the cardiovascular therapeutic management. For instance, low BP can 
reflect either a high or low cardiac output (depending on SVR) or myocardial impairment, requiring 
totally different cardiovascular interventions; moreover, oxygen delivery might be impaired despite 
normal BP in the phase of compensated shock. Hence, a standardized approach in which BP 
evaluation is used to estimate end-target organ perfusion, with hypotension being the main criterium 
for interventions (Figure 1.10 A) does not fit all the possible pathophysiological scenarios that can 
underlie hypotensive symptoms (Figure 1.10 B) and may contribute to underestimate the occurrence 
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of early haemodynamic disturbances. Moreover, since vasopressors and inotropes have different 
mechanisms of action and cardiovascular effects [138], the choice of treatment in the presence of 
hypotension can only be determined when additional information on cardiac function and end-target 
organ perfusion is gathered [49]. 
Comprehensive haemodynamic monitoring, integrated with clinical assessment, could help clinicians 
to build a better picture of the status of the circulation and end organ perfusion. It would also provide 
useful insights on the underlying pathophysiology, support haemodynamic management of the infants 
and monitor the effects of the interventions, with the ultimate goal of developing an individualized 
haemodynamic approach optimized for the patient's specific pathophysiology and clinical situation 
(Figure 1.10 C) [13,49]. 
 
 
Figure 1.10. Empirical “one-size-fits-all” approach, irrespective of underlying physiology (A); 
haemodynamic management stratified according to presumed underlying pathophysiology (B); 
individualized haemodynamic management tailored to the underlying pathophysiology and to the 





Nevertheless, the development of a personalized haemodynamic management requires more complex 
algorithms than standard protocol, as it takes into account the specific characteristics and 
cardiovascular physiology of each individual neonate at a specific time with the use of adaptive target 
values for different haemodynamic variables [49]. 
The ideal technique for neonatal haemodynamic assessment is expected to fulfil the following 
conditions: to be non-invasive, easily applicable, practical and inexpensive; to be validated against a 
gold-standard reference method; to be accurate and precise, even under conditions typical of the 
transitional circulation, such as the presence of shunts; and, eventually, to provide continuous 
information [139]. Although a monitoring system that fits all these requirements into one device is 
not available yet, the following techniques meet at least part of these criteria, and all together 
contribute to depict a comprehensive overview of cardiac function, cardiovascular status and end-
target organ perfusion: functional echocardiography, non-invasive cardiovascular monitoring and 
NIRS. These techniques are reviewed in the next section.   
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1.3.2. Non-invasive monitoring techniques 
Colour-Doppler echocardiography  
Since its introduction in the medical field, the diagnostic use of ultrasound has spread universally, 
and Doppler assessment has enabled to examine blood flow velocity within vessels and cardiac 
structures. The Doppler technique is the basis of functional echocardiography, which has achieved an 
important role in neonatal haemodynamic assessment and currently represents the method of choice 
for the non-invasive evaluation of cardiac output in the neonatal population.  
A practical example of the Doppler phenomenon is given by the change in the pitch of sound when a 
vehicle with a siren passes by. When traveling towards, the pitch of the sound is increases as the 
vehicle becomes closer, so the sound appears to have a higher frequency; conversely, the frequency 
appears lower when the vehicle is traveling away. In ultrasound, the shifting reflectors that produce 
the returning signal echoes are red blood cells, and similar shifts in ultrasound frequency occur as the 
blood cells move away from or towards the probe. The extent of the difference between the emitted 
and the received ultrasound frequencies depends primarily on blood flow velocity. The angle of 
insonation of the ultrasound beam also has a great influence on the extent of Doppler shift; hence, 
minimizing this angle is a key step in Doppler measurements. An insonation angle <20° produces 
only a 6% reduction in velocity estimation, and is therefore considered acceptable; for higher angles, 
correction can be made, but for values >60° this process becomes inaccurate. If the blood flow 
direction is orthogonal to the imaging plane, no shift is produced [140]. 
Two different types of spectral Doppler can be used to assess the velocity of blood flow: continuous-
wave (CW) and pulsed-wave (PW). PW Doppler emits a single pulse and then pauses to detect 
received signals. By selecting a timeframe for receiving the data, only velocities from a specific 
spatial range of interest can be measured; therefore, at any given sampling rate there is a maximal 
velocity that can be detected, which is called the Nyquist limit. Above this limit, which is usually set 
a 2 m/s, the Doppler signal aliases and shows an apparent opposite direction of motion; decreasing 
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the imaging depth to increase the sampling frequency, or decreasing the frequency of the ultrasound 
beam can be useful to overcome aliasing [140]. In CW Doppler, two separate crystals simultaneously 
emit and receive signal, and continuous signal transmission detects a wide range of velocities 
anywhere in the line of the ultrasound beam; hence, CW Doppler has no upper limit for velocity 
detection.  
Colour Doppler allows visualisation of the velocity of blood within an image plane, superimposing 
blood flow velocities on a colour scale on the corresponding B-mode image. Velocities moving 
towards the transducer are by convention colour-coded as red, whereas velocities moving away are 
coded as blue. A turbulent flow is characterized by the addition of yellow or green to the pixels, while 
colour reversal represents aliasing at the Nyquist limit. PW Doppler is employed for the computation 
of a colour flow map; given the complexity of the calculation and the high sampling requirement, the 
temporal resolution of colour flow imaging is limited, but this technique remains extremely useful 
for the evaluation of shunts and blood flow in regions of interest. Choosing the proper gain settings 
is the key; for low-velocity signals (e.g., venous returns) it is important to reduce the velocity scale 
to enable proper visualization [140]. 
For the estimation of blood flow, the cross-sectional area of the vessel or structure of interest and the 
velocity of flow by Doppler are needed. The velocity-time integral (VTI) is the area under the Doppler 
spectral curve and represents the distance that a column of blood will travel during 1 heart cycle. 
When the cross-sectional area of the great vessels is known, the stroke volume can be calculated. In 
the case of pulsatile flow pattern, the VTI of the corresponding PW Doppler waveform is the area 
under a velocity time curve and is equivalent to the stroke distance. Multiplying this value for the 
cross-sectional area of interest gives an estimate of stroke volume, from which it is then possible to 
derive cardiac output by multiplying the stroke volume with the heart frequency. Left ventricular 
output (LVO) and right ventricular output (RVO) can be estimated by measuring cross-sectional area 
and Doppler flow velocity in the outflow tract of the left and right ventricle, respectively. In neonates, 
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the estimation of flow volume is subject to significant variability, which mainly derives from the 
estimation of vessel diameters which are squared to estimate area, with the effect that any associated 
errors are also squared. In order to minimize this variability, for longitudinal follow-up of ventricular 
output, if one assumes a constant outflow tract diameter, the minute distance (VTI x heart rate) is less 
prone to error. 
The accuracy of these measurements is subject to a beat-to-beat variability and also depends on the 
angle of insonation and on the quality of the 2D imaging; the optimization of image quality and data 
averaging upon multiple measurements help to minimize errors. When compared to accurate invasive 
reference methods for the determination of cardiac output, such as the Fick method, thermodilution 
technology or phase contrast MRI, the precision of the echocardiographic assessment of LVO shows 
an error around 30%, and is also burdened by relatively high interindividual and intraindividual 
variability [141]. Moreover, it should be taken into consideration that, in the presence of intracardiac 
(e.g., PFO) and transductal shunting, LVO and RVO are not interchangeable: a left-to-right 
transductal shunt will increase LVO, whereas interatrial left-to-right shunting will affect RVO. 
Hence, the discrepancy between the two ventricular outputs can provide additional information on 
the shunt entity. Since the estimation of systemic blood flow towards end-target organs is of most 
interest, LVO always needs to be interpreted in the context of potential shunts across fetal channels. 
In addition to LVO determination, following a set sequence of views with definite anatomic features 
illustrated in Figure 1.11, echocardiography allows a longitudinal assessment of systemic and 
pulmonary blood flow, the ductal status (e.g., patent with a haemodynamically significant or a 
restrictive transductal shunt), the presence of an interatrial shunt and it allows to rule out any 





Figure 1.11. Common echocardiographic windows and views used in neonatal functional 
echocardiography. Abbreviations: LA, left atrium; Mv, mitral valve; RA, right atrium; Tv, tricuspid 
valve; LV, left ventricle; RV, right ventricle; Ao, aorta; RPA, right pulmonary artery; Desc Ao, 
descending aorta; PDA, patent ductus arteriosus. Adapted from El-Khuffash and McNamara, Semin 
Fetal Neonatal Med (2011) [142]. 
 
The list of anatomic structures and haemodynamic measurements that can be obtained from each of 
these echocardiographic views is detailed in Table 1.2.   
 49 
 
Table 1.2. Checklist of anatomic features and haemodynamic measurements from each view using 
different echocardiographic windows. Edited from Groves et al. Ped Res (2018) [140] 
 
View Structure Function 
Subcostal situs view Normal abdominal situs 
Pulsatile descending aorta 
Inferior vena cava/right atrium 
Inferior vena cava filling and 
respiratory variation 
Diastolic flow in descending aorta 
Subcostal atrial view Intra-atrial septum 
Superior vena cava into right atrium 
Pulmonary veins into left atrium 
Filling of cardiac chambers 
Direction of interatrial shunt 
Apical and subcostal 
four-chamber view 
Both ventricles and intraventricular septum 
Opening mitral and tricuspid valves 
Atrioventricular concordance 
Mitral and tricuspid inflow 
pattern, tricuspid regurgitation 
Tissue Doppler and speckle 
tracking 
Ejection fraction from area length  
Apical and subcostal 
five-chamber view 
Pulmomary artery crossing over aorta (to 
exclude transposition) 
Aortic stroke distance (LVO) 
Parasternal long 
axis view 
Normal motion of mitral and aortic valves 
Interventricular septum 
Tricuspid and pulmonary valves 
Aortic and pulmonary valve 
annulus 
Pulmonary stroke distance (RVO) 




Aortic valve morphology and coronary origin 
Pulmonary valve morphology 
Intraventricular septum 
Main pulmonary artery with right and left 
branches 
Ductal patency and size  
Drainage of pulmonary veins into left atrium 
(high parasternal view or “crab view”) 
Septum morphology (flattening) 
Pulmonary stroke distance (RVO) 
Direction, pattern and velocity of 
transductal shunt 
Ductal view Ductal patency and size Direction, pattern and velocity of 
transductal shunt 




In addition to the relatively limited precision in cardiac output assessment, especially in the presence 
of transductal and interatrial shunting, echocardiography requires an intensive operator training and 
does not allow a continuous monitoring of LVO. Despite of the above limitations, however, it 
provides fundamental information on the pathophysiologic causes underlying haemodynamic 
instability, and the integration of functional echocardiography with the clinical picture of the sick 
neonate is of great support in the development of an individualized therapeutic approach and allows 
to monitor the effectiveness of such intervention. 
 
Electrical velocimetry  
Electrical velocimetry (EV), or electrical cardiometry, is a non-invasive monitoring technique of the 
haemodynamic status based on the variations of thoracic electrical conductivity. 
The monitoring of trans-thoracic bioimpedance for the evaluation of haemodynamic parameters had 
been first published in 1949 by Kedrov and Liberman [143] and further developed by Kubicek et al. 
in 1966 [144]. The algorithm has been further modified over the following years, and several 
electrical biosensing monitors are now available that differ in the methodology used to analyse 
changes in electrical impedance. This thesis will focus on EV, which has been developed following 
the modification of the transthoracic bioimpedance algorithm by Bernstein and Osypka in 2003 [145]. 
This technique measures the changes of transthoracic electrical bioimpedance related to the cardiac 
cycle using a set of 4 surface sensors, applied as shown in Figure 1.12. 
A harmless electrical alternating current of constant amplitude is applied via the pair of outer sensors 
to the thorax. As blood is the most conducting tissue in the thorax, there will be a voltage change 
resulting from the movement of blood that occurs during the cardiac cycle, measured using an inner 
pair of  surface ECG sensors. The ratio of applied current and measured voltage equals the 




The measured bioimpedance over time can be expressed as the superposition of three components: 
Z(t) = Z0 + DZC + DZR 
where Z0 is the quasi-static portion of the impedance (also referred to as the base impedance), mostly 
determined by thoracic fluids including the thoracic blood volume, DZR are the changes of impedance 
related to respiration, and DZC are the changes of impedance related to the cardiac cycle. DZR is 
considered an artifact to the estimation of stroke volume and, as such, is suppressed. 
 
Figure 1.12. Placement sites for electrical velocimetry sensors in infants and neonates, as per the 
manufacturer’s recommendations. Adapted from Narula et al. J Cardiothor Vasc An (2017) [146]. 
 
EV is based on the fact that the conductivity of blood flow in the aorta changes during the cardiac 
cycle and ascribes the significant bioimpedance changes occurring shortly after aortic valve opening 
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to the alignment of the erythrocytes at the aortic level (Figure 1.13). When the valve is closed, the 
electrical current applied circumferences the red blood cells, resulting in a higher voltage 
measurement and lower conductivity. Very shortly after aortic valve opening, due to their mechanical 
properties, the disc-shaped red blood cells are forced to align in parallel with the blood flow: now the 
electrical current passes through red blood cells more easily, resulting in a lower voltage measurement 
and thus higher conductivity. The change from a random orientation of red blood cells to their 
alignment upon opening of the aortic valve determines a characteristic increase of conductivity, which 




Figure 1.13. Electrical velocimetry analysis of the rate of change in conductivity and ECG signals 
before and after aortic valve opening. Abbreviations: AoV, aortic valve; dZ(t), conductivity; ECG, 
electrocardiogram; LVET, left ventricular ejection time. Adapted from Narula et al. J Cardiothor 
Vasc An (2017) [146]. 
 53 
 
The beginning of flow time (left ventricular ejection time) and the peak acceleration of the aortic flow 
and the end of flow time, which corresponds to the closure of the aortic valve, are then identified and 
used to derive stroke volume (SV), HR and additional haemodynamic parameters, including left 
cardiac output (CO). Moreover, the steeper the slope of the conductivity, the quicker the alignment 
process and, thus, the higher the heart contractility. A full list of EV-derived haemodynamic 
parameters is shown below. If non-invasive MABP and central venous pressure values are inputted 
into the device, it is also possible to derive SVR. 
The agreement between CO measured by transthoracic echocardiography and by EV has been 
previously evaluated by Noori et al. in healthy term neonates during the transitional period, who 
reported an acceptable agreement and precision between the two techniques [147]. Similar results 
have been reported by Grollmuss et al. in term neonates after an arterial switch operation [148]. The 
same authors also compared the agreement between CO measured with the two techniques in low and 
very-low-birth-weight preterm infants, indexing SV and CO for the body weight; according to their 
findings, the limits of agreement fell within the 30% criterion for method interchangeability [149]. 
Despite of an overall good agreement, a trend towards a CO overestimation by EV at high CO values 
in the preterm population has been documented in two studies [150,151]; consistent with these 
findings, van Laere et al. reported increased EV measurements of CO in preterm infants with a 
haemodynamically significant PDA, compared to those with small or no PDA [152]. 
However, when evaluating this literature, it should be taken into account that transthoracic 
echocardiography does not represent the absolute gold-standard for CO calculation, due to the 
previously mentioned inter- and intraobserver variability and its suboptimal precision compared to 
real gold-standards for CO assessment (i.e., Fick principle-based or indicator dilution technologies). 




Near-infrared spectroscopy  
Adequate oxygenation can be defined as a balanced equilibrium between oxygen delivery and 
consumption at systemic and regional levels. The impairment of blood flow and of subsequent oxygen 
delivery in vital organs is among the major causes underlying morbidity and mortality in critically ill 
patients of all ages. Accurate circulatory assessment, monitoring both the macro- and 
microcirculation, could prevent clinical complications related to ischaemia and hypoxia [153]. NIRS 
allows to estimate regional tissue oxygenation, which is a proxy of regional blood flow, and tissue 
oxygen extraction, if simultaneous monitoring of arterial oxygen saturation is performed. 
In the 1940s, infrared light started to be used for the development of pulse oximeter, which, by 
providing a non-invasive assessment of arterial oxygenation and allowing the detection of global 
hypoxic states, marked a turning point in the history of intensive care [154]. Nevertheless, it was only 
in the late 1970s that the same physical principle was refined into a monitoring technique able to 
assess the regional concentration of oxygenated and deoxygenated haemoglobin within different 
tissues and to examine its changes over time, thus providing an estimate of local oxygen delivery and 
consumption [155]. 
NIRS is a spectroscopic technique which exploits the optical properties of biological tissues, namely 
the wavelength-dependent absorption and scattering coefficients (defined as the mean number of 
absorption and/or scattering events per unit length a photon travels), in order to obtain clinically 
relevant information such as regional oxygen saturation, extrapolated from the concentration of 
oxygenated (HbO2) and deoxygenated haemoglobin (dHb).   
The physical principle on which NIRS is based is the modified Beer–Lambert law [156]. This 
principle relates the attenuation of light to the properties of the tissue through which the light is 
traveling according to the following equation:  
A=log10 (I0/I)= µa * c * r * x+K 
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where A is the attenuation, I0 the incident photon wavelength, I the detected photon wavelength, µa 
the wavelength-dependent absorption coefficient, c the chromophore concentration, r the source-
detector separation distance, x the path-length factor (length travelled by I0, tissue-specific value), 
and K the photon absorption constant. Since K is assumed constant during the measurement period, 
it is possible to determine the changes in concentration of the chromophore from the measured 
changes in attenuation.  
NIRS uses light in the near infrared range (wavelength 700–1000nm). Unlike visible light, which is 
strongly absorbed by haemoglobin, and infrared light, strongly absorbed by water, near-infrared light 
is relatively ‘transparent’ in biological tissues; while the concentration of the chromophores such as 
myoglobin, melanin and bilirubin remain constant, haemoglobin absorbs near infrared light in a 
manner dependent on its oxygenation state [157,158] (Figure 1.14). In order to optimize the 
wavelength-dependent absorption characteristics of haemoglobin, current commercial NIRS devices 
are commonly set between 700-850nm. At 800 nm, HbO2 and dHb absorption coefficients are 
overlapping; hence, the photons emitted at this wavelength allow the assessment of total haemoglobin 
concentration within the tissue examined, from which it is possible to estimate the local blood volume 
[159]. Because of the larger proportion of blood contained in the lumen of venous vessels, venous 
haemoglobin accounts for the greatest degree of photon absorption (80-85%), whereas arteries and 
capillaries account for 15-20% and 5%, respectively [160]. 
Within biological tissues, photons can be absorbed or scattered; multiple scattering events results in 
a ‘diffuse’ path taken by the photons. Relative to absorption, scattering is the main event when light 
enters tissue and so diffusion (quantified by the tissue-specific scattering coefficient μs) is the main 
determinant for the photon path and for the time the photon takes to be detected. While passing 
through a few centimetres of biological tissue, photons can be subjected to thousands of scattering 
events that stochastically govern their trajectory; as a consequence, the photon path is irregular and 




Figure 1.14. Absorption spectra for oxygenated haemoglobin (HbO2), deoxygenated haemoglobin 
(dHb), and water. As highlighted in the square, at 800 nm HbO2 and dHb absorption coefficients are 
overlapping. Adapted from Martini and Corvaglia, J Perinatol (2018) [161]. 
 
 
Figure 1.15. Example of photon trajectory through biological tissue. S=source; D = detector; ρ = 
source-detector distance. The shaded part highlights the “banana-shaped” area crossed by the 
photon. Adapted from Martini and Corvaglia J Perinatol (2018) [161]. 
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There are several approaches to the measurement of light in biological tissues, two of which are 
described below: 
• Time-resolved: the system measures the flight time of transmitted photons from the source to 
the detector. There are a number of theoretical advantages of this technique over other 
approaches: it is less susceptible to movement artefact, it is possible to obtain absolute 
quantitation of chromophore concentration and by obtaining data of photon flight times across 
the head it is possible using multiple sources and detectors it is possible to reconstruct 3D 
images of blood volume and oxygenation (optical tomography) [162]. Using optical 
tomography it has been possible to obtain images of IVH in a preterm infant and functional 
response to passive motor movement in a newborn infant [163,164]. 
• Spatially-resolved: by using a single light source and multiple closely spaced detectors, 
spatially-resolved NIRS is able to resolve scattering to a fixed constant enabling an absolute 
assessment of the ratio of HbO2 to total haemoglobin, expressed as the percentage of oxygen 
saturation [165]. The commercial NIRS oximeters most commonly used in current clinical 
practice belong to this category, included that used in the present research project (NIRO 
200NX, Hamamatsu Photonics K.K., Japan). The light source of this oximeter emits near-
infrared light at three different wavelengths and is coupled with a set of two detectors and, as a 
general rule, the photons emitted cross a so-called “banana-shaped” area and their depth of 
penetration directly correlates with the source-detector distance rho (Figure 1.15) [166]. 
The NIRO 200NX provides a percentage value of mixed cerebral oxygen saturation, known as 
the tissue oxygenation index (TOI), and a normalised value for total haemoglobin concentration 
(normalized tissue haemoglobin index (nTHI) as well as conventional spectroscopic 
measurements of change in HbO2, Hb and total haemoglobin. However, different oximeters use 
different nomenclatures for mixed tissue oxygenation, and also different algorithms for deriving 
the values. As an example, the percentage of mixed tissue oxygenation is defined as regional 
oxygen saturation (rSO2) by INVOS oximeters (Somanetics/Covidien, Mansfield, MA, USA). 
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TOI calculation is derived from a modification of the radiative transfer equation for photon diffusion 
in biological tissue. By estimating the local gradient of attenuation with respect to each source-
detector separation and then differentiating A(r) with respect to r, yields the relation: 
 
 
In the first order approximation the scatter coefficient (μs’) can be treated as a constant (k) with respect 
to the wavelength, therefore the relative concentrations of oxygenated (HbO2) and deoxygenated 
haemoglobin (dHb) can be obtained (k.HbO2 and k.dHb, respectively) and resolved to the desired depth. 
As a result, TOI can be calculated as the ratio of [HbO2] to total haemoglobin: 
 
TOI (%) =        [HbO2]___ . 100 
             [HbO2]+[Hb] 
 
When NIRS monitoring is combined with simultaneous monitoring of peripheral arterial oxygen 
saturation (SpO2), it is possible to calculate the fractional tissue oxygen extraction (FTOE) of the 
investigated tissue according to the following formula [167]: 
 
FTOE (a.u.) =  [SpO2- TOI] . 100 
               [SpO2] 
 
FTOE reflects the balance between oxygen delivery and oxygen consumption at a tissue level. 
Increased values may indicate a higher level of oxygen consumption than oxygen delivery or, if the 
tissue oxygen consumption is assumed to be constant, may indicate a reduced tissue oxygen delivery. 
Decreased FTOE values may, on the other hand, reflect a reduction in tissue oxygen extraction due 




The first report on the use of NIRS to investigate cerebral haemodynamics and oxygenation in 
neonates with perinatal asphyxia dates back to 1985 [168]. The brain has been the organ most 
extensively explored by NIRS in infants and neonates, especially in conditions at risk of hypoxic 
brain damage and related neurological sequelae, such as cardiac surgery [169,170], perinatal asphyxia 
[133,171] or during the enhanced haemodynamic instability that characterizes the first days of life 
[172,173]. The interest in the use of cerebral NIRS monitoring in the context of postnatal transition 
the has led to the proposal of reference curves for cerebral oxygenation and FTOE during the first 72 
hours, specific for different gestational ages [174]. These curves depict the dynamic features of 
cerebral haemodynamics during this postnatal transition. However, a limitation to the applicability of 
these curves is related to the use of single-brand devices (INVOS oximeters) and of small adult 
sensors for cerebral NIRS monitoring. A comparison with neonatal sensors, performed within the 
same study on a small number of infants (n=16), has revealed that the measurement discrepancy 
between the two sensor types can be as high as 15%. As discussed later in this section, different 
oximeters are associated with significant reading discrepancies. 
NIRS provides continuous real-time information and is easily applicable even in the smallest preterm 
infants, where its use has shed light on the cerebral haemodynamic fluctuations involved in the 
pathophysiology of neurological complications of preterm birth. For example, specific CBF changes 
characterized by a preliminary ischemic-hypoxic phase, followed by a transient hyperperfusion, have 
been described as likely haemodynamic antecedents of IVH development [120,175]. Moreover, a 
greater burden of cerebral hypoxia during the first 48-72 hours after preterm birth have been observed 
in preterm infants who developed IVH during the transitional period [176,177]. The change between 
hypoxia-ischaemia and reperfusion is also thought to be involved in the development of PVL [126].  
Early NIRS monitoring has also provided important findings also in relation to neurodevelopmental 
outcomes in at-risk neonates. In particular, the haemodynamic changes documented with the 
intraoperative use of NIRS in infants undergoing cardiac surgery were found to be associated with 
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poor neurodevelopment at 12 months [178]. Similarly, preterm infants with low cerebral oxygenation 
during the transitional period or over the first weeks of life showed a poorer psychomotor outcome 
within their first 3 years of life [179–181]. 
The introduction of NIRS in neonatal care to investigate cerebral haemodynamics has been an 
essential landmark to obtain longitudinal haemodynamic information in the investigation of the 
physiological mechanism of cerebral autoregulation. The mixed tissue oxygenation measured by 
NIRS is highly advantageous to the study of cerebral tissue oxygenation, as it reflects the amount of 
oxygen in the arterial, capillary and venous bed. As venous blood is the largest component, the 
cerebral tissue oxygen saturation equates most with mixed venous saturation. This is determined by 
cerebral oxygen delivery (a product of CBF, SaO2 and Hb) and cerebral oxygen metabolism [75]. 
Assuming stable cerebral metabolism, SaO2 and [Hb], the changes occurring in cerebral oxygenation 
likely result from fluctuations of CBF [182]; hence, cerebral oxygenation can be considered a proxy 
for CBF and accordingly used for the evaluation of cerebral autoregulation and cerebrovascular 
reactivity. Details on the mathematical models adopted to assess these parameters and the related 
findings are provided in section no. 1.2.1. 
However, when interpreting NIRS data, the following possible limitations should also be considered. 
1. The accuracy and precision of NIRS measurements is questionable: although parts of the body 
are affected by a greater variability, cerebral oxygenation is not exempt of a noticeable within-
subject variability [183,184], and slight shifts of the sensor placement may result in significant 
cTOI variations.  
2. Comparability and reproducibility of measurements between different NIRS monitors 
represent an additional weakness of this technology. A 3-10% difference between the NIRO 
and INVOS instruments, with the NIRO reading lower, has been previously reported in 
several studies [185,186], whereas the Fore-Sight (CAS Med.Medical Systems, Brandord, 
Connecticut, USA) and SenSmart X-100 (NONIN Medical, Plymouth, Minnesota, USA) have 
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shown significantly higher values of cerebral oxygenation than the NIRO and INVOS [186], 
with increasing discrepancies at low cerebral oxygenation levels, suggesting an oxygen-level-
dependency of the reading sensibility [186]. One of the leading reasons that underlies these 
discrepancies is the use of different mathematical algorithms of signal processing by different 
manufacturers to calculate oxygen saturation, and the lack of a calibration standard. 
Furthermore, different technical calibrations likely underlie the significant differences 
observed between adult and neonatal NIRS sensors [174,187]. 
It is possible that, despite the long use of cerebral NIRS monitoring in neonatal research, this large 
technical and methodological heterogeneity has hindered the ability to draw definite conclusions 
about its role in routine clinical practice. In order to be truly effective, a monitoring system must not 
only alert the clinician about a potential clinical deterioration, but the availability of effective 
intervention, which would ideally improve short-term and long-term outcomes, is also required [188]. 
In this regard, the European collaborative group named SafeBoosC (Safeguarding the Brains of our 
smallest Children) designed a set of randomized control trials aimed to evaluate the effective 
usefulness of cerebral NIRS in extremely preterm infants during the transitional period. The principal 
hypothesis being tested is whether continuous cerebral oximetry measurements with NIRS can reduce 
the burden of cerebral hypoxia and hyperoxia in these infants, and an evidence-based treatment 
guideline was developed to be applied if cerebral oxygenation was out of range. This group has 
completed a phase II randomized controlled trial of continuous cerebral NIRS monitoring during the 
first 72 h of life (experimental), compared with blinded NIRS monitoring with standard care (control) 
[189]. In the experimental group, the mean burden of hypoxia was significantly reduced compared 
with controls, demonstrating that cerebral oxygenation can be stabilized by the routine application of 
cerebral NIRS monitoring in combination with a dedicated treatment guideline [190]. Although an 
association between the early burden of cerebral hypoxia, but not of hyperoxia, and severe intracranial 
haemorrhage has been observed at an explorative analysis [177], the ultimate goal would be to 
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demonstrate improved survivals without neurological impairment in association with this approach. 
In this regard, a randomized multicentric clinical phase III trial with a primary outcome of death or 
severe brain injury and secondary outcome of death or moderate-severe neurodevelopmental 




1.3.3. Values and pitfalls of currently available techniques 
Theoretically, the validation of a monitoring system that matches together multiple techniques aimed 
at investigating different aspects of neonatal haemodynamics would provide valuable information for 
a better understanding of the underlying physiology in sick and at-risk neonates. In particular, 
functional echocardiography, by evaluating cardiac function and anatomy, enables assessment of 
normal cardiac structure, ruling out possible heart defects, is able to assess the effectiveness of cardiac 
contractility, confirm the presence of a PDA and its haemodynamic impact and to assess the entity of 
potential shunts at different levels. By providing continuous assessment of CO, cardiac contractility 
and SVR, EV may be useful to identify an early impairment of the haemodynamic status and the 
possible underlying cause. Since normal cardiac output does not necessarily imply adequate end-
organ perfusion, the inclusion of NIRS in this comprehensive monitoring system contributes to the 
detection of perfusion impairment at a regional level, that may occur before or even without a 
concomitant reduction of global blood flow. When cardiac output is impaired, the evaluation of end-
target perfusion also provides valuable information in regard of the severity of this impairment and 
of its effects at a regional level. 
If used simultaneously and in an integrated manner, the combination of NIRS, EV and functional 
echocardiography may help to shed light on the haemodynamic mechanisms underlying specific 
pathophysiological conditions typically associated with preterm birth, such as IVH or PVL 
development, or on the haemodynamic consequences of perinatal hypoxia-ischaemia at different 
levels. Besides, a more extensive use of this comprehensive system to monitor the effects of 
cardiovascular therapies may aid to assess its potential usefulness in the therapeutic haemodynamic 
management. 
This system, however, is not exempt of a number of potential biases. As stated before, the techniques 
that are currently available for a continuous haemodynamic monitoring in infants and neonates are 
 64 
 
burdened by specific limitations; in particular, the accuracy and reproducibility issues of the provided 
measurements contribute to hinder the applicability of these techniques in clinical decision making. 
When the current literature based on the combination of NIRS and echocardiography is evaluated, 
the following considerations needs to be made. The use of data averaging over prolonged time 
intervals for the evaluation of continuous parameters might overlook time and frequency fluctuations 
of potential clinical relevance. Although functional echocardiography is considered by many the 
current gold-standard methodology for the non-invasive evaluation of cardiac output in neonatal 
settings, it does not allow a continuous assessment of dynamic cardiovascular parameters [192] and, 
as such, it may be blind to relevant haemodynamic fluctuations occurring between one evaluation and 
the next. In this regard, the translation of non-invasive cardiac output monitoring techniques into 
neonatal settings represents a landmark towards the development of a continuous monitoring system 
that matches together cardiovascular and regional haemodynamics, monitored with NIRS. 
However, it should be borne in mind that the approach of validating EV against echocardiographic-
derived estimations of CO is questionable, due to the imprecision of transthoracic echocardiography. 
CO using echocardiography is derived by the assumption of a perfect round shape of the outflow tract 
which hinder the exact measurement of the cross-sectional area, the variability related to the angle of 
insonation, the inaccuracy of tracking the Doppler velocity envelope for VTI assessment and the 
effects of potential shunts [13]. Hence, targeted studies evaluating the agreement between non-
invasive techniques for continuous haemodynamic monitoring and invasive gold-standard methods 
are warranted to adequately define their effective accuracy in the determination of central blood flow. 
While waiting for such evidence, EV represents a helpful tool for continuous trend monitor over time 
and its data can be matched with NIRS-derived trends to correlate ongoing haemodynamic changes. 
Furthermore, the cardiovascular parameters obtained by EV are not limited to CO, but also include 
an estimate of SV, cardiac contractily and SVR, which are very important to obtain a broader 
evaluation of the neonatal haemodynamic status, especially during the transitional period. Despite the 
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potential of these measurements, these additional parameters have not been largely explored in 
neonatal settings [193–197] and thus warrants to be the objective of further targeted research. 
It has been recently shown that a comprehensive haemodynamic approach, integrated with clinical 
assessment, reduced the clinical recovery time in preterm infants with a compromised haemodynamic 
status [198,199]. However, it must be underscored that it is not the sole monitoring that will improve 
outcome, but it is rather the appropriateness of the interpretation of the obtained haemodynamic 




2. AIMS AND HYPOTHESES 
This present research project was developed with the aim to add further knowledge on the 
cardiovascular and cerebrovascular physiology of preterm infants during postnatal transitional, 
explored using a non-invasive system of integrated multiparametric monitoring.  
The preterm infant is exposed to a number of antenatal, perinatal and postnatal factors (the exposome) 
which interact with transitional haemodynamics. A better understanding of these interactions will 
facilitate the development of individualized haemodynamic approaches that are based on specific 
characteristics of each infant, with possible implications for the outcomes of this delicate population. 
A core hypothesis for the present research was that the haemodynamic status of preterm infants during 
the transitional period varies dynamically over time, and that the early exposome may exert a 
significant influence on cardiovascular and cerebrovascular haemodynamic parameters and on their 
interactions during this phase. This hypothesis was developed at 3 levels (discussed in more detail 
below): haemodynamic cardiovascular and cerebrovascular parameters; dynamic interactions 
existing between two different haemodynamic parameters (i.e., cardiac output determinants); 
dynamic fluctuations of the haemodynamic parameters in response to brief and brisk variations of 
vital parameters (i.e., the so-called cardio-respiratory events). 
Two innovative methodological elements were introduced in this research project. First, the 
combination of a totally non-invasive and continuous haemodynamic monitoring system with 
echocardiography, which is largely validated for the evaluation of neonatal haemodynamic but allows 
only intermittent evaluation. Second, the use of a sophisticated bedside software tool, described in 
detail in paragraph 3.3, which ensured simultaneous recording and integrated analysis of the multiple 
parameters obtained with the different devices. The perfect signal synchronization guaranteed by this 
software allowed the calculation of complex inter-parametric correlations, such as a non-invasive 
biomarker of cerebrovascular reactivity. 
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Using this methodological approach, the present dissertation aimed to test the following hypotheses:  
 
Hypothesis I: Cardiovascular and cerebrovascular parameters of preterm infants during postntatal 
transition are subjected to parameter-specific variations over time. Moreover, the antenatal, perinatal 
and postnatal factors to which preterm infants have been exposed exert factor-specific influences on 
cardiovascular and cerebrovascular haemodynamics during the transitional phase (Chapter 4). 
 
Hypothesis II: The relationship between CO and its two direct determinants (namely, SV and HR) 
is not linear, but varies at different SV and HR ranges and according to relevant haemodynamic 
characteristics of the preterm infant during the transitional period (Chapter 5). 
 
Hypothesis III: The cardiovascular and cerebrovascular haemodynamic response to cardio-
respiratory events during the first 72 hours of life is determined not only by the event features, but 






3.1. Ethics, Patients and Settings 
This research project was conducted in conformity with principles and regulations of the Helsinki 
Declaration. The study protocol was approved by the Ethics Committee of St. Orsola-Malpighi 
Hospital, Bologna, Italy (protocol no. 328/2017/O/Oss). Written informed consent was obtained from 
the parents/legal guardians of each infant. The infants’ enrolment was performed between March 
2018 and September 2020.  
Infants with a GA <32 weeks and/or a birth weight <1500 g, admitted to the Neonatal Intensive Care 
Unit (NICU) of S. Orsola-Malpighi were consecutively enrolled in this observational prospective 
research within the first 12 hours of life. Major congenital malformations, including congenital heart 
disease, and antenatal diagnosis of genetical abnormalities were exclusion criteria. Infants with 
conditions that may have had influenced cerebral oxygen saturation, such as anaemia [201] (defined 
as haematocrit <30%) or persistent pulmonary hypertension requiring inhaled nitric oxide [202] were 
also excluded from the study. 
For each infant, the following antenatal and perinatal data were collected: 
• GA; 
• weight, length and head circumference at birth; 
• antenatal steroids (complete course vs. incomplete course or not given); 
• antenatal status of Doppler velocimetry (normal vs. evidence of absent or reversed end-
diastolic flow [AREDF] in the umbilical artery and/or ductus venosus) and pulsatility index 
in the middle cerebral artery (MCA-PI, normal vs. below the 5th percentile, which indicates 
the occurrence of the brain sparing phenomenon) [203]; 




During the study period, the following clinical data were also recorded:  
• status of ductus arteriosus (see “Echocardiographic evaluation” paragraph for the used 
definitions); 
• development of IVH and related timing (see “Cranial ultrasound evaluation” paragraph for 
the used definitions); 
• type of respiratory support (mechanical ventilation, continuous positive airway pressure 
[CPAP], nasal cannula or self-ventilating in air [SVIA]) and related modifications; 
• systolic, diastolic and mean arterial blood pressure values, measured at regular intervals (i.e., 
from 30’ to 6-hourly) throughout the study period using the oscillometric technique; 
• need for cardiovascular drugs (dopamine and/or dobutamine), dosage and treatment duration; 
• haemoglobin levels from the blood exams routinely performed during the study period; 
• development of sepsis and/or necrotizing enterocolitis during the study period.  
 
3.2. Ultrasound evaluation 
Cranial ultrasound  
A cranial ultrasound scan (CrUSS) was performed using an ultrasound scanner CX50 (Philips 
Healthcare) and a convex 8-5 MHz transducer through the anterior, mastoid and posterior fontanelle. 
The first CrUSS evaluation was carried out at the time of enrolment and repeated 6-12 hourly in the 
presence of PDA or if an incipient IVH was noted, otherwise 12-24 hourly. CrUSS was mainly aimed 
to rule out ultrasonographic brain abnormalities and to detect IVH development as well as its 
localization (mono/bilateral) and severity (classified according to Volpe’s grading) [118]. In the 
presence of a PDA, the blood flow velocity in the anterior cerebral artery (ACA), accessed from the 





A screening echocardiogram aimed at ruling out cardiac defects and at evaluating cardiac 
contractility, LVO and the ductal status was routinely performed at the time of enrolment using an 
ultrasound scanner CX50 (Philips Healthcare) with a linear 12-MHz probe, and repeated 6-12 hourly 
in the presence of a PDA, or 12-24 hourly if there was no evidence of PDA. The ductal diameter was 
measured from the high parasternal view at the point of maximum constriction, caring to avoid 
colour-Doppler interference outside the vessel wall. The ductal flow pattern was evaluated from the 
parasternal short axis using continuous-wave Doppler and, based on the ratio of end-diastolic to peak-
systolic velocity, was defined as pulsatile (≥0.5) or restrictive (<0.5) [204]. The left atrium to aortic 
root (LA:Ao) ratio was measured on M-Mode scans from the parasternal long axis view, using the 
leading-edge-to-leading-edge technique. Flow velocity in the descending aorta (DAo) was measured 
using pulsed-wave Doppler from low subcostal sagittal view. Flow velocity in the ACA was measured 
as previously described.  
Based on these echocardiographic features, the ductal status was classified as follows: hsPDA 
(pulsatile shunt pattern and LA:Ao ratio ≥1.5 and/or evidence of reversed end-diastolic flow in the 
DAo or ACA) [152]; restrictive PDA (restrictive shunt pattern and LA:Ao ratio <1.5); no evidence 
of a PDA.  
LVO was also calculated according to the formula [(left ventricular outflow VTI) x (HR) x (left 
ventricular outflow cross-sectional area)] and indexed to body weight [205]. The left ventricular 
outflow diameter was measured from the parasternal long axis view using the leading-edge technique 
between the hinges of the aortic valve, whereas VTI was estimated sampling the left ventricular 
outflow tract from an apical five-chamber view with pulse-waved Doppler, applying the insonation 





3.3. Non-invasive multiparametric monitoring and ICM+ software 
Non-invasive multiparametric monitoring 
The enrolled infants underwent a continuous, non-invasive multiparametric monitoring using near 
infrared spectroscopy, pulse oximetry and electrical cardiometry. The monitoring was commenced 
within 12 hours after birth and continued up to 72 hours of life. In the case of persistence of 
haemodynamic instability or of echocardiographic evidence of a hsPDA after 72 hours of life, the 
monitoring was carried on until the achievement of a stable haemodynamic condition or until a 
restrictive PDA pattern or ductal closure were obtained. 
The list of the devices used for the multiparametric monitoring and of the parameters that were 
continuously recorded from each device is detailed below:  
• Near-infrared spectroscopy: cerebral tissue oxygenation index (cTOI) was detected using a 
NIRO-200NX oximeter (Hamamatsu Photonics K.K, Japan), set on a 1Hz sampling rate, with 
disposable neonatal sensors placed on the central forehead.  
Using the ICM+ software (see paragraph below), continuous values of cerebral fractional 
oxygen extraction (cFTOE) were calculated from peripheral arterial oxygen saturation (SpO2) 
and cTOI values according to the following formula: cFTOE = (SpO2 − cTOI)/SpO2 [167]. 
• Electrical velocimetry: an ICON® device (Osypka Medical Inc., Berlin, Germany), whose 
sampling frequency was set on the beat-to-beat option, was used for non-invasive 
haemodynamic monitoring of the following cardiovascular parameters: heart rate (HREV, 
bpm), stroke volume (SV, ml/kg), cardiac output (COEV, ml/kg/min), index of contractility 
(ICON), systemic vascular resistance (SVR, dyn.s/cm5/m2). Neonatal Cardiotronic Sensors™ 
(Cardiotronic, Osypka Medical Inc., Berlin, Germany) were placed as in Figure 1.12, 
according with the manufacturer’s recommendations [146]. 
• Pulse oximeter: heart rate (HRPO) and SpO2 were detected using a pulse oximeter Masimo 
Radical-7 (Masimo Corporation, Irvine, CA, USA), whose averaging time was set at 2-sec. 
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Masimo neonatal disposable sensors (Masimo Corporation, Irvine, CA, USA) were placed in 
the right hand.  
 
ICM+ software 
ICM+® (https://icmplus.neurosurg.cam.ac.uk, Cambridge Enterprise, UK) is a pioneering clinical 
research software solution that offers high-resolution data collection and real time analysis from 
multiple bedside monitoring sources, facilitating personalised medicine. This software have been 
used for over 25 years of clinical research in intracranial dynamics and intensive care of traumatic 
brain injury [206], becoming a hub for a worldwide scientific network in brain monitoring.  
During this period, the application of the ICM+ software has been successfully extended to neonatal 
haemodynamic research. In particular, by calculating the correlation between MABP and CBF, this 
software enables real time information on cerebral autoregulation to be displayed at the bedside. In 
recent research using ICM+, a non-invasive index of cerebrovascular reactivity (TOHRx) has also 
been described [101]. TOHRx is known as the tissue oxygenation-heart rate reactivity index, and 
describes cerebral vascular reactivity using the correlation coefficient between slow waves of cerebral 
oxygenation and the heart rate, with positive TOHRx values indicating impaired cerebrovascular 
reactivity. Using this software, the MABP range where cerebrovascular reactivity is strongest has 
been calculated [207]; the authors observed that preterm infants who died or had worse IVH presented 
with a higher mean absolute deviation from optimal MABP than those who survived. 
In the context of this research project, a collaboration agreement was made with the Brain Physics 
Laboratory, Department of Neuroscience of the Cambridge University (Cambridge, UK) for the 
licenced use of the ICM+ software for data collection and analysis.  The period between November 
2017 and February 2018 was dedicated to the technical set-up of the electronic interfaces needed to 
connect the ICM+ software with the previously listed devices used for the research project. 
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The monitoring devices of the enrolled infants were connected via a RS232 cable to a laptop running 
the ICM+ software which, as illustrated in the laptop screenshot of Figure 2.1. recorded all the 
obtained parameters continuously and simultaneously throughout the whole monitoring duration.  
 
Figure 2.1. Example screenshot of a real-time ICM+ recording during one of the monitoring periods.  
 
After the recording was completed, the ICM+ traces were retrospectively inspected. Time periods 
showing signal interruptions or a HR discrepancy >20% between pulse oximeter and electrical 
velocimetry were considered as likely artefacts and, as such, were ruled out from data analysis. 
Moreover, during the monitoring the nursing staff was provided with a diary where to annotate dates 
and times of handling, cares or invasive procedures. The monitoring epochs associated with the 






3.4. Statistical analysis 
Statistical analysis was performed using IBM SPSS, version 26 (IBM Corp. Released 2019. IBM 
SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp) and Stata software, version 15 
(StataCorp, 2017, Stata Statistical Software: Release 15, College Station, Texas, USA: StataCorp 
LP). 
Data distribution was evaluated using the Shapiro-Wilk test for normality. Depending on the 
distribution, either parametric or non-parametric tests were used. Continuous variables were 
expressed as median (interquartile range [IQR]) or mean (standard deviation [SD]) as appropriate, 
whereas categorical variables were summarized as frequencies and percentages. A statistical test was 
considered significant if P value was < 0.05 (two-tailed) for all the data included in this dissertation. 
The specific statistical methods used in each study included in this thesis are described in detail in 




4. TEMPORAL PATTERNS AND CLINICAL DETERMINANTS OF 
CARDIOVASCULAR AND CEREBROVASCULAR HAEMODYNAMICS 
DURING THE TRANSITIONAL PERIOD 
4.1. Introduction and aim 
The transition from intrauterine to extrauterine life represents a critical phase of physiological 
adaptation, which impacts on several organs and systems. Due to the cardiovascular and respiratory 
immaturity of premature infants, the first 72 hours of life are often characterized by significant 
haemodynamic instability [208,209] and by impaired cerebral autoregulation [210], which have been 
implicated in the pathophysiology of brain injury [47,120,121,175,211]. 
A deeper knowledge of in-vivo cardiac and brain haemodynamics during the post-natal transition, 
and in particular how cardiovascular and cerebrovascular parameters change over time would bring 
valuable information for the management of the preterm population during this delicate phase. 
Moreover, whether specific conditions that characterize the clinical status of each individual infant 
exert a relevant influence on these parameters will help inform the ultimate goal of developing 
individualized approaches for monitoring, treatment and care. 
Much of the physiological data currently available on transitional haemodynamics are based on pre-
clinical or in-vitro experiments, whereas clinical evidence mainly relies upon intermittent techniques 
of haemodynamic assessment (e.g., functional echocardiography) or require invasive monitoring 
approaches (e.g., cerebral autoregulation assessment using continuous BP monitoring). We developed 
an integrated multiparametric monitoring system to investigate the haemodynamic changes occurring 
at a cardiovascular and cerebral level, including the evaluation of cerebrovascular reactivity, over the 
first 72 hours of life. As this monitoring is totally non-invasive, it was possible to extend this 
comprehensive evaluation to preterm infants.  
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The research objective addressed in this section aimed at defining the temporal patterns and main 
clinical determinants of cardiovascular and cerebrovascular parameters, measured non-invasively and 
continuously during the first 72 hours of life. 
 
4.2. Methods and Statistics 
Methods  
Patient recruitment, ultrasound evaluation and data collection, including the multiple parameters 
obtained by non-invasive multiparametric monitoring, are described in detail in Chapter 3. 
Using the ICM+ software, after the removal of time intervals with evidence of major artifacts, values 
of cTOI, cFTOE, COEV, HREV, ICON and SVR were averaged over 24-h periods (i.e., one value per 
each day of life) and used for statistical analysis. 
For periods where the proportion of missing data <50%, the moving correlation coefficient between 
cerebral oxygenation and heart rate (TOHRx) was retrospectively calculated with the ICM+ software 
using 5-min time windows between 10-s average values of cTOI and HR (Figure 4.1), as previously 
described [101]. The ICM+ traces of each enrolled neonate were visually inspected, and the best 
quality signal among HREV and HRPO was used for the calculation.  
The physiological rationale of TOHRx is based on fact that in premature neonates HR is the main 
determinant of cardiac output, whereas the use of a 5-min window for TOHRx calculation has its 
rationale in the physiology of slow brain waves detected by NIRS. Zero or negative TOHRx indicate 
that CBF does not depend on total blood flow, which means that brain vasculature is able to self-
regulate CBF. Positive TOHRx values, on the other hand, indicate that CBF is dependent on total 
blood flow, and therefore cerebrovascular reactivity may be impaired. This marker has been 
previously used to investigate the individual optimal values of MABP at which cerebral 






Figure 4.1. ICM+ screenshot illustrating the calculation of the moving correlation coefficient (R) between cerebral oxygenation (cTOI) and the heart 
rate (HR), defined as TOHRx. 
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Statistical analysis 
Data distribution was evaluated using the Shapiro-Wilk test for normality. Continuous variables were 
expressed as median (IQR) or mean (SD) as appropriate, whereas categorical variables were 
summarized as frequencies and percentages.   
Since cTOI, cFTOE, COEV, HREV, ICON and SVR did not follow a normal distribution, to account 
for repeated measurements on each subject, generalized linear mixed-effects models (GLMMs) using 
the days of life (day 1, 2 and 3) as within-subject repeated measures were used to evaluate time trends 
and the effect of relevant clinical factors on each outcome parameter. Fixed-effects hypothesis was 
tested using Satterthwaite’s small-sample adjustment. Sequential Bonferroni adjustment was applied 
for multiple comparisons. Intercepts at the patient level constituted the random part of model, 
assuming equal variances and null covariances (scaled identity). 
TOHRx followed a normal distribution; therefore, to account for repeated measurements on each 
subject, a linear mixed-effects model (LMM) was developed to analyse its time trends and the effect 
of relevant clinical factors. Fixed-effects hypothesis testing, multiple comparisons adjustment 
methods, random-component specification and covariance structure were the same as those of the 
previously described GLMM models. 
To improve the LMM and GLMMs sensitivity, those variables whose status changed over time, such 
as MABP values, the ductal status (closed, restrictive or haemodynamically significant), dopamine 
(ongoing or not), dobutamine (ongoing or not) and the mode of respiratory support were handled as 
time-dependent covariates. Since both LMMs and GLMMs allow for unbalanced repeated measures, 
no imputation of missing data was performed. For each model, the magnitude of multicollinearity of 
model terms was analysed using the variance inflation factor; no collinearity issues were found. The 
list of the fixed effects included in the GLMMs and LMMs is detailed below: 
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• Evaluation of time trends: days of life, GA, ductal status, days of life by ductal status (all 
models); treatment with dopamine and/or dobutamine (CO, SV, HR, ICON and SVR models); 
umbilical Doppler status (cTOI, cFTOE and TOHRx models). 
• Evaluation of clinical determinants: GA, Apgar score at 5 minutes, antenatal steroids 
administration, umbilical Doppler status, ductal status, dopamine administration, dobutamine 
administration, respiratory support modality. MABP was also included in SVR, cTOI, cFTOE 
and TOHRx models, whereas CO was added to cTOI and cFTOE models.  
 
4.3. Results 
As shown in the enrolment flow chart (Figure 4.2), a total of 72 preterm neonates fulfilling the 
inclusion criteria were enrolled between March 2018 and September 2020. Eight infants underwent 
sole NIRS and pulse oximeter monitoring, since EV was not available during the time window of the 
study monitoring. For the sake of data homogeneity, these infants were ruled out and only those with 
complete NIRS, EV and pulse oximetry data (n=64) were included in the data analysis.  
 
Figure 4.2. Flow chart of the infants’ enrolment and inclusion. EV, electrical velocimetry.  
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The neonatal characteristics of the population included in this research are summarized in Table 
4.1, while their clinical and haemodynamic features on day 1, 2 and 3 are provided in Table 4.2.  
 
Table 4.1. Neonatal characteristics of the study population.  
Neonatal characteristics n = 64 
Gestational age (weeks), mean (standard deviation, SD) 29.6 (2.7) 
Birth weight (g), mean (SD) 1182 (345) 
Length at birth (cm), mean (SD) 37 (3.7) 
Head circumference at birth (cm), mean (SD) 26.8 (2.7) 
Antenatal corticosteroids, n (%)  
Complete course 47 (73.4) 
Incomplete course 12 (18.8) 
Not given 5 (7.8) 
Intrauterine growth restriction, n (%) 21 (32.8) 
Umbilical artery Doppler status, n (%)  
AREDF w/ brain sparing 6 (9.4) 
AREDF w/o brain sparing 12 (12.8) 
Small for gestational age, n (%) 18 (28.1) 
Caesarean section, n (%) 55 (86) 
Male gender, n (%) 33 (51.6) 
Twinhood, n (%) 18 (28.1) 
Apgar score at 1 min, median (interquartile range [IQR]) 7 (5-8) 
Apgar score at 5 min, median (IQR) 9 (8-9) 
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Table 4.2. Clinical and haemodynamic features of the study population during the transitional 
period. 
Monitoring period (days of life)  Day 1 Day 2 Day 3 
Weight (g), mean (standard deviation, SD) 1176 (351) 1131 (344) 1078 (339) 
Haemoglobin (g/dl), mean (SD) 15.9 (2.1) 15.4 (2.6) 15.3 (2.9) 
Status of ductus arteriosus, n (%)    
Haemodynamically significant 35 (54.7) 17 (26.6) 12 (18.8) 
Restrictive 19 (29.7) 19 (29.7) 5 (7.8) 
Closed 10 (15.6) 28 (43.8) 47 (73.4) 
















Respiratory support, n (%)    
Mechanical ventilation 16 (25) 15 (23.4) 14 (21.9) 
Continuous Positive Airway Pressure 43 (67.2) 40 (62.5) 32 (50) 
Nasal cannulas or self-ventilating in air 5 (7.8) 9 (14.1) 18 (28.1) 
Surfactant administration, n (%) 35 (54.7) 38 (59.4) 38 (59.4) 




























° classified accordingly to the maximum severity achieved. 
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According to our local NICU protocol, dobutamine was administered in the presence of hypotension 
(defined as a MABP lower than GA associated with any among steady tachycardia, capillary refill 
time >3 sec, decreased urine output or metabolic acidosis) [213,214] and echocardiographic evidence 
of impaired cardiac contractility, whereas dopamine was commenced in hypotensive infants without 
evidence of impaired cardiac contractility or who did not respond to dobutamine and/or volume 
expansion. The starting dosage of dopamine and dobutamine was 5 mcg/kg/min; none of the treated 
infants required higher doses. Based on the infant’s haemodynamic response, dopamine was 
gradually tapered to 3 mcg/kg/min before suspension. 
Daily echocardiographic features in the presence of a hsPDA are detailed in Table 4.3; a 
concomitant PFO was evident in all the infant. Of the 35 infants who initially presented with a 
hsPDA, 21 (60%) underwent spontaneous ductal closure. Pharmacological PDA treatment was 
required in 14 neonates (40%); of these, 8 were treated with a single paracetamol course, 3 with a 
single ibuprofen course and 3 with paracetamol followed by ibuprofen, due to lack of effectiveness 
to the first treatment course. Of the 14 infants requiring pharmacological PDA closure, 4 did not 
respond to pharmacological treatment and required surgical PDA ligation.  
Of note, the number of infants who developed IVH within this group was 1 (grade II, 2.9%) on day 
1, 4 (23.5%) on day 2 (of which: grade II, n=2; grade III, n=2), and 3 (25%) on day 3 (of which: 
grade 1, n=2; grade III, n=1). All the infants who developed a grade III IVH had evidence of 
diastolic reflow in the ACA at the ultrasound scans that preceded IVH detection.  
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Table 4.3. Daily echocardiographic features of infants with a haemodynamically significant patent 
ductus arteriosus (hsPDA) during the transitional period. 
 
Monitoring period (days of life)  Day 1 (n=35) Day 2 (n=17) Day 3 (n=12) 
Ductal size, median (interquartile range [IQR])    








Direction of transductal shunt, n (%)    
Predominantly or entirely right-to-left 1 (2.9) 0 (0) 0 (0) 
Bidirectional 6 (17.1) 1 (5.9) 0 (0) 
Predominantly or entirely left-to-right 28 (80) 16 (94.1) 12 (100) 
Direction of shunt across the foramen ovale 
Predominantly or entirely right-to-left 
Bidirectional 













LA:Ao ratio, median (IQR) 1.3 (1.2-1.6) 1.6 (1.5-1.7) 1.6 (1.4-1.8) 
Diastolic reflow, n (%) 













Time trends of cardiovascular and cerebrovascular parameters during the transitional period 
For each of the haemodynamic parameters, time trends over the first 72 hours after birth were 
evaluated using the models previously described; the list of the fixed effects included in each model 
has been listed in the Methods section of this chapter.  
COEV time trends over the first 3 days of life are illustrated in Figure 4.3. COEV changed significantly 
over this period (p=0.024); in particular, the pairwise comparison revealed a significant COEV 
increase between day 1 and day 2 (b 20.094, 95% confidence interval [CI] 2.410-37.778; p=0.020), 
whereas a slight, non-significant decrease to intermediate values was observed between day 2 and 3. 
 
Figure 4.3. Estimated means of cardiac output (COEV) during the first 3 days of life. The bars indicate 
the 95% confidence interval. Predictors are fixed at a gestational age of 29.6 weeks. The asterisks 
indicate contrasts significant at the 5% (*).  
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Time trends of SV depicted a parabolic curve, with a tendence towards an increase between day 1 
and day 2, followed by a parallel decrease between day 2 and day 3 (Figure 4.4). However, according 
to the results of the GLMM, these fluctuations were not statistically significant. 
 
 
Figure 4.4. Estimated means of stroke volume (SV) during the first 3 days of life. The bars indicate 
the 95% confidence interval. Predictors are fixed at a gestational age of 29.6 weeks. 
 
Time trends of HR, illustrated in Figure 4.5, showed significant changes over the first 3 days of life 
(p<0.001). After the first 24 hours, HR outlined a slight but significant increase, which was 
maintained until 72 hours of life (day 2 vs. day 1: b 3.505, 95% CI 1.367-5.643, p=0.001; day 3 vs. 
day 1: b 4.195, 95% CI: 1.810-6.580, p<0.001). No significant HR difference was observed between 
day 2 and day 3 at pairwise comparison. 
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Figure 4.5. Estimated means of heart rate (HR) during the first 3 days of life. The bars indicate the 
95% confidence interval. Predictors are fixed at a gestational age of 29.6 weeks. The asterisks (**) 
and circles (°°) indicate contrasts significant at the 1%. 
 
Cardiac contractility changed significantly over the first 72 hours of life (p=0.026), outlining a 
progressive improvement, illustrated in Figure 4.6. In particular, ICON values on day 3 were 
significantly higher compared with those on day 1 (b 10.793, 95% CI 1.861-19.724, p=0.012), 
whereas the comparisons between day 1 and 2 and between day 2 and 3 did not reach statistical 
significance, despite of the increasing trends. 
SVR values underwent significant changes over the first 72 hours of life (p<0.001), illustrated in 
Figure 4.7. In particular, SVR significantly increased on day 3 compared to day 1 (b 1.564, 95% CI 
0.790-2.339, p<0.001) and 2 (b 1.115, 95% CI 0.467-1.762, p<0.001), whereas no significant 




Figure 4.6. Estimated means of cardiac contractility index (ICON) during the first 3 days of life. The 
bars indicate the 95% confidence interval. Predictors are fixed at a gestational age of 29.6 weeks. 
The asterisks indicate contrasts significant at the 5% (*).  
 
 
Figure 4.7. Estimated means of systemic vascular resistance (SVR) during the first 3 days of life. The 
bars indicate the 95% confidence interval. Predictors are fixed at a gestational age of 29.6 weeks. 
The asterisks (**) and circles (°°) indicate contrasts significant at the 1%.  
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Time trends of TOHRx over the first 72 hours of life are illustrated in Figure 4.8. Cerebrovascular 
reactivity showed a significant improvement during this period (p=001): in particular, TOHRx on day 
3 were significantly decreased compared with day 1 (b -0.068, 95% CI -0.118,-0.019; p=0.003) and 
day 2 (b -0.057, 95% CI -0.102;-0.012, p=0.007). Although the TOHRx curve depicted a slight 
decrease during the first 48 hours of life, the difference between TOHRx values on day 1 and day 2 
were not statistically significant.  
 
Figure 4.8. Estimated means of the correlation coefficient between cerebral oxygenation and heart 
rate (TOHRx) during the first 3 days of life. The bars indicate the 95% confidence interval. Predictors 
are fixed at a gestational age of 29.6 weeks. The asterisks (**) and circles (°°) indicate contrasts 
significant at the 1%. 
 
Time trends of cTOI and cFTOE over the first 72 hours of life are illustrated in Figure 4.9 and Figure 
4.10, respectively. These parameters remained overall stable over the first 72 hours of life and no 
significant differences emerged among their daily values at the GLMM models.  
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Figure 4.9. Estimated means of cerebral tissue oxygenation index (cTOI) during the first 3 days of 




Figure 4.10. Estimated means of cerebral fraction of tissue oxygen extraction (cFTOE) during the 
first 3 days of life. The bars indicate the 95% confidence interval. Predictors are fixed at a gestational 
age of 29.6 weeks.   
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Given the known impact of PDA on transitional haemodynamic features, the time trends of the 
haemodynamic parameters were also stratified according to the infants’ ductal status (Figure 4.11). 
On day 1, the presence of a hsPDA was associated with significantly higher SV (p=0.011) and COEV 
values (p=0.006) compared with a closed or restrictive duct. Between 24 and 48 hours, infants with 
a closed or restrictive duct showed an increase in SV and COEV, and the difference with the hsPDA 
group, who maintained stationary SV and COEV values during the transitional period, was no longer 
significant. 
With regard to HR, hsPDA was associated with an increase of this parameter from 24 hours onwards, 
which led to significantly higher mean HR values compared with those observed in infants with a 
restrictive or a closed duct (p <0.001 on day 2 and p=0.021 on day 3). 
Although cardiac contractility improved in both groups during the transitional period, infants with a 
hsPDA showed higher ICON values compared to those with a restrictive or closed DA, with 
significant differences between the two groups on day 1 (0.009) and 3 (p=0.048). 
With regard to SVR, infants with a restrictive or closed duct trended toward a gradual increase over 
the first 72 hours, whereas in those with a hsPDA, SVR remained stable between day 1 and day 2, 
before starting to increase on day 3. Although SVR levels after 24 hours of life were slightly lower 
in infants with a hsPDA, this difference was not significant.  
Although the trend patterns in both groups showed a noticeable improvement of cerebrovascular 
reactivity after the first 48 hours of life, infants with a hsPDA had significantly higher values of 
TOHRx in on day 1 (p=0.001) and on day 2 (p=0.017) compared to those with a restrictive or a closed 
DA, indicating a poorer control of cerebral perfusion in relation to BP. The TOHRx reduction 





Figure 4.11. Estimated means of cardiac output (COEV), stroke volume (SV), heart rate (HR), cardiac 
contractility (ICON), systemic vascular resistance (SVR), cerebral oxygenation (cTOI), cerebral 
fractional oxygen extraction (cFTOE) and of the correlation coefficient between cTOI and HR 
(TOHRx) during the first 3 days of life in neonates with a haemodynamically significant patent ductus 
arteriosus (hsPDA, red line and dots) or with a restrictive or closed duct (blue line and squares). 
Predictors are fixed at a gestational age of 29.6 weeks and adjusted for ongoing dopamine and 
dobutamine (COEV, SV, HR, ICON, SVR) and antenatal Doppler status (TOHRx, cTOI, cFTOE). The 
bars indicate the 95% confidence interval. The asterisks indicate contrasts significant at 5% (*) and 
1% (**) between the two groups. 
 
Finally, cTOI and cFTOE trends in the two groups were evaluated. Overall time patterns of these 
cerebral haemodynamic parameters were stable in both groups; although infants with a hsPDA 
showed slightly lower cTOI and increased cFTOE values on day 3 compared to those with a restrictive 
or a closed duct, especially on day 3, no significant difference was observed at the between-group 
comparison. 
Of note, due to their potential effects on the observed findings, it is important to emphasise that the 
present results have been corrected for GA (both cardiovascular and cerebrovascular parameters), 
ongoing dopamine and ongoing dobutamine treatment (cardiovascular parameters) and for antenatal 
Doppler status (cerebrovascular parameters). The graphs shown in Figure 4.11 are fixed at a GA of 




Clinical determinants of cardiovascular and cerebrovascular haemodynamic parameters during the 
transitional period 
For each of the haemodynamic parameters measured in this dissertation, a pool of antenatal, perinatal 
and postnatal clinical variables that make up the neonatal exposome during the transitional period 
was included as fixed effects in the GLMM and LMM models.  
The GLMM results investigating the effects of relevant clinical characteristics on association COEV 
are shown in Table 4.4. COEV was significantly lower in infants with abnormal umbilical Doppler 
without evidence of antenatal brain sparing. Compared to those with a restrictive PDA or with a 
closed duct, infants with a hsPDA had a significantly higher COEV. Moreover, a significant COEV 
reduction was observed during dopamine administration.  
The results of the GLMM evaluating the association between SV and relevant clinical characteristics 
are shown in Table 4.5. SV was significantly higher in infants with a hsPDA compared to those with 
a restrictive or closed DA, whereas a significant reduction of SV was observed during dopamine 
administration. Moreover, SV significantly increased with increasing GA.  
The association between HR and relevant clinical characteristics is detailed in Table 4.6. A significant 
negative correlation between HR and GA was documented: the lower the GA, the higher the HR. 
Infants with echocardiographic evidence of a hsPDA had significantly higher HR compared to those 
with a restrictive PDA or a closed duct.  
Results of the GLMM investigating the association between the cardiac contractility index and 
relevant clinical characteristics are shown in Table 4.7. A significant, positive correlation between 
ICON and GA was observed. Moreover, significantly higher ICON values were observed during 
dobutamine administration and in the presence of a hsPDA compared to a restrictive or a closed duct.  
The association between SVR and relevant clinical characteristics is shown in Table 4.8. SVR was 
significantly and positively associated with mean arterial pressure. Infants with a haemodynamically 
significant PDA had lower SVR compared to those with a restrictive PDA or a closed duct, whereas 
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infants with antenatal evidence of umbilical Doppler impairment showed significantly increased SVR 
compared to those with normal umbilical flowmetry. A significant, negative correlation was observed 
between SVR and GA: the lower the GA, the higher the SVR. No significant associations were 
observed with the other variables included in the model. 
 
Table 4.4. Multivariable generalized linear mixed model evaluating the correlation between clinical 
variables and cardiac output (COEV). Abbreviations: AREDF, absent or reversed end-diastolic flow. 




Intercept 252.869 122.123 16.892; 498.846 0.036 
Gestational age 5.984 4.338 -2.570; 14.537 0.169 
Apgar at 5 minutes -14.496 9.761 -33.742; 4.751 0.139 
Antenatal steroids      
Full course 1.368 22.379 -42.758; 45.495 0.951 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 19.763 23.884 -27.331; 66.858 0.409 
AREDF, no brain sparing -54.637 26.591 -107.069; -2.205 0.041 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant 21.262 8.947 3.620; 38.904 0.018 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes -44.694 21.708 -87.498; -1.890 0.041 
No Ref.     
Dobutamine administration      
Yes 2.158 18.340 -34.004; 38.320 0.906 
No Ref.     
Respiratory support      
Invasive ventilation 31.994 23.074 -13.503; 77.490 0.167 
Non-invasive ventilation Ref. 
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Table 4.5. Multivariable generalized linear mixed model evaluating the correlation between 
clinical variables and stroke volume (SV). Abbreviations: AREDF, absent or reversed end-diastolic 
flow. 




Intercept 0.398 0.851 -1.280; 2.076 0.641 
Gestational age 0.074 0.031 0.014; 0.135 0.016 
Apgar at 5 minutes -0.043 0.069 -0.179; 0.092 0.529 
Antenatal steroids      
Full course -0.034 0.159 -0.347; 0.278 0.830 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 0.167 0.169 -0.166; 0.500 0.324 
AREDF, no brain sparing -0.321 0.182 -0.679; 0.038 0.080 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant 0.184 0.058 0.069; 0.298 0.002 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes -0.378 0.145 -0.663; -0.092 0.010 
No Ref. 
   
 
Dobutamine administration      
Yes 0.117 0.122 -0.123; 0.357 0.338 
No Ref. 
   
 
Respiratory support      
Invasive ventilation 0.165 0.155 -0.140; 0.470 0.287 
Non-invasive ventilation Ref. 




Table 4.6. Multivariable generalized linear mixed model evaluating the correlation between 
clinical variables and heart rate (HR). Abbreviations: AREDF, absent or reversed end-diastolic 
flow. 




Intercept 215.788 13.177 189.821; 241.755 <0.001 
Gestational age -2.281 0.437 -3.142; -1.420 <0.001 
Apgar at 5 minutes -0.322 1.018 -2.329; 1.685 0.752 
Antenatal steroids      
Full course -1.640 2.278 -6.130; 2.849 0.472 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 0.405 2.609 -4.737; 5.547 0.877 
AREDF, no brain sparing -4.365 2.852 -9.985; 1.256 0.127 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant 2.433 1.214 0.040; 4.825 0.046 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes 4.263 2.750 -1.155; 9.682 0.122 
No Ref. 
   
 
Dobutamine administration      
Yes 1.412 2.286 -3.093; 5.917 0.537 
No Ref. 
   
 
Respiratory support      
Invasive ventilation -1.844 2.739 -7.242; 3.553 0.501 
Non-invasive ventilation Ref. 





Table 4.7. Multivariable generalized linear mixed model evaluating the correlation between clinical 
variables and the cardiac contractility index (ICON). Abbreviations: AREDF, absent or reversed 
end-diastolic flow. 




Intercept 10.579 46.6318 -81.386; 102.543 0.821 
Gestational age 3.238 1.609 0.065; 6.411 0.046 
Apgar at 5 minutes -2.356 3.603 -9.462; 4.749 0.514 
Antenatal steroids      
Full course 5.844 8.250 -10.427; 22.114 0.480 
Incomplete course or not given Ref.     
Umbilical Doppler status      
AREDF, brain sparing 13.345 8.768 -3.947; 30.637 0.130 
AREDF, no brain sparing -2.874 11.150 -24.862; 19.114 0.797 
Normal Ref.     
Ductal status      
Haemodynamically significant 10.409 4.318 1.894; 18.924 0.017 
Restrictive or closed Ref. . . . . 
Dopamine administration      
Yes -16.908 9.292 -35.233; 1.418 0.070 
No Ref.     
Dobutamine administration      
Yes 16.496 7.978 0.762; 32.231 0.040 
No Ref.     
Respiratory support      
Invasive ventilation 11.326 9.749 -7.901; 30.554 0.247 




Table 4.8. Multivariable generalized linear mixed model evaluating the correlation between clinical 
variables and systemic vascular resistance (SVR). Abbreviations: AREDF, absent or reversed end-
diastolic flow. 




Intercept 53.553 8.101 37.570; 69.356 <0.001 
Gestational age -1.875 0.302 -2.470; -1.280 <0.001 
Apgar at 5 minutes 0.912 0.688 -0.445; 2.268 0.186 
Antenatal steroids      
Full course 0.168 1.593 -2.975; 3.311 0.916 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 5.032 1.700 1.679; 8.386 0.003 
AREDF, no brain sparing 4.687 1.597 1.536; 7.838 0.004 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant -1.528 0.481 -2.478; -0.579 0.002 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes 0.237 1.139 -2.011; 2.484 0.836 
No Ref. 
   
 
Dobutamine administration      
Yes 0.493 1.010 -1.489; 2.476 0.624 
No Ref. 
   
 
Respiratory support      
Invasive ventilation -0.020 1.234 -2.415; 2.455 0.987 
Non-invasive ventilation Ref. 
   
 




The results of the GLMM investigating the association between cTOI and relevant clinical 
characteristics are shown in Table 4.9. A significant, positive correlation was observed between cTOI 
and GA. Cerebral oxygenation was found to be significantly associated with cardiac output: higher 
CO values were associated with an increased cTOI. No significant associations were observed with 
the other variables included in the model. 
The association between cFTOE and relevant clinical characteristics are shown in Table 4.10. A 
significant, negative correlation was observed between cFTOE and GA; cerebral tissue oxygen 
extraction was increased in more preterm infants. Moreover, we observed a significant association 
between antenatal steroids and cFTOE, which was reduced if the infants’ mothers had received a full 
steroid course.  
The LMM results investigating the association between TOHRx and relevant clinical characteristics 
are shown in Table 4.11. A significant inverse correlation was found between TOHRx and MABP, 
indicating that the lower the blood pressure, the higher the risk of impaired cerebrovascular reactivity. 
Infants with antenatal evidence of abnormal umbilical Doppler and remodelling of cerebral blood 
flow experienced a significant impairment of cerebrovascular reactivity during the first 72 hours of 
life. Similarly, the presence of a hsPDA was associated with significantly higher TOHRx values, 




Table 4.9. Multivariable generalized linear mixed model evaluating the correlation between clinical 
variables and cerebral oxygenation (cTOI). Abbreviations: AREDF, absent or reversed end-diastolic 
flow. 




Intercept 48.469 9.381 29.447; 66.970 <0.001 
Gestational age 0.778 0.313 0.161; 1.394 0.014 
Apgar at 5 minutes -0.066 0.696 -1.439; 1.307 0.925 
Antenatal steroids      
Full course 2.486 1.572 -0.615; 5.586 0.115 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 0.209 1.682 -3.109; 3.526 0.901 
AREDF, no brain sparing 0.462 2.069 -3.618; 4.542 0.824 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant 0.023 0.950 -1.850; 1.896 0.981 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes -1.299 1.892 -5.030; 2.431 0.493 
No Ref. 
   
 
Dobutamine administration      
Yes -1.116 1.616 -4.303; 2.071 0.491 
No Ref. 
   
 
Respiratory support      
Invasive ventilation -0.771 1.966 -4.649; 3.107 0.695 
Non-invasive ventilation Ref. . 
  
 
Cardiac output 0.016 0.006 0.003; 0.028 0.014 




Table 4.10. Multivariable generalized linear mixed model evaluating the correlation between clinical 
variables and cerebral fraction of tissue oxygen extraction (cFTOE). Abbreviations: AREDF, absent 
or reversed end-diastolic flow. 




Intercept 0.398 0.079 0.241; 0.554 <0.001 
Gestational age -0.006 0.003 -0.011; -0.001 0.036 
Apgar at 5 minutes 0.003 0.005 -0.008; 0.013 0.621 
Antenatal steroids      
Full course -0.030 0.014 -0.058; -0.003 0.033 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 0.005 0.015 -0.025; 0,036 0.736 
AREDF, no brain sparing -0.001 0.027 -0.054; 0.053 0.981 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant -0.003 0.009 -0.020; 0.015 0.782 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes 0.021 0.025 -0.029; 0.071 0.409 
No Ref. 
   
 
Dobutamine administration      
Yes 0.018 0.020 -0.021; 0.058 0.366 
No Ref. 
   
 
Respiratory support      
Invasive ventilation -0.002 0.017 -0.036; 0.032 0.910 
Non-invasive ventilation Ref. 
   
 
Cardiac output -0.185 0.070 -0.323; -0.047 0.009 




Table 4.11. Multivariable linear mixed model evaluating the correlation between clinical variables 
and moving correlation coefficient between heart rate and cerebral oxygenation (TOHRx). 
Abbreviations: AREDF, absent or reversed end-diastolic flow. 




Intercept 0.108 0.172 -0.236; 0.453 0.532 
Gestational age -0.003 0.006 -0.014; 0.008 0.602 
Apgar at 5 minutes -0.003 0.013 -0.028; 0.022 0.788 
Antenatal steroids      
Full course -0.008 0.029 -0.065; 0.049 0.775 
Incomplete course or not given Ref. 
   
 
Umbilical Doppler status      
AREDF, brain sparing 0.110 0.030 0.049; 0.171 0.001 
AREDF, no brain sparing 0.062 0.039 -0.015; 0.141 0.102 
Normal  Ref. 
   
 
Ductal status      
Haemodynamically significant 0.093 0.023 0.048; 0.138 <0.001 
Restrictive or closed  Ref. 
   
 
Dopamine administration      
Yes 0.050 0.038 -0.027; 0.126 0.199 
No Ref. 
   
 
Dobutamine administration      
Yes 0.019 0.034 -0.047; 0.086 0.565 
No Ref. 
   
 
Respiratory support      
Invasive ventilation 0.052 0.040 -0.027; 0.132 0.196 
Non-invasive ventilation Ref. 
   
 
Mean arterial blood pressure -0.004 0.002 -0.007; -0.001 0.015 
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Overall, these results allowed the identification of three main clusters of factors that exerted a 
significant, independent influence on both cardiovascular and cerebrovascular haemodynamics. 
These clusters were antenatal Doppler status, gestational age at birth and ductal status, that 
respectively contributed to the antenatal, perinatal and postnatal individual characteristics of each 
infant. 
For this reason, a graphical representation of the cardiovascular and cerebrovascular haemodynamic 
profiles that emerged in relation to different features of these three clinical determinants was 
elaborated (Figure 4.12). For the sake of clarity, the estimated z-score means of the previously 
described multivariate models were included in the charts and GA was stratified according with the 
definitions standardly adopted in neonatal nomenclature: extremely preterm (<28 weeks), very 
preterm (28-31 weeks) and moderately preterm (≥32 weeks). 
 
Figure 4.12 (page 105). Radar charts of cardiovascular and cerebrovascular haemodynamic profiles 
according to the antenatal Doppler status (A), gestational age (B) and ductal status (C) of the 
enrolled infants. The radial axis values indicate the estimated z-score means of the parameters 
included in each chart. 
Abbreviations: AREDF, absent or reversed end-diastolic flow; cTOI, cerebral tissue oxygenation 
index; cFTOE, cerebral fraction of tissue oxygen extraction; CO, cardiac output; HR, heart rate; HS, 
haemodynamically significant; ICON, cardiac contractility index; SV, stroke volume; SVR, systemic 





From the results presented, cardiovascular and cerebrovascular haemodynamics during the first 72 
hours of life in preterm infant undergo specific fluctuations reflecting the circulatory adaptation to 
postnatal life. Furthermore, the adaptive responses to this haemodynamic transition are significantly 
influenced by specific antenatal, perinatal and postnatal conditions that contribute to determine 
individual haemodynamic profiles. 
 
Temporal patterns of cardiovascular and cerebrovascular parameters during the transitional 
period  
The evaluation of the temporal patterns of the main cardiovascular parameters has provided a 
multifaceted picture of the adaptive functional changes occurring during the transitional period. 
 
• Temporal patters of cardiovascular parameters and influence of a haemodynamically significant 
patent ductus arteriosus 
Cardiac output is the result of the interaction between preload, myocardial contractility, heart rate and 
afterload. A significant increase in CO was observed between day 1 and day 2, whereas on day 3, a 
slight, non-significant decrease. Similar trend patterns have been previously reported by Noori et al. 
in extremely preterm infants during the transitional period [47]. The temporal patterns of the two 
direct determinants of CO, namely SV and HR, were then assessed. Although SV fluctuations within 
the first three days of life did not reach statistical significance, a trend toward an increase of SV was 
observed between 24 and 48 hours, followed by a slight decrease between 48 and 72 hours of life. 
After the first 24 hours HR showed a small but significant increase, which was maintained until 72 
hours of life. 
The CO trend patterns observed during the transitional period resembled the underlying changes of 
SV and HR. In particular, both these parameters contributed to the significant CO increase observed 
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between 24 and 48 hours. These findings are consistent with data obtained by Cappelleri et al. in late 
preterm infants during the first 48 hours of life using a non-invasive cardiac output monitoring based 
on thoracic bioreactance [215]; in their study, the increase of CO was predominantly driven by SV 
rather than HR. The inclusion of infants with lower GA, which is associated with an increased resting 
HR, may explain the influence of HR on CO observed in the present data. 
Cardiac contractility gradually improved over the first 72 hours after preterm birth, with a statistically 
significant increase between day 1 and day 3. Due to the structural and functional immaturity of the 
preterm myocardium, the contractile function of premature neonates is often reduced; however, 
consistent with the present results, a significant improvement in cardiac contractility has been 
previously reported in very-low-birth-weight infants over the first 5 days of life [21]. These findings 
support the evidence of a gradual adaptation of myocardial function to the postnatal changes in 
systemic haemodynamics, which may be driven by a progressive increase in intracellular calcium 
influx during the early postnatal period [13]. 
SVR rose significantly after the first 48 hours of life. This increase in afterload may have played a 
role in determining the slight CO reduction observed between day 2 and day 3, which was mainly 
driven by SV. On the other hand, the improvement in cardiac contractility and increase in HR 
observed from 24 hours onwards may have prevented a significant reduction in CO in face of the 
raised afterload. 
Several echocardiographic studies have investigated transitional changes in cardiovascular function. 
While some studies considered early transitional data as a whole [216] or focused on the first 24 hours 
of life [18,217,218], others performed serial evaluations over the first 48 [172,219,220] or 72 hours 
after birth [47]. In two echocardiographic studies performed on extremely preterm infants, a 
significant improvement in tissue Doppler imaging velocities of septum, left and right ventricle [219] 
and significantly increased CO, septal peak systolic and early diastolic strain rate have been reported 
between the first and the second day of life. Although no difference was observed in left ejection or 
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shortening fractions [220], tissue Doppler imaging and myocardial deformation measurements are 
able to detect subclinical myocardial dysfunctions before ventricular impairment becomes clinically 
apparent [221]. Sirc et al. described a progressive LVO increase in preterm infants <1250g within the 
first 48 hours, which resulted from improvement in the diastolic relaxation of the left ventricle [172]. 
This finding is in line with the increased SV and CO that we observed between day 1 and day 2. Noori 
et al. [47] performed a 12-hourly echocardiographic evaluation of LVO, RVO and left ventricular 
myocardial performance index over the first 72 hours of life in a small cohort of extremely preterm 
infants who developed IVH during this period compared with those who did not. The latter group 
underwent a trend toward a slight LVO increase on day 2, similar to that observed in the present 
results, whereas the myocardial performance of the left ventricle remained stable over time. 
Although the dynamic changes observed in cardiovascular parameters may be multifactorial, it is not 
possible to disregard the role of PDA on the observed findings. For these reasons, the patterns of 
these parameters were also assessed in relation to the daily ductal status and compared between 
infants with a hsPDA and those with a restrictive or a closed duct. 
The present results confirm a significant role of ductal status on cardiovascular transitional 
haemodynamics. In particular, the presence of a hsPDA during the first 24 hours of life was associated 
with significantly increased mean values of SV and CO and an enhanced cardiac contractility. Given 
that 80% of the infants with a hsPDA showed a predominantly or entirely left-to-right shunt across 
the DA following the first echocardiographic evaluation, we can postulate that the rise in venous 
return resulting from the transductal shunt transiently enhance the tension developed by the cardiac 
muscle fibres by extending the myocyte sarcomere length according to the Frank-Starling law. This 
assumes that SV values lie in the steeper part of the curve during this early phase. 
After the second day of life, SV in the hsPDA group did not increase further, but rather showed a 
slight decrease on day 3. This could be ascribed to the establishment of a left-to-right shunt across 
the foramen ovale [222,223], which may have contributed to reduce the volume overload on the left 
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sections. During the same period, a significant rise in HR was observed in infants with a hsPDA 
compared to those with a restrictive or closed DA. Since these results were adjusted for ongoing 
inotropes and GA, this increase in HR likely reflects a compensatory mechanism aimed at the 
maintenance of stable CO levels in the presence of a persistent transductal left-to-right shunt. 
However, the few data currently available investigating the relationship between HR and hsPDA, 
evaluated during different time periods (i.e., before pharmacological or surgical DA closure) have 
yielded controversial results [26,224,225]. On day 2 and 3, CO was still slightly higher in hsPDA 
infants than in those with a non-significant or closed DA; however, the improvement in CO observed 
in the latter group contributed to the lack of statistical between-group difference at these time points.  
In infants whose DA underwent a physiological closure or showed non-significant haemodynamic 
characteristics, the time patterns of CO, HR, ICON and SVR were characterized by a progressive 
increase throughout the transitional period, suggesting a gradual improvement of the overall 
cardiovascular function. A progressive improvement in calcium handling [226], which plays an 
important role in both cardiac contractility and vascular tone, may underlie the observed findings. 
Moreover, HR, cardiac contractility and SVR are largely controlled by the autonomic nervous system 
and catecholamines [227]. During gestation, the autonomic control of the cardiovascular system 
undergoes considerable development; however, the sympathetic branch develops more rapidly than 
the parasympathetic one, and this non-synchronous maturation underlies the predominant 
sympathetic effects observed in preterm infants in the early phases after birth [228]. Also 
catecholamines play a critical role during this phase: the increase in epinephrine and norepinephrine 
levels that typically follows cord clamping is heightened in preterm infants, although this rise occurs 
more slowly (i.e. within hours rather than minutes), probably due to their immaturity [229]. We can 
therefore postulate a possible modulating role for both sympathetic maturation and catecholamine 
rise in the observed cardiovascular patterns. 
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• Temporal patters of cerebrovascular parameters and influence of a haemodynamically significant 
patent ductus arteriosus 
Cerebral autoregulation is aimed at maintaining stable cerebral perfusion despite fluctuating blood 
pressure. However, since this mechanism is not an “on-off” phenomenon, depending on the infant’s 
level of immaturity and upon other underlying factors, it might be present, attenuated, or absent at 
different given times [208]. The failure of the preterm cerebral vasculature to maintain a stable CBF 
over a wide range of systemic BP results in the so-called pressure-passive circulation [75], whose 
possible role in the development of IVH has been previously described [48,89]. 
According to the present results, a significant improvement in cerebrovascular reactivity was 
observed from 48 hours of life onwards. This timing coincides with the period of highest IVH risk 
[230] and includes the transitional phase characterized by a high incidence of hypotension [213]. In 
this regard, we observed a significant independent relationship between daily-averaged MABP and 
cerebrovascular reactivity: the lower the blood pressure, the higher the TOHRx. A similar association 
had been previously reported [93,188], suggesting that in preterm infants the baseline MABP may lie 
closer to the lower limit of the autoregulation range. 
The presence of a left-to-right transductal shunt may contribute to lower BP and to influence 
cerebrovascular reactivity in this delicate phase. In this regard, transitional TOHRx trends were also 
evaluated in relation to the DA status. During the first 48 hours after birth, infants with a hsPDA 
showed significantly higher values of TOHRx compared to those with a non-significant or closed 
duct, independently of their gestational age. This finding suggests that the haemodynamic 
perturbances associated with a hsPDA may challenge the physiological mechanisms of cerebral 
autoregulation and, together with the evidence of a hsPDA-related cerebral diastolic steal in all the  3 
infants who developed severe IVH during the transitional period, provides indirect support to the 
available evidence on the possible predisposing role of hsPDA on IVH development [32]. However, 
due to the low number of infants presenting with an IVH during the transitional period in this study 
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(in particular of high grade), a powered statistical evaluation of the trend patterns in relation to the 
development of this complication was not feasible.  
Although not statistically significant, the mild fluctuations of cTOI and cFTOE observed during the 
first 72 hours respectively resembled and mirrored the pattern previously described for CO. Similar 
parabolic patterns were depicted by Alderliesten et al. in their reference values curves for both 
cerebral oxygenation and oxygen extraction [174]. These authors also reported a non-significant trend 
toward a lower cerebral oxygenation and an increased cFTOE in infants with a hsPDA, especially on 
day 3. A similar finding was observed in the present cohort, when data were evaluated in relation to 
the ductal status. However, as in the study by Alderliesten et al., these differences did not reach 
statistical significance; this is consistent with most of the available literature investigating the 
relationship between cerebral oxygenation and hsPDA [229–232], which failed to prove a significant 
association. 
• Conclusions 
Overall, the present data suggest that cardiovascular function gradually improves over the first 72 
hours of life, reflecting the underlying adaptation to postnatal circulation. This improvement was also 
consistent with the progressive increase in MABP observed during the transitional period. The 
adoption of continuous EV monitoring for this integrated haemodynamic evaluation has provided 
valuable information to elicit the in-vivo trajectory of PDA-related physiological changes during 
transition; however, echocardiographic assessment remains crucial not only to ascertain the presence 
of a hsPDA, but also to assess the function of left and right cardiac sections and to validate the 
pathophysiological observations obtained with non-invasive CO monitoring.  
• Limitations 
The increasing ranges of the 95% CIs of the daily parametric values from day 1 to 3 in infants with a 
hsPDA (see Figure 4.11) reflect the shift in the ductal status from haemodynamically significant to 
restrictive or closed observed in the enrolled infants during the transitional period, documented in 
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Table 4.2. Due to the progressive decrease of infants in the hsPDA group, this shift may represent a 
potential limitation to the assessment of cardiovascular and cerebrovascular haemodynamic 
fluctuations in relation to the ductal status; hence, the present results, and especially those observed 
on day 3, need to be further confirmed on larger samples. 
 
Clinical determinants of cardiovascular and cerebrovascular haemodynamic parameters during 
the transitional period 
In addition to the temporal patterns of cardiovascular and cerebrovascular haemodynamic parameters, 
the influence that several antenatal, perinatal and postnatal factors exert on these parameters during 
the transitional phase was also evaluated. 
• Haemodynamically significant patent ductus arteriosus 
The presence of a hsPDA was associated with higher values of stroke volume, heart rate, cardiac 
output and increased cardiac contractility. These findings, that are consistent with the temporal 
patterns of these parameters observed in infants with a hsPDA, reflect the volume overload associated 
to the left-to-right transductal shunt. Similar increases in LVO and SV, evaluated by 
echocardiography, have been reported in preterm infants with a hsPDA [225,231]. By stretching the 
myocyte sarcomere, the resulting increase in the venous return to the left atrium may enhance the 
force generated during the ventricle contraction, which further contributes to maintenance of the SV 
and CO. 
Previous echocardiographic and cardiovascular MRI studies failed to demonstrate a significant 
association between myocardial contractility and the presence of a hsPDA [223,232,233]; however, 
this available literature did not investigate early postnatal transition, but later phases, when the 
persistence of a hsPDA may have resulted in cardiac function remodelling. 
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As previously discussed, the higher resting HR observed in infants with a hsPDA may reflect a 
compensatory mechanism aimed at supporting CO, which at a post-ductal level is decreased. 
Furthermore, the presence of a hsPDA was associated with globally lower values of SVR. This 
finding is consistent with current knowledge of decreased SVR in association with this condition 
[234], and it further contributes to the increased SV observed in hsPDA infants. 
• Gestational age 
Gestational age exerted a significant impact on most of the cardiovascular and cerebrovascular 
haemodynamic parameters examined in the present research. With regard to cardiovascular 
parameters, more preterm infants showed significantly higher resting HR and SVR, whereas a 
significant reduction in SV and cardiac contractility was observed.  
In the present population, a 1-week decrease in GA led to a 2.2-point increase in resting HR; hence, 
the resting frequency of two neonates born at 25 and 32 weeks of gestation may differ of more than 
15 bpm. These results are consistent with those by Alonzo et al. [235], who has recently proposed 
reference HR ranges in premature neonates based on GA and post-menstrual age, and with previous 
EV-based data obtained between 72 and 96 hours of life [196]. 
As previously mentioned, due to the asynchronous development between the sympathetic and the 
parasympathetic branches, the sympathetic activity predominates at lower GAs [228]. Likewise, 
higher levels of plasmatic catecholamines and of their urinary metabolites have been observed in 
preterm infants compared to term or near-term controls [236,237]. This may contribute to the 
significantly increased SVR and HR values observed in the more preterm infants. 
A possible role of mineralocorticoids and corticosteroids on the higher SVR observed at lower GAs 
can also be supposed. By enhancing the cytosolic calcium availability, these hormones are actively 
involved in the regulation of vascular smooth muscle tone. An inverse relationship between serum 
cortisol levels and GA has been documented in several studies [238–240]. Another important factor 
to consider is that free rather than bound cortisol is the active form of the hormone, therefore reduced 
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levels of binding globulin and albumin, which are often observed in very preterm neonates even in 
the early postnatal phases, may increase cortisol activity, with possible effects on the vascular tone. 
A positive relationship between GA and cardiac contractility was also observed. The immature 
myocardium is characterized by fewer contractile elements with an underdeveloped sarcoplasmic 
reticulum, thus mainly relying on L-type calcium channels, and hence on extracellular calcium 
concentration, to trigger contraction [13,14]. Furthermore, data from animal models have shown that 
in the preterm heart the expression of β1‐adrenoceptors, which exert an inotropic function, is halved 
compared with the term heart [23]. These maturational differences of the myocardial tissue contribute 
to a poorer contractile function and likely underlie the reduced cardiac contractility observed with 
lower GAs. Similar findings were described by Saleemi et al., who documented poorer myocardial 
performance at 48 hours of life in extremely preterm infants compared with higher GA groups [216], 
and by Eriksen et al. [241], who reported a GA-dependent increase in myocardial function indices in 
moderately preterm neonates, evaluated on day 3. 
Based on these findings, the lower SV values observed in more preterm infants likely results from 
the combination of a poorer myocardial function, an increased afterload and a higher resting HR. In 
particular, with regard to the latter factor, the SV reduction results from the shorter time of diastolic 
ventricular filling associated with higher HR [25].  
On the cerebral side, a significant positive correlation between GA and cerebral oxygenation was 
observed, whereas cFTOE increased at decreasing GAs. These results confirmed the previously 
described relationship between GA and these parameters [174,242,243]. Although the underlying 
causes have not been fully clarified, it is possible that the enhanced cardio-respiratory instability that 
characterizes the most preterm neonates may be associated with a relatively reduced CBF and oxygen 
delivery to the brain parenchyma, which contributes to the increased oxygen extraction observed. 
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• Cardiovascular drugs 
Dobutamine is an inotropic agent with the primary pharmacologic effect of increasing myocardial 
contractility that is exerted by a dose-dependent stimulation of a- and b-adrenergic receptors; hence, 
it represents the drug of choice in neonates with myocardial dysfunction. At moderate doses (5 
µg/kg/min), dobutamine mainly results in an increased cardiac output, whereas a vasopressor effect 
is elicited at higher doses [138]. According to the present results, dobutamine led to a significant 
improvement in cardiac contractility, consistently with its mechanism of action. However, no 
significant difference in CO was observed between infants receiving dobutamine and those who did 
not. This data can be explained by the fact that, according to our NICU protocol, dobutamine was 
administered in the presence of hypotension with echocardiographic evidence of reduced cardiac 
output and impaired myocardial contractility; as the evidence of increased cardiac contractility in the 
treated infants suggests, dobutamine effectively corrected the myocardial dysfunction that underlaid 
the low cardiac output, based on which this treatment was undertaken. Hence, while the drug was 
ongoing, the treated infants achieved CO levels similar to those of untreated infants, whose 
myocardial function was physiologically preserved. 
Dopamine is a vasopressor agent largely adopted for the therapeutic management of hypotensive 
preterm infants; its cardiovascular effects lie in a dose-dependent stimulation of a- and b-adrenergic 
and dopaminergic receptors [138]. The present results revealed a significant decrease in CO in 
association with dopamine administration. Current data on the effect of dopamine on cardiac output 
have led to contrasting results [244–246]. Although an increased afterload has been acknowledged as 
the most plausible mechanism to explain a CO reduction during dopamine administration, consistent 
with the poor tolerance of the preterm myocardium to afterload during early transitional phases 
[21,28], concomitant ductal patency may entail more complex haemodynamic interactions. In 
particular, in the presence of an increased pulmonary blood flow secondary to a hsPDA, dopamine 
may increase PVR out of proportion to SVR, reducing the extent of the left-to-right transductal shunt 
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and improving systemic blood flow [138]. While one may assume that the observed decrease in CO 
was associated with a dopamine-driven increase in afterload, surprisingly, treated infants did not show 
a significant SVR increase compared to the untreated group. Hence, it could be hypothesized that 
treated infants had a lower baseline SVR compared with untreated ones and achieved similar SVR as 
a result of dopamine administration. However, it is also possible that the need for dopamine treatment 
may have selected a subgroup with significantly compromised transitional haemodynamics, in which 
even subtle afterload modifications may have affected the left cardiac output. 
• Role of cardiac output and mean arterial blood pressure on cerebral haemodynamics 
According to the present results, cerebral oxygenation and cerebral fractional oxygen extraction in 
VLBW infants during the first 72 hours of life significantly depend upon cardiac output. Blood flow 
and oxygen delivery to the brain tissue results from the composite interactions of BP, SVR and cardiac 
function, which thus deserve to be carefully monitored during the transitional phase, when 
hypotension more often occur.  To date, the relationship between cerebral oxygenation, cerebral 
fractional oxygen extraction and cardiac output has been investigated in a few studies, based on 
echocardiographic measurements, which have yielded controversial results [121,247–249]. A 
common limitation of these studies is the comparison between continuous NIRS-based values, 
variously averaged over different time periods, and intermittent CO values detected by 
echocardiography. Although this technique is widely used for the non-invasive estimation of CO, the 
information provided is time-limited, and may overlook potentially relevant fluctuations occurring in 
the period that lays between serial echocardiographic evaluations. These potential fluctuations, 
however, may also influence the time-averaged values of cerebral oxygenation calculated over that 
period, and it is possible that this methodological bias underlies the lack of correlation between 
cerebral oxygenation and echo-derived CO reported in previous studies [247]. Hence, the evaluation 
of the correlation between continuously monitored CO, cTOI and cFTOE adopted in the present 
research represents a novel approach compared to the available literature. 
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The significant association observed between cTOI and CO highlights the importance of optimizing 
cardiac output during the transitional period in order to maintain an adequate oxygen delivery to the 
brain tissue. A similar inverse relationship between CO and cFTOE during the transitional period has 
been previously documented [250]. Under normal circumstances, the delivery of oxygen outweighs 
its consumption at a tissue level. In neonates with ongoing respiratory and/or cardiovascular 
complications, decreased oxygen delivery is compensated by an increase in oxygen extraction in 
order to maintaining a stable tissue oxygenation. Hence, the increasing cFTOE associated with 
decreasing CO reflects an adaptive compensatory response aimed at improving tissue oxygen 
diffusion when oxygen delivery is reduced or compromised [249]. It is estimated that this mechanism 
can boost oxygen extraction up to 50–60% from baseline in case of decreased CBF; however, after a 
critical point characterized by the maximal oxygen extraction, a further reduction in oxygen delivery 
would lead to anaerobic metabolic conditions [13].  
No significant relationship was found between MABP and cTOI, nor between MABP and cFTOE. 
This latter result is consistent with the available literature from the transitional period and afterwards 
[249–251]. Conversely, we observed an inverse, significant correlation between MABP and TOHRx. 
Since low BP may cause a drop of CPP below the lower limit of autoregulation, this finding reflects 
the expected physiology and is consistent with previous data by Gilmore et al. [93], based on 
continuous BP monitoring. Of note, since MABP tends to increase for increasing GA, it is possible 
that the effect of blood pressure prevailed over that of GA in the multivariate model evaluating 
TOHRx clinical determinants. 
• Antenatal steroids 
Infants who received a complete course of antenatal steroids showed lower cFTOE levels during 
transition compared with those who received an incomplete course or none. Glucocorticoid 
administration to women at risk of preterm delivery to accelerate fetal lung maturation has become a 
main standard of care [252]. Data from animal models suggest that synthetic glucocorticoids, such as 
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betamethasone (i.e., the steroid used for the antenatal prophylaxis in the present population), are 
associated with an extensive decrease in CBF, mediated by an increase in cerebral vascular resistance, 
that leads to a 30-40% reduction of oxygen delivery to subcortical and hindbrain structures. This 
finding was found to persist 48 h after treatment administration [253]. The CBF reduction was less 
enhanced if only a single betamethasone dose was administered [254].  
In experimental settings, antenatal administration of synthetic glucocorticoids has been shown to 
mimic the maturational effects of advancing GA on the cardiovascular response to hypoxia by 
sensitizing carotid chemoreflexes and enhancing vasoconstrictor neuroendocrine responses mediated 
by cortisol and catecholamines [255]. Hence, it is possible that, following a full course of antenatal 
steroids, the occurrence of an antenatal decrease in CBF together with an enhanced maturation of 
cardiovascular responses to hypoxia may determine a more mature adaptation of the mechanisms 
involved in brain oxygen extraction, reflected by the lower cFTOE levels. 
• Placental-related intrauterine growth restriction 
Due to the fact that our hospital is a referral centre for placental-related pregnancy complications, the 
study population was characterized by a high IUGR prevalence with evidence of absent or reversed 
end-diastolic flow in the umbilical artery. This allowed us to study in detail the cardiovascular and 
cerebrovascular haemodynamic characteristics of this population during transition, with particular 
regard to the evidence, or not, of a compensatory antenatal increase of CBF. In conditions of chronic 
hypoxaemia such as placental insufficiency, the fetus redistributes its circulation and cardiac output 
to maximise oxygen and nutrient supply to the brain at the expenses of other vascular beds: this 
phenomenon, defined as brain-sparing [256], is characterized by a decrease in cerebral vascular 
resistance; the resulting cerebral vasodilatation is associated with a reduced pulsatility index in 
cerebral arteries. The middle cerebral artery is usually adopted as the gold-standard for this 
assessment, and a MCA-PI below the 5th percentile indicates the occurrence of this haemodynamic 
remodelling [203]. 
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According to the present data, SVR was significantly increased in neonates with placental-related 
IUGR, either with or without evidence of brain sparing, implying a postnatal persistence of systemic 
vasoconstriction. Data from preterm infants during the first week of life have described an inverse 
relationship between birth weight and BP in small-for-gestational-age infants, but not in those born 
with an adequate weight [257]. In a similar fashion, among children born preterm, an increase in 
systemic arterial stiffness and mean blood pressure has been shown in those with intrauterine growth 
retardation [258]. Moreover, large epidemiological evidence from human studies has linked IUGR 
with early-onset hypertension and increased mortality from cardiovascular diseases in adult life [259–
263]. Based on this evidence, it may be possible that placental-related IUGR causes specific and 
persistent changes in vascular structure and in the vessel dynamics, with long-term implications on 
cardiovascular health. 
Infants with umbilical AREDF but no evidence of brain sparing showed a significant reduction of 
CO compared with those with normal antenatal Doppler. It is possible that this reduction was driven 
by a concomitant SV decrease, although the SV reduction observed in the present data did not reach 
statistical significance. 
As previously demonstrated by fetal echocardiographic studies, the chronic exposure to increased 
placental vascular resistances is associated with an adaptive remodelling of the left ventricle, 
characterized by an impaired diastolic function [264,265]. On the other hand, the brain-sparing related 
cerebral vasodilation determines a decrease in left ventricular afterload, thus shifting the fetal cardiac 
output in favour of the left ventricle to enhance cerebral blood supply [266]. 
It is possible that the lower CO observed in infants with umbilical AREDF without evidence of brain 
sparing may result from their chronic antenatal exposure to pressure overload, with subsequent 
cardiac remodelling leading to a reduced left ventricular filling. Similar findings of decreased CO and 
increased SVR at birth were reported in an experimental lamb model of fetal growth restriction [267]. 
These results are in line with echocardiographic data obtained in term neonates during the early and 
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the late transitional period by Fouzas et al. [268], who provided evidence on the association between 
placental-related IUGR and described distinct changes in cardiac morphology, characterized by a 
subclinical myocardial dysfunction that may affect cardiovascular adaptation to extrauterine life. 
However, MCA Doppler data were not available in their population. Cardiac function and arterial 
biophysical properties have also been investigated between day 2 and 5 after birth in term infants 
with a birth weight <3° percentile and normal MCA Doppler, with evidence of increased SVR and 
impaired left myocardial function with speckle tracking analysis compared with infants with an 
adequate weight [269]; this study, however, was based on ponderal and growth criteria rather than on 
antenatal Doppler data.  
The present results also demonstrated significant differences in cerebrovascular reactivity in relation 
to cerebral vascular redistribution, with selectively increased TOHRx values in infants with antenatal 
brain sparing. This finding is in accordance with previous evidence of a transitional impairment of 
cerebral autoregulation, measured as the correlation between MABP and cTOI, in preterm infants 
small for gestational age [270] or with antenatal CBF redistribution [108]. Consistent with these 
findings, data from human IUGR fetuses with brain sparing have documented a prenatal loss of 
vasoreactivity in response to maternal hyperoxygenation, which failed to elicit the expected rise in 
cerebral vascular resistance [271].  
The altered cerebrovascular reactivity observed in association with brain sparing likely results from 
the structural remodelling of the cerebral vasculature observed in animal models of chronic fetal 
hypoxia and characterized by a reduced vascular density in the white matter, decreased perivascular 
astrocytes and increased permeability of the blood brain barrier, associated with a shift from calcium- 
and nitric oxide-mediated toward an adrenergic-mediated vasoreactivity [272,273]. Whether this 
altered cerebrovascular reactivity persists over time, it has not been ascertained; of note, an increased 




In summary, cardiovascular and cerebrovascular haemodynamics of preterm infants during the 
transitional period may be significantly influenced by specific antenatal, perinatal and postnatal 
factors; in particular, antenatal disturbances of fetal Doppler flowmetry, GA and the presence of a 
hsPDA showed the most extensive effects, which should be thus taken into account in the 
haemodynamic assessment and management of this population. 
In particular, lower GA were associated with significantly increased SVR and HR, reduced SV and 
cardiac contractility, lower cerebral oxygenation and higher cerebral oxygen extraction. These 
findings suggest that, during transition, extremely preterm infants may benefit from a tailored 
cardiovascular approach, aimed at optimizing blood volume and cardiac contractility (e.g., 
dobutamine) rather than at supporting blood pressure by increasing SVR (e.g., dopamine). Moreover, 
the association between CO, cerebral oxygenation and oxygen extraction highlights the importance 
of this parameter for the maintenance of stable cerebral haemodynamics in this delicate population. 
Since the prevalence of a hsPDA increases at lower GA, however, the management of most preterm 
infants cannot disregard the ductal status. According to the present findings, a hsPDA significantly 
affects cerebral autoregulation and is associated with higher CO, SV, HR, enhanced cardiac 
contractility and decreased SVR. Hence, identifying infants with a hsPDA is very important; in the 
presence of a hsPDA, greater attention should be paid on preventing CBF fluctuations, and 
cardiovascular treatments should be carefully tailored on individual SVR, SV and cardiac contractility 
features. 
Antenatal abnormal umbilical Doppler led to significantly raised SVR during the transitional period. 
This suggests that therapeutic cardiovascular approaches that increase SVR may be 
counterproductive in this population. In addition to the umbilical Doppler status, the establishment of 
antenatal brain sparing should also be assessed, since this condition has resulted to be associated with 
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a greater impairment of cerebral autoregulation and may thus identify a subgroup of infants at higher 
risk for neurological complications.  
• Limitations 
As seen from the clinical and neonatal characteristics of the population included in this research, a 
good proportion of the study infants were generally well-adapted and underwent a successful 
physiological transition to postnatal life. This may have contributed to the low prevalence of severe 
IVH observed in the present population. Since IVH is rather a consequence than a causative factor of 
transitional haemodynamic cardiovascular and cerebrovascular fluctuations [48,89,120], this 
condition was not included in the fixed effects of the GLMMs and LMM evaluating the main 
haemodynamic determinants during transition. However, the small number of infants who developed 
IVH, especially of high grade (i.e., n=3), did not allow to run a powered analysis to elicit the 
haemodynamic patterns associated with this complication, which thus warrants to be investigated in 
targeted, larger studies. On the other hand, the present population may constitute a reference cohort 
to evaluate the trend patterns of the main haemodynamic parameters and their association with 
relevant clinical factors in overall physiological conditions.  
The unavailability of a simultaneous invasive BP monitoring needs to be acknowledged as a possible 
limitation as, if available, it would have allowed to examine the continuous trajectories of MABP 
over time, to compare TOHRx values against indices of cerebral autoregulation, based on continuous 
BP monitoring [78,93], or to investigate the dynamic correlation existing between cardiac output and 
afterload. However, although arterial catheterization represents the current gold-standard technique 
for continuous blood pressure measurement, it should be considered that a tendency towards less 
invasive approaches, including a decreased use of arterial lines, is being increasingly adopted in 
neonatal settings [275–277], and that this procedure is not exempt from adverse events.  
CO2 is a potent modulator of cerebral vasculature and, as such, may have had an influence on 
cerebrovascular parameters. Unfortunately, continuous monitoring of transcutaneous or end-tidal 
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CO2 was not available to be included in the multiparametric monitoring system used for in present 
research, so it was not possible to examine CO2 trends and their effects on the present data. However, 
the regular arterial blood gases that were performed during the monitoring period showed stable levels 
of PaCO2, and the management of ventilated neonates was aimed at maintaining PaCO2 and PaO2 as 
stable as possible. 
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5. INTERPARAMETRIC CARDIAC CORRELATIONS 
5.1. Introduction and aim 
Cardiac output is the result of a complex interplay between different haemodynamic factors, which 
include preload, diastolic filling, intra-cardiac flow patterns, contractility and afterload [5,13]. 
Nevertheless, the two direct determinants of CO are SV and HR. It has long been assumed that, in 
neonates, SV is relatively fixed and HR is thus the main modulating factor of CO [13]. However, 
more recent studies have shown that, in preterm infants, fluctuations in cardiac output more often 
result from changes in the stroke volume rather than in the heart rate [25,26]. 
Due in part to immaturity of their autonomic and cardiovascular systems, preterm neonates have 
significantly higher resting heart rates when compared to term infants and older children; in addition, 
the chronotropic effects of the drugs that are frequently used to support their cardiovascular function 
may lead to further HR increases which, by shortening the time for diastolic ventricular filling, can 
subsequently lead to a SV decrease [20]. On the other hand, SV is directly affected by the presence 
of haemodynamically significant shunts, of which the most relevant is that across a large PDA. 
Several other factors, including inotropes and vasopressors, may contribute to influence the 
contractile function of the immature myocardium, the preload and the afterload, with indirect effects 
on SV. Hence, it is plausible that the relationship between HR, SV and CO is not fixed and linear, 
but rather dynamic, and may vary at different ranges of HR, SV and upon the individual 
characteristics of each infant, with potentially relevant practical implications. 
The research objective addressed in this section aimed at investigating the relationship between CO 
and its two direct determinants, monitored beat-to-beat during the first 72 hours of life, at different 
SV and HR ranges and according to relevant clinical and haemodynamic characteristics. For this 
purpose, the agreement between COEV and that measured by echocardiography was also preliminarily 
analysed. 
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5.2. Methods and Statistics  
Methods 
Patient recruitment, ultrasound evaluation and data collection, including the multiple parameters 
obtained by non-invasive multiparametric monitoring, are described in detail in Chapter 3. 
Echocardiographic cardiac output values (COECHO) were calculated as previously described in 
Chapter 3; the values included in the Bland-Altman analysis were obtained by averaging the VTI over 
5 cycles and indexed for the infants’ weight. In order to rule out a possible bias related to inter-
operator variability, all the echocardiographic measurements included in the analysis were obtained 
by a single operator, blind to EV data at the time of the scan. For COEV, 30-sec averaged data around 
the time of the echocardiographic evaluation were used for Bland-Altman analysis. 
Beat-to-beat data of COEV, SV and HREV obtained by EV monitoring throughout the whole 
transitional period were used to evaluate the parametric correlations existing among these parameters. 
COEV and SV were indexed using the infants’ daily weight. 
 
Statistical analysis 
The agreement between daily cardiac output values obtained using echocardiography (COECHO) and 
electrical velocimetry (COEV) over the first 72 hours of life was assessed and illustrated using the 
Bland–Altman plot. COECHO values were used as reference. To best handle repeated measures, the 
analysis was performed separately on each day of life. Differences in agreement according to the 
presence of hsPDA were investigated using a generalized least squares (GLS) random-effects 
model, with the absolute delta between COECHO and COEV as the dependent variable. The agreement 
between the two methods was also calculated as the percent error of COEV compared to COECHO, 
which is given by the formula |(#$!" − #$!#$%)/#$!#$%| × 100. The 95% confidence interval 
(CI) of mean error was estimated using the bias-corrected bootstrap method. 
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GLS random-effects models were also used to analyse the association of COEV with heart rate (HREV) 
and stroke volume (SV) at 1, 2 and 3 days of age. GLS estimators are useful when there is a degree 
of correlation between the residuals because observations are clustered into groups that have 
something in common (in this case, subject-specific beat-to-beat haemodynamic parameters). To 
investigate the presence of non-linear inter-parametric relationships, HR was collapsed into a 
categorical variable of seven groups using the following breakpoints: <120, 120–129, 130–139, 140–
149, 150–159, 160–169 and ≥170 bpm. Similarly, SV was collapsed into a categorical variable of six 
groups (<1.60, 1.60–1.99, 2.00–2.19, 2.20–2.49, 2.50–2.99 and ≥3.00 ml/kg). 
The clinical covariates that were mainly related to the cardiovascular status of preterm infants (GA, 
umbilical Doppler status, administration of dopamine and dobutamine, ductal status and type of 
ventilation) were included in the multivariable models to examine their impact on the association of 
CO with HR and SV. To improve the model sensitivity, those variables whose status changed over 
time (e.g., ductal status, mode of respiratory support, ongoing cardiovascular drugs) were handled as 
time-dependent covariates. To illustrate the moderating effect of such clinical features, we plotted the 
predictions from regression models corresponding to different HR and SV ranges—in case of no 
interaction, the trajectories are parallel. Contrast in the predicted means of CO at each level of HR 
and SV were examined with the Wald test. The standard errors of the regression coefficients and the 
predicted means of CO were estimated with the robust method. Normality of the overall error 
component was checked using the Q–Q plot. No collinearity issues were found. 
In a secondary analysis, GLS random-effects models were used to investigate the association between 




The infants included in this sub-analysis coincide with the sample previously described in Chapter 4. 
The relevant neonatal and clinical characteristics of this population at baseline and over the 
monitoring period are available in Table 4.1 and 4.2, respectively. 
 
Bland Altman analysis 
In order to rule out a possible bias related to inter-operator variability, only the echocardiographic 
measurements obtained by a single operator (Dr Silvia Martini) were included in the analysis: this 
explains the different number of measurements over the first 3 days and the fact that the measurements 
were lower than the actual study sample. 
The mean difference between COEV and COECHO was 10.7 ml/kg/min (95% CI 1.3, 20.1) on day 1, 
7.1 ml/kg/min (95% CI –2.1, 16.3) on day 2, and 11.0 ml/kg/min (95% CI 4.3, 17.8) in day 3 of life. 
The corresponding mean percentage error (MPE) of COEV was 7.6% (95% CI 4.9%, 11.3%) on day 
1, 7.3% (95% CI 4.1%, 13.4%) on day 2, and 7.3% (95% CI 5.5%, 9.5%) on day 3 of life. 
As shown in Figure 5.1, there was no evidence of proportional bias, i.e., the two methods agreed 
equally through the range of measurements. The 95% limits of agreement illustrated in the charts, 
which are defined as the mean difference ±1.96 times the standard deviation of the differences and 
indicate how far apart measurements are likely to be for most individuals, were –55.3 to 76.7 
ml/kg/min on day 1, –55.8 to 70.0 ml/kg/min on day 2, and –33.4 to 55.5 ml/kg/min on day 3. In 
general, EV measurements were systematically higher in patients with haemodynamically significant 
PDA than in those with closed or restrictive PDA (mean difference in differences = 10.1 mg/kg/min; 






Figure 5.1. Bland–Altman plot of cardiac output measured with electrical velocimetry (COEV) versus echocardiography (COECHO) on day 1, 2 and 3 
of life. Red-dashed lines indicate the upper and lower limit of agreement. Short-dashed lines indicate the 95% confidence interval for the mean 
difference. Abbreviations: hsPDA, haemodynamically significant patent ductus arteriosus; SD, standard deviation.
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Interparametric cardiac correlations 
Data on beat-to-beat CO, HR and SV obtained with EV at 1, 2 and 3 days of age and the number of 
observations for each neonate on which the related analysis was based are shown in Table 5.1. 
 
Table 5.1. Beat-to-beat haemodynamic parameters at 1, 2 and 3 days of age. Abbreviations: SD, 
standard deviation. 
Parameter Day 1 Day 2 Day 3 
Avg. n. of obs. per subject 34,133 63,499 60,217 
Cardiac output, ml/kg/min    
Mean ± SD 314.9 ± 90.1 335.2 ± 104.5 323.5 ± 93.6 
Median 304.0 318.7 312.3 
Interquartile range 254.3–365.5 260.7–397.9 253.7–381.0 
Interdecile range* 208.0–439.9 208.1–487.3 212.7–453.0 
Avg. n. of obs. per subject 34,271 64,005 60,736 
Heart rate, bpm    
Mean ± SD 141.2 ± 14.9 145.0 ± 17.5 145.5 ± 15.2 
Median 140 143 144 
Interquartile range 131–151 132–157 135–156 
Interdecile range* 123–161 124–169 127–166 
Avg. n. of obs. per subject 33,936 62,640 59,044 
Stroke volume, ml/kg    
Mean ± SD 2.30 ± 0.64 2.37 ± 0.70 2.29 ± 0.63 
Median 2.24 2.29 2.22 
Interquartile range 1.86–2.69 1.87–2.82 1.83–2.68 
Interdecile range* 1.52–3.16 1.51–3.36 1.54–3.14 
*Distance between the 1st decile (10th percentile) and the 9th decile (90th percentile).   
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Results of the univariate GLS random-effects model evaluating the beat-to-beat association of COEV 
with HR at different HR ranges are shown in Table 5.2. HR between 140 and 149 bpm were chosen 
as the reference interval according to currently available literature [196,235]. 
 
Table 5.2. Generalized least square random-effects model for heart rate (HR) versus cardiac output. 
Regression coefficients are expressed as ml/kg/min. Abbreviations: CI, confidence interval. Asterisks 
indicate contrasts significant at the 5% (*) and 1% (**) level. 
Characteristic 
Day 1 Day 2 Day 3 
Coef. 95% CI Coef. 95% CI Coef. 95% CI 
HR, bpm       
<120 –16.6* –31.7, –1.5 –36.6** –51.1, –22.1 –25.6** –41.1, –10.1 
120–129 –8.8 –21.2, 3.6 –16.5** –24.7, –8.3 –14.5* –26.1, –2.8 
130–139 –3.8 –13.7, 6.1 –7.0* –13.7, –0.4 –3.2 –9.4, 3.0 
140–149 Ref.  Ref.  Ref.  
150–159 13.3** 7.1, 19.4 11.8** 4.9, 18.7 11.5** 5.8, 17.3 
160–169 18.1** 7.5, 28.6 3.6 –8.3, 15.5 14.3* 2.8, 25.8 
≥170 24.4* 0.8, 48.1 –5.2 –22.3, 11.8 5.3 –11.8, 22.5 
Intercept 315.3** 295.4, 335.2 335.7** 313.3, 358.2 322.1** 303.7, 340.5 
 
On day 1, CO significantly increased if HR rose above the reference range, with greater increases at 
higher HR ranges, as suggested by the correlation coefficients shown in Table 5.2, whereas a HR 
drop <120 bpm led to a significant CO reduction. 
On day 2, significant CO increases compared to the reference HR were achieved only within the HR 
range between 150 and 159. Higher HR increases did not contribute to improve CO; although the 
correlation between HR values ≥170 bpm and CO showed a negative coefficient, this finding was not 
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statistically significant. Conversely, when HR decreased <140 bpm, a progressive, significant 
reduction of CO was observed. 
On day 3, compared to the reference interval, a significant increase of CO was obtained at HR ranges 
between 150 and 169 bpm, whereas an opposite effect was observed when HR dropped <130 bpm, 
in a linear fashion.  
Estimated means of CO in relation to different HR ranges on day 1, 2, 3 and during the whole 
transitional period are illustrated in Figure 5.2. An overall trend towards a progressive CO increase 
at increasing HR values was observed for HR ranges <160. While further HR increases still 
contributed to increase CO on day 1, negative correlations between the two parameters were observed 
on day 2 and 3, flattening the overall curve for HR values ≥160 bpm. 
 
Figure 5.2. Estimated means of cardiac output (Y-axis) at different levels of heart rate (X-axis), 
overall (black squares, black continuous line) and by day of age. 
 
Figure 5.3 illustrates the results of the multivariable GLS analysis evaluating the impact of GA, 
umbilical Doppler status, administration of dopamine and dobutamine, ductal status and type of 




Figure 5.3. Estimated means of CO (Y-axis, ml/kg/min) at different levels of HR (X-axis, bpm) on day 1, 2 and 3, by gestational age, antenatal Doppler status 
(umbilical AREDF vs. normal umbilical Doppler), dopamine/dobutamine administration, ductal status (haemodynamically significant [HS] patent ductus 
arteriosus [PDA] vs. restrictive or closed) and type of ventilation (invasive vs. noninvasive). Asterisks indicate contrasts significant at 5% (*) and 1% (**) level.
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No significant effects were observed for GA, antenatal Doppler status and ongoing mechanical 
ventilation. On the other hand, the administration of dopamine and dobutamine significantly 
influenced the correlation between HR and CO, with diverse effects observed at different days of life.  
On day 1, the administration of dopamine was associated with an overall reduction of cardiac output 
in infants who received this treatment compared to those who did not, net of the other covariates 
included in the GLS analysis and illustrated in Figure 5.3. Moreover, if HR fell <120 bpm, dopamine 
administration was associated with a greater CO reduction, whereas at HR ranges ≥160 bpm, the 
correlation between HR and CO turned negative, showing a progressive decrease in CO for increasing 
HR, whereas this correlation was maintained positive in infants who did not receive dopamine. 
Conversely, dobutamine administration on day 1 significantly increased CO at HR ranges between 
120 and 159 bpm; however, for further HR increases, this positive effect was no longer evident and 
the correlation between HR and CO turned negative, whereas infants who did not receive dobutamine 
were able to increase their CO even at HR ranges ≥160. However, dobutamine administration was 
not associated with an overall CO decrease at high HR ranges; in fact, the CO levels observed at HR 
≥170 in treated infants were comparable to the untreated group.  
With regard to the ductal status, significantly higher CO at HR ranges <160 were observed during the 
first 24 hours in infants with a hsPDA, whereas at further HR increases, their HR-CO curve remained 
flat. On the other hand, those with a restrictive or closed duct maintained a steeper curve at HR ≥160. 
On day 2, substantial changes were observed in the dopamine curve. Similar CO ranges were 
observed in the two groups; however, while the two curves were almost overlapping for HR up to 
149 bpm, the relationship between HR and CO turned negative at HR values ≥150 in infants who 
received this vasopressor treatment. Although no significant between-group difference was observed, 
a progressive reduction of CO values was observed for further HR increases in association with 
dopamine treatment. Dobutamine maintained a significant positive effect in enhancing CO at HR 
ranges between 120 and 149; although further HR increases led to slight and gradual CO reductions, 
the CO levels achieved at HR ≥170 were comparable to those observed in the untreated group. At 
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this phase, the significant impact of hsPDA was no longer observed, and the HR-CO curves between 
the two groups were almost overlapping. 
No significant differences in the HR-CO curves in relation to dopamine and dobutamine 
administration were observed on day 3. Of note, at this phase dobutamine administration did not lead 
to a substantial CO improvement compared to the untreated group at similar HR; rather a trend 
towards reduced CO values was observed at highest HR ranges (≥170). Conversely, dopamine 
showed slightly, but not significantly increased CO values compared to untreated infants when HR 
laid between 140 and 160. 
 
Results of the univariate GLS random-effects model evaluating the beat-to-beat association of CO 
with SV at different SV volumes are shown in Table 5.3. 
 
Table 5.3. Generalized least square random-effects model for stroke volume (SV) versus cardiac 
output. Regression coefficients are expressed as ml/kg/min. Abbreviations: CI, confidence interval. 
Asterisks indicate contrasts significant at the 5% (*) and 1% (**) level. 
Characteristic 
Day 1 Day 2 Day 3 
Coef. 95% CI Coef. 95% CI Coef. 95% CI 
SV, ml/kg       
<1.60 Ref.  Ref.  Ref.  
1.60–1.99 49.5** 44.2, 54.8 50.0** 45.4, 54.7 47.9** 41.4, 54.4 
2.00–2.19 81.2** 75.0, 87.4 84.3** 78.8, 89.8 84.2** 76.7, 91.6 
2.20–2.49 110.2** 103.3, 117.2 113.5** 107.0, 120.0 115.3** 107.0, 123.6 
2.50–2.99 149.6** 140.5, 158.6 153.1** 144.9, 161.4 157.0** 147.5, 166.6 
≥3.00 219.9** 205.9, 233.8 229.4** 217.0, 241.9 228.2** 211.3, 245.1 
Intercept 215.6** 205.8, 225.4 222.7** 213.5, 232.0 221.5** 213.3, 229.7 
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Estimated CO means in relation to different SV ranges on day 1, 2, 3 and during the whole transitional 
period are illustrated in Figure 5.4. The correlation between CO and SV was strong and followed a 
linear fashion: the greater the SV, the higher the CO. This trend was confirmed throughout the whole 
transitional period, with no substantial differences in relation to the day of life. 
 
Figure 5.4. Estimated means of cardiac output (Y-axis) at different levels of stroke volume (X-axis), 
overall (black squares, black continuous line) and by day of age. 
 
Figure 5.5 illustrates the results of the multivariable GLS analysis evaluating the impact of GA, 
umbilical Doppler status, administration of dopamine and dobutamine, ductal status and type of 
ventilation on the association between different SV ranges and CO on each day of life. 
No significant effect over the first 3 days of life was observed for mechanical ventilation and antenatal 
Doppler status. Conversely, infants <28 weeks’ gestation showed significantly higher CO values at 
increasing SV; in particular, a SV ≥ 2.5 ml/kg resulted in a significant CO improvement throughout 
the whole transitional period compared to those with higher GAs from day 1 to 3, whereas on day 2 
significantly higher CO compared to moderately preterm infants were obtained at SV≥ 2 ml/kg.   
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Figure 5.5. Estimated means of CO (Y-axis, ml/kg/min) at different levels of SV (X-axis, ml/kg) on day 1, 2 and 3, by gestational age, antenatal Doppler status 
(umbilical AREDF vs. normal umbilical Doppler), dopamine/dobutamine administration, ductal status (haemodynamically significant [HS] patent ductus 
arteriosus [PDA] vs. restrictive or closed) and type of ventilation (invasive vs. noninvasive). Asterisks indicate contrasts significant at 5% (*) and 1% (**) level; 
significant pairwise comparisons between gestational age classes <28 weeks (1), 28–<32 weeks (2) and ≥32 weeks (3) are reported as 1/2, 1/3 or 2/3.
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The presence of a hsPDA resulted in significant CO increases for SV≥ 2.5 ml/kg on day 1 and 2 
compared to a restrictive or closed duct. Similar SV ranges were also associated with a significant 
CO increase in infants treated with dopamine on day 3 compared to the untreated group.  
 
Results of GLS random-effects model evaluating the beat-to-beat association of SVEV with HR at 
different HR ranges are shown in Table 5.4. As for the previous model, HR between 140 and 149 
bpm were chosen as the reference interval according to currently available literature [196,235]. 
On each day of life, any HR increase above the reference interval (140-149 bpm) was associated with 
a concomitant SV reduction; conversely, HR reductions below the reference range led to progressive 
increments of SV. 
 
Table 5.4. Generalized least square random-effects model for heart rate (HR) versus stroke volume  
on day 1, 2 and 3. Regression coefficients are expressed as ml/kg. Abbreviations: CI, confidence 
interval. Asterisks indicate contrasts significant at the 5% (*) and 1% (**) level. 
Characteristic 
Day 1 Day 2 Day 3 
Coef. 95% CI Coef. 95% CI Coef. 95% CI 
HR, bpm       
<120 0.38** 0.25, 0.51 0.28** 0.18, 0.38 0.32** 0.19, 0.46 
120–129 0.24** 0.14, 0.34 0.19** 0.12, 0.26 0.21** 0.12, 0.31 
130–139 0.12** 0.05, 0.19 0.09** 0.04, 0.15 0.12** 0.07, 0.16 
140–149 Ref.  Ref.  Ref.  
150–159 –0.05* –0.10, –0.01 –0.06* –0.11, –0.01 –0.06** –0.10, –0.02 
160–169 –0.15** –0.22, –0.09 –0.25** –0.34, –0.16 –0.17** –0.25, –0.09 
≥170 –0.24** –0.38, –0.10 –0.46** –0.60, –0.33 –0.37** –0.48, –0.26 
Intercept 2.24** 2.11, 2.38 2.37** 2.22, 2.53 2.28** 2.16, 2.41 
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Estimated means of SV in relation to different HR ranges on day 1, 2, 3 and during the whole 
transitional period are illustrated in Figure 5.6. The negative linear fashion that characterizes the 
relationship between SV and HR is clearly evident in this figure.  
 
 
Figure 5.6. Estimated means of stroke volume (Y-axis) at different levels of heart rate (X-axis), 
overall (black squares, black continuous line) and by day of age. 
 
Figure 5.7 illustrates the results of the multivariable GLS analysis evaluating the impact of GA, 
umbilical Doppler status, administration of dopamine and dobutamine, ductal status and type of 
ventilation on the association between HR at different ranges and SV on each day of life. 
This finding illustrated in this figure basically resembled those observed in Figure 5.3, which depicted 
the correlation between HR and CO. This is due to the strong, linear relationship existing between 




Figure 5.7. Estimated means of SV (Y-axis, ml/kg) at different levels of HR (X-axis, bpm) on day 1, 2 and 3, by gestational age, antenatal Doppler status (umbilical 
AREDF vs. normal umbilical Doppler), dopamine/dobutamine administration, ductal status (haemodynamically significant [HS] patent ductus arteriosus [PDA] 
vs. restrictive or closed) and type of ventilation (invasive vs. noninvasive). Asterisks indicate contrasts significant at the 5% (*) and 1% (**) level.
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Discussion 
Electrical velocimetry is a non-invasive monitoring technique that, based on the analysis of the 
variations in thoracic electrical bioimpedance in relation to peak aortic blood flow acceleration, 
allows for continuous trend monitoring of cardiac output and other haemodynamic parameters, 
including SV, HR, SVR and also cardiac contractility estimation [278]. In the recent years, EV has 
been progressively introduced in NICU settings, with increasing evidence on the feasibility of its 
application in preterm infants [147–149,151,194,279–281]. 
 
Bland-Altman analysis 
The agreement between EV and transthoracic echocardiography in the assessment of cardiac output 
has proved acceptable in previous neonatal studies [148,149,151,279]. Recently, Sanders et al. have 
published a metanalysis aimed at assessing the accuracy and precision of this method for non-invasive 
CO monitoring. Eleven studies from the paediatric population were included; of these, 2 focused on 
the neonatal population and compared EV against echocardiography [147,280]. For paediatric 
studies, the pooled bias was low (−0.02 L/min); however, the pooled MPE, which reflects the 
accuracy of the monitoring technique, was relatively high (42%). Available literature on the neonatal 
population have reported %bias and MPE ranging from 1% to 9% and from 25% to 60%, respectively 
[149,280–282]. 
In the present study, the mean difference between COEV and COECHO ranged between 7.1 and 11 
ml/kg/min over the first 3 days of life, with a corresponding MPE ranging between 7.3% and 7.6%; 
these results indicate an overall good agreement between the two techniques and compared to the 
available literature, are characterized by a low MPE, which indicates satisfactory accuracy. 
Echocardiography is considered by many as the current gold-standard for CO assessment in the 
neonatal population. Although this technique has several advantages over EV, including the 
capability to evaluate cardiac anatomy and to diagnose ductal patency and its haemodynamic impact, 
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it requires specific training and experience-dependent expertise, and is prone to both inter- and intra-
operator variability. Moreover, it has been previously shown that echocardiographic CO assessment 
itself is burdened by a MPE of around 30% when compared to invasive gold-standard methods [141]. 
Hence, it cannot be considered as the absolute gold-standard to validate the reliability of EV in 
detecting CO. Alternative invasive techniques, such as transpulmonary dilution and arterial pulse 
contour analysis, guarantee more accurate CO determinations. However, these methods require 
arterial and central venous catheterization, which limits their applicability in the neonatal population 
and underlie the scarceness of data for EV comparison [278].  
According to our results, the presence of a hsPDA led to a systematic COEV overestimation of 
additional 10 mg/kg/min compared to echocardiography. It has been previously demonstrated that 
the presence of physiological shunts, such as through a PFO or a patent duct, may overestimate EV-
derived CO compared to echocardiographic assessments; in particular, the presence of a PDA, alone 
or combined with PFO, was associated with the highest relative difference compared to 
echocardiographic measurements [283]. Since a physiological PFO was evident in most of the 
monitored infants, we chose to evaluate the impact of hsPDA. A significant impact of hsPDA on 
COEV measurements has also been reported by Torigoe et al.; however, they reported a negative bias 
in association with this condition [280]. 
The mechanisms through which a hsPDA may influence COEV measurements, likely results from the 
interference of the transductal shunt on the volumetric changes and on the alignment changes of 
erythrocytes in the aorta during the cardiac cycle. Although an excellent correlation between EV and 
the invasive Fick method has been documented in children with congenital heart disease, the majority 




Interparametric cardiac correlations 
Following the assessment of the reliability of COEV measurements, the correlation existing between 
CO, HR and SV, measured by EV, was evaluated. 
According to the results presented, the relationship between CO and HR is not perfectly linear, but 
depends upon different HR ranges, whereas CO is strongly correlated with SV. Furthermore, 
associated factors with an active impact on cardiac function, such as administration of cardiovascular 
drugs or the presence of a hsPDA, significantly modulate these interparametric relationships. These 
findings are consistent with previous echocardiographic evidence by Winberg et al. [25], who 
investigated the correlation between changes in heart rate, left ventricular output, and left ventricular 
stroke volume in a small cohort of preterm neonates over the first 3 weeks of life, showing that the 
individual mean left ventricular output poorly correlated with HR, while a closer relationship was 
observed with SV. 
An added value of the present research is that the relationship between HR and CO was evaluated at 
different HR ranges and during different days of life. From this evaluation we found a HR rise above 
determinate thresholds (i.e., 170 bpm) negatively impacts on CO; this likely results from the decrease 
of diastolic ventricular filling time as HR increases. The greatest impact of HR in determining CO 
was observed during the first day of life: CO significantly increased even at the highest HR ranges, 
whereas similar findings were not observed on day 2 and 3. The poorer myocardial performance that 
the present data (see Chapter 4) and the currently available literature have documented by 
echocardiography during the first 24 hours [172,219,220] may have a role in the greater CO 
dependence upon HR observed in on day 1. Since diastolic filling and relaxation seem to be 
predominantly compromised in this early phase, the ability of the myocardium to effectively increase 
CO by increasing SV may be transiently impaired. Once the myocardial function improves, the 
impact of SV on CO determination progressively increases, whereas that of HR tends to become less 
predominant. 
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According to the present data, in infants with a hsPDA, increasing SV was associated with greater 
increases in CO. Moreover, at lower HR ranges, these infants showed significantly higher CO 
compared to those with a restrictive or a closed duct, whereas at higher HR ranges, the curve flattened 
down. A similar relationship between LVO, SV, and HR had been previously documented in preterm 
infants undergoing DA ligation, suggesting that in the presence of a symptomatic PDA, changes in 
CO is determined more by SV than HR [26]. We have previously observed (Chapter 4) significantly 
higher SV in the presence of a hsPDA compared with a restrictive or closed duct.  Hence, it could be 
hypothesized that the shortened diastolic time occurring at increased HRs may hinder ventricular 
filling, whereas at lower HR ranges the longer diastolic filling time allows a full SV contribution to 
CO determination for increased SV according to the Frank-Starling curve.  
A similar mechanism could underlie the greater benefits of dobutamine administration on CO 
observed at HR ranges <150 bpm during the first 2 days of life: if associated with a longer diastolic 
filling time, the improvement in myocardial function driven by this inotrope may be more efficient 
in enhancing CO. Of note, as previously described in Chapter 4, in the present population dobutamine 
administration effectively enhanced cardiac contractility without being associated with a significant 
HR increase. 
Conversely, dopamine administration during the first 24 hours was associated with a significantly 
lower CO, which further decreased at higher HR ranges. Consistent with previous evidence that the 
immature myocardium is particularly sensitive to afterload [21,27,28], it could be hypothesized that 
even a small afterload increase driven by dopamine administration further impairs myocardial 
function during the first 24 hours, thus leading to a reduction of SV and, subsequently, of CO. 
Moreover, the inverse relationship observed between HR and SV, may enhance these negative effects 
at higher HR ranges. Of note, the negative effect of dopamine administration on the relationship 
between HR and CO was no longer evident on day 2 and on day 3: it is possible that the progressive 
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improvement of cardiac function occurring after the first 24 hours after birth allows a progressive 
myocardial adaptation to increased afterload. 
In extremely preterm infants, CO was found to depend more on SV than on HR. Since HR is inversely 
related with GA (see Chapter 4), more preterm infants have higher resting HR, which may be closer 
to their functional peak capacity. Hence, strategies aimed at enhancing SV (e.g., volume filling) rather 
than at increasing HR may effectively contribute to improve CO.  
Finally, the correlation between HR and SV has demonstrated that SV changes are inversely related 
to the HR changes; hence, under otherwise stable conditions, the beat-to-beat fluctuations in HR are 
counterbalanced by changes in SV, with the ultimate goal of maintaining stable CO values. 
The present evidence of a strong, positive correlation between SV and CO and of non-linear 
relationship between HR and SV may have important clinical implications. First, progressive 
increases of HR are not always beneficial for CO but may rather exert negative effects, that are further 
enhanced under specific haemodynamic conditions. Second, especially after the first 24 hours of life, 
SV represents a predominant determinant of CO and, as such, should represent a first-line target of 
the therapeutic approaches aimed at CO improvement. Third, the vasopressors and inotropes that are 
often adopted to support preterm infants’ cardiovascular function may exert direct and indirect effects 
on the relationship between CO and its main determinants, whose knowledge would contribute to 
optimize the therapeutic haemodynamic management during transition in this delicate population. 
The use of beat-to-beat data sampling over a 72-hour period from 64 neonates represents a point of 
strength of this analysis as it allowed to obtain a solid pool of data, which would have not been 
achieved with sole intermittent echocardiography evaluations. On the other hand, although EV 
achieved adequate levels of precision and accuracy when compared to echocardiographic CO 
assessment, the slight overestimation of CO observed at the Bland-Altman analysis in the presence 
of a significant transductal shunt may have partially biased the findings observed in relation to a 
hsPDA. Finally, since the research design was not preliminarily targeted to evaluate inter-operator 
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variability of echocardiographic CO assessment, only data from a single expert operator were 
included in the Bland-Altman analysis, and this could be not fully representative of routine clinical 
practice. The inter-operator agreement within COECHO and between COEV and COECHO deserves to be 
investigated in future targeted research.   
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6. CARDIOVASCULAR AND CEREBROVASCULAR RESPONSES 
TO CARDIO-RESPIRATORY EVENTS 
6.1. Introduction and aim 
Due to the immaturity of the physiological mechanisms involved in respiratory control and 
oxygenation, intermittent episodes of hypoxia and/or bradycardia are very frequent among premature 
infants [284]. These episodes, also defined as cardio-respiratory events (CRE), have been associated 
with several adverse neonatal outcomes, including higher rates of retinopathy of prematurity, 
bronchopulmonary dysplasia, sleep disordered breathing and poor neurodevelopment [285].  
The unfavourable effects of CRE on cerebral haemodynamics in the preterm population have also 
been established [286,287]. A transient decrease in cerebral oxygenation has been documented during 
both bradycardic and hypoxic episodes, which can be deeper if the two events occur simultaneously 
[288,289]. Fluctuations between cerebral hypoxia and hyperoxia activate a pro-oxidant cascade that 
triggers an inflammatory response and alters the balance of neurotransmitters [285]. These 
mechanisms have been associated not only with the development of white matter injury in animal 
studies [290], but also with different patterns of neurocognitive impairment in preterm neonates [291–
293].  
The haemodynamic instability that characterizes the first 72 hours after preterm birth and the 
immaturity of the cardiovascular and cerebrovascular systems may worsen the impact of CRE on 
cerebral haemodynamics throughout this period, with possible impairment of cerebrovascular 
autoregulation. This is suggested by recent evidence of the association between early hypoxic burden 
and higher rates of IVH [176,294]. Moreover, during the transitional period, specific conditions, such 
as a hsPDA, influence the haemodynamic status of premature neonates and as such may also influence 
the haemodynamic effects of CRE [32]. 
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Current literature on CRE and their impact on cerebral perfusion and oxygenation is mostly based on 
infants aged from few weeks to few months. To the best of our knowledge, the haemodynamic impact 
of CRE in these situations still has to be elucidated. Moreover, evidence on functional cardiac changes 
during CRE in the preterm population is very scarce, and only related to bradycardic episodes without 
desaturation [295].  
The aim of this study was to investigate combined cardiovascular and cerebrovascular responses in 
response to different types of CRE in preterm infants during the transitional period, and to evaluate 
whether these responses may be influenced by antenatal, perinatal or postnatal factors.  
 
6.2. Methods and Statistics 
Methods 
Patient recruitment, ultrasound evaluation and data collection, including the multiple parameters 
obtained by non-invasive multiparametric monitoring, are described in detail in Chapter 3. Since the 
occurrence of cardio-respiratory events during mechanical ventilation may underlie different 
pathophysiological mechanisms, for the sake of data homogeneity, invasively ventilated preterm 
infants were not included in the analysis related to cardio-respiratory events, which was therefore 
limited to the subgroup of infants assisted with non-invasive respiratory support (e.g., nasal CPAP, 
nasal cannulas) or self-ventilating in air. Moreover, the limited number of infants among those 
included in this sub-group that required inotrope medications during the monitoring period did not 
allow to handle this variable with a powered analysis; hence, in order to rule out possible confounding 
factors on haemodynamic parameters, these infants were also excluded. 
Based on SpO2/HR values, CRE were defined as follows: isolated desaturations (ID), defined as SpO2 
<85% [296,297]; isolated bradycardias (IB), defined as any HR fall <100 bpm or >30% below the 
baseline before the event [297–299]; combined desaturation and bradycardia (DB), if the two events 
occurred within a 30-sec time window [300]. Event duration was calculated as the period spent below 
 147 
the SpO2/HR thresholds used for CRE definition; due to their doubtful clinical relevance, events <10 
sec were ruled out from the analysis [296]. Moreover, CRE with baseline SpO2 <90% were ruled out 
from the analysis. For each parameter, the last stable values before the event onset (baseline) and their 
zenit/nadir, concomitant to the lowest SpO2 and/or HR (event), were tracked down (Figure 6.1); 




The analytical strategy used for this analysis is based on generalized estimating equations (GEEs), 
introduced by Zeger and Liang [301]. This method is appropriate for the analysis of correlated data 
that arise from longitudinal studies, in which measurements/data from different subjects are collected 
at different time points; the interpretation of regression coefficients is the same as in regression 
models. A pool of >1000 events nested within 40 infants was adequately powered to test the 
relationship between cerebrovascular and cardiovascular responses and the independent variables 
included in the GEE models.  
In particular, GEEs with a normal distribution and autoregressive correlation structure were used to 
analyse the effects of different CRE types on the %D of cerebrovascular (cTOI and cFTOE) and 
cardiovascular parameters (HR, SV, COEV, ICON, SVR), to compare %D between bradycardic events 
with HR nadir < or ≥ 80bpm and to compare SpO2 during and after desaturations in relation to oxygen 
adjustments. GEEs with normal distribution and exchangeable correlation structure were used to 
assess the impact of clinical variables (gestational age, antenatal Doppler status, antenatal steroids 
administration, ductal status and ongoing respiratory support) and of different CRE types on %DcTOI, 
%DcFTOE and %DCO. In these models, the PDA status and the mode of ventilatory support were 
used as time-dependent covariates, and all the events were nested within individuals. Standard errors 




Figure 6.1. Example of an isolated desaturation using ICM+ screenshot of simultaneous changes occurring in the study parameters during a cardio-
respiratory event characterized by desaturation and bradycardia. The arrows indicate the time points used for baseline and event values. Adapted 
from Martini et al. J Physiol (2020) [302].  
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Corvaglia et al. 2014; Eichenwald, 2016); and combined
desaturation and bradycardia (DB), if the two events
occurred within a 30 s time window (Poets et al. 1993).
Event duration was calculated as the period spent below
the SpO2/HR thresholds used for CRE definition; as a
result of their doubtful clinical relevance, events <10 s
were ruled out from the analysis (Finer et al. 2006).
Moreover, CRE with baseline SpO2 <90% were ruled out
from the analysis.
For each parameter, the last stable values before the
event onset (baseline) and their zenit/nadir, concomitant
to the lowest SpO2 and/or HR (event), were tracked
down (Fig. 1); percentage changes (%!) between base-
line and event values were then calculated and used for the
statistical analysis.
Statistical analysis
The analytical strategy used in the present is based on
generalized estimating equations (GEEs), introduced by
Zeger & Liang (1986). This method is appropriate for the
analysis of correlated data that arise from longitudinal
studies, in which measurements/data from different sub-
jects are collected at different time points; the inter-
pretation of regression coefficients is the same as in
regression models.
In particular, GEEs with a normal distribution and
autoregressive correlation structure, which is appropriate
when time-varying outcomes or covariates are investigated
(Ballinger, 2004), were used to analyse the effects of
different CRE types on the %! of cerebrovascular (cTOI
and cFTOE) and cardiovascular parameters (HR, SV,
CO, iCON and sVR), aiming to compare %! between
bradycardic events with HR nadir <80 bpm or !80 bpm,
as well as compare SpO2 during and after desaturations
in relation to oxygen adjustments. GEEs with normal
distribution and autoregressive correlation structure were
also used to assess the impact of different antenatal
and neonatal variables on %!cTOI, %!cFTOE and
%!CO. In these models, the PDA status and the mode
of ventilatory support were used as time-dependent
covariates, and all the events were nested within
individuals. SEs were adjusted for the number of
non-redundant parameters. A pool of>1000 events nested
within 40 infants was adequately powered to test the
relationship between cerebrovascular and cardiovascular
responses and the independent variables included in the
GEE models.
Baseline and event values for each monitored parameter
were compared using Wilcoxon signed-rank test, whereas
repeated measures ANOVA for continuous variables and
chi-squared or Fisher’s exact test for categorical variables
were used to analyse changes of clinical, anthropometric
and haemodynamic characteristics of the study population
over the study period.
SPSS, version 25.0 (IBM Corp., Armonk, NY, USA) was
used for the statistical analyses. P < 0.05 was considered
statistically significant.
Results
Forty neonates were included in the present study,
as illustrated in the study flow chart (Fig. 2).
The characteristics of the study population are
shown in Table 1. Daily anthropometric, clinical and
haemodynamic features during the study period are
Figure 1. Example of an isolated desaturation using ICM+
The arrow indicate the time points for baselin and event values. cTOI, cerebral tissue oxygenation index; nTHI,
normalized total haemoglobin index; O2Hb, oxygenated haemoglobin index; HHb, deoxygenated haemoglobin
index; SpO2, peripheral arterial oxygen saturation; cFTOE, cerebral fraction of oxygen extraction; HR, heart rate
measured by electrical velocimetry; BPM, heart rate measured by pulse oximeter; SV, stroke volume; CO, cardiac
output; iCON, index of cardiac contractility; SVR, systemic vascular resistances.
C! 2020 The Authors. The Journal of Physiology C! 2020 The Physiological Society
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6.3. Results 
This analysis was performed in December 2019 on the 40 neonates non-invasively ventilated or self-
ventilating in air enrolled between March 2018 and December 2019. The results were published in 
September 2020 [302]. In the present dissertation the antenatal Doppler data of the included infants 
have been stratified according to the presence/absence of the brain sparing phenomenon, and the PDA 
status has been handled as a binomial variable (hsPDA vs. restrictive or closed DA) for the sake of 
data homogeneity in respect to the analyses described in the other chapters. 
The neonatal characteristics of the subgroup of infants included in this analysis are shown in Table 
6.1, whereas their daily clinical and haemodynamic features are detailed in Table 6.2. All the infants 
received caffeine prophylaxis for apnoea of prematurity. 
A total of 1426 events were recorded from the study cohort over the first 72 hours of life; of these, 
903 were ID (63.3%), 224 IB (15.7%) and 299 DB (21%). Baseline and event values of each study 
parameter for each event type are provided in Table 6.3. 
Of the 1202 events characterized by a SpO2 drop, 795 events (66.1%), of which 638 ID and 157 DB, 
resolved spontaneously or with physical stimulation, whereas the remaining 407 (33.9%), of which 
265 ID and 142 DB, required an increase in the fraction of inspired oxygen (FiO2). This latter group 
was characterized by significantly deeper nadir values of SpO2 (70 [interquartile range, IQR, 63.3-
74.2] %) and HR (127 [IQR 103-143] bpm) compared to those events which did not require FiO2 
adjustments (SpO2 81 [IQR 78.8-82.7] %, p<0.001; HR 142 [IQR 121-156] bpm, p<0.001). The zenit 
SpO2 in the recovery phase was significantly higher after those desaturation events requiring a FiO2 
adjustment compared to those who resolved without FiO2 changes (SpO2 97 [IQR 95.7-98.2] % vs. 
95.5 [IQR 93-97.6] %, p=0.002). 
  
 150 
Table 6.1. Clinical characteristics of the sub-group of infants included in CRE analysis. 
 
Neonatal characteristics  (n=40) 
Gestational age (weeks), mean (standard deviation, SD) 30.5 (2.2) 
Birth weight (g), mean (SD) 1279 (326) 
Length at birth (cm), mean (SD) 38.5 (2.9) 
Head circumference at birth (cm), mean (SD) 28 (2.1) 
Antenatal corticosteroids, n (%) 
Complete course 




Intrauterine growth restriction, n (%) 17 (42.5) 
Umbilical artery Doppler status, n (%) 15 (37.5) 
AREDF w/ brain sparing 10 (25) 
AREDF w/o brain sparing 5 (12.5) 
Small for gestational age, n (%) 13 (32.5) 
Caesarean section, n (%) 37 (92.5) 
Male gender, n (%) 20 (50) 
Twinhood, n (%) 11 (27.5) 
Apgar score at 1 min, median (interquartile range [IQR]) 7 (6-8) 




Table 6.2. Clinical and haemodynamic characteristics of the subgroup of infants included in CRE 
analysis) on day 1, 2 and 3 after birth. 
 
Clinical and haemodynamic characteristics Day 1 Day 2 Day 3 
Weight (g), mean ± standard deviation (SD) 1266 ± 330 1219 ± 328 1161 ± 316 
Status of ductus arteriosus, n (%) 
   
Haemodynamically significant 13 (32.5) 8 (20) 3 (7.5) 
Restrictive 18 (45) 14 (35) 7 (17.5) 
Closed 9 (22.5) 18 (45) 30 (75) 
Ventilatory support, n (%) 
   
Continuous Positive Airway Pressure 34 (85) 31 (77.5) 27 (57.5) 
Nasal cannulas or self-ventilating in air 6 (15) 9 (22.5) 17 (42.5) 
Intraventricular haemorrhage, n (%) 
Grade I  










Baseline values, mean ± SD 
Peripheral arterial oxygen saturation (%) 
 
96.5 ± 2.8  
 
96 ± 3.2 
 
95.8 ± 2.7 
Cerebral tissue oxygenation index (%) 74.3 ± 8.2 75.9 ± 8.0 75.2 ± 7.7 
Cerebral fraction of oxygen extraction 0.23 ± 0.09 0.21 ± 0.08 0.22 ± 0.08 
Heart rate (bpm) 150.5 ± 16.7 147.1 ± 17.8 152.3 ± 18.2 
Stroke volume (ml/kg) 
Cardiac output (ml/kg/min) 
2.23 ± 0.65 
331.3 ± 94.7 
2.49 ± 0.7 
356.6 ± 91.5 
2.38 ± 0.61 
357.3 ± 99.1 
Index of cardiac contractility 104.6 ± 45.3 120.2 ± 44.7 115.7 ± 40.9 









Table 6.3. Baseline and event values of the haemodynamic parameters for isolated desaturations, 
combined desaturations and bradycardias, isolated bradycardias. 
Events/parameters  
Baseline 
(mean ± SD) 
Event 
(mean ± SD) 
Isolated desaturations (n=903)  
Peripheral arterial oxygen saturation (%) 
 
95.6 ± 3.1  
 
76.9 ± 8.3 
Cerebral tissue oxygenation index (%) 75.2 ± 7.9 67.3 ± 8.5 
Cerebral fraction of oxygen extraction 0.21 ± 0.08 0.14 ± 0.11 
Heart rate (bpm) 152.1 ± 15.6 144.7 ± 18 
Stroke volume (ml/kg) 
Cardiac output (ml/kg/min) 
2.44 ± 0.65 
362.3 ± 95.5 
2.52 ± 0.68 
360.1 ± 103.8 
Index of cardiac contractility 117.6 ± 46.3 115.9 ± 48.7 




) 9211 ± 4623 9206 ± 4690 
Combined desaturations and bradycardias (n=299) 
Peripheral arterial oxygen saturation (%) 
 
96.3 ± 2.7 
 
73.6 ± 9.3 
Cerebral tissue oxygenation index (%) 76.4 ± 7.7 63.6 ± 8.9 
Cerebral fraction of oxygen extraction 0.20 ± 0.08 0.16 ± 0.11 
Heart rate (bpm) 156.8 ± 17.6 86.5 ± 13.4 
Stroke volume (ml/kg) 
Cardiac output (ml/kg/min) 
2.22 ± 0.6 
340.1 ± 93.8 
2.60 ± 0.67 
239.8 ± 70.9 
Index of cardiac contractility 107.7 ± 36.1 97.2 ± 34.3 




) 11558 ± 5190 16220 ± 10439 
Isolated bradycardias (n=224) 
Peripheral arterial oxygen saturation (%) 
 
96.4 ± 2.2 
 
94.5 ± 4.6 
Cerebral tissue oxygenation index (%) 75.1 ± 7.9 72.6 ± 7.1 
Cerebral fraction of oxygen extraction 0.22 ± 0.08 0.23 ± 0.07 
Heart rate (bpm) 137.7 ± 19.1 89.8 ± 9.8 
Stroke volume (ml/kg) 
Cardiac output (ml/kg/min) 
2.54 ± 0.67 
335.8 ± 87.1 
2.77 ± 0.57 
263.4 ± 58.6 
Index of cardiac contractility 109.3 ± 34.8 107.4 ± 28.2 




) 11378 ± 5027 13805 ± 6710 
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Percentage changes of cerebrovascular parameters in response to different CRE types are shown in 
Figure 6.2; %DcTOI significantly differed among CRE types, with the deepest reductions observed 
during DB compared to ID (p<0.001) and IB (p<0.001), whereas IB had the mildest impact. Both ID 
(p<0.001) and DB (p<0.001) led to a significant reduction of %DcFTOE compared to IB, which 
showed minimal effects on this parameter. A significant difference in %DcFTOE was also observed 
between ID and DB (p=0.019).  
 
Figure 6.2. Percentage change (%D) of cerebral tissue oxygenation index (cTOI) and cerebral 
fraction of tissue oxygen extraction (cFTOE) during isolated desaturation (ID), isolated bradycardia 
(IB) and combination desaturation and bradycardia (DB). The central line in the boxplot is the 
median, the margins of the box are the 25th and the 75th percentiles and the whiskers represent 1.5 
times the interquartile range (1.5*IQR). P-values for significant comparisons (generalized 
estimating equations) are provided. 
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Figure 6.3 illustrates percentage variations of cardiovascular parameters in response to different CRE 
types. Consistent with the definition of DB and IB, a significant HR drop was observed during these 
events compared to ID (p<0.001 for both comparisons); however, the HR decrease was significantly 
deeper if bradycardia was accompanied by a concomitant desaturation (p=0.020). Despite the %DSV 
increase, there was significant overall reduction of %DCO during bradycardic episodes, either when 
alone or associated with desaturation, compared to ID (p<0.001 for both comparisons). Conversely, 
when compared to ID, %DSVR significantly increased during DB (p<0.001) and IB (p<0.001). The 
combination of desaturation and bradycardia also resulted in significant reduction of %DICON 
compared to desaturations alone (p=0.043). 
 
Figure 6.3. Percentage change (%D) of heart rate (HR), stroke volume (SV), cardiac output (CO), 
index of cardiac contractility (ICON) and systemic vascular resistance (SVR) during isolated 
desaturation (ID), isolated bradycardia (IB) and combination desaturation and bradycardia (DB). 
The central line in the boxplot is the median, the margins of the box are the 25th and the 75th 
percentiles and the whiskers represent 1.5 times the interquartile range (1.5*IQR). P-values for 
significant comparisons (generalized estimating equations) are provided. 
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For bradycardic events (DB and IB), %D of cardiovascular and cerebrovascular parameters were 
compared between CRE with a nadir HR ≥ (n=419) or <80 bpm (n=104). As shown in Figure 6.4, a 
nadir HR <80 bpm was associated with significantly deeper %DcTOI (p=0.015), %DCO (p<0.001) 
and more positive %DsVR (p<0.001) compared to nadir HR values ≥ 80 bpm, while no significant 
effect was observed for %DcFTOE, %DSV and %DICON. 
The results of GEE models, detailed in Table 6.4, confirmed the impact of different CRE types on 
%DcTOI, %DcFTOE and %DCO and showed that different neonatal characteristics exert a significant 
influence on these parameters. In particular, the presence of an hsPDA was independently associated 
with greater cTOI reductions (p=0.007) and higher cFTOE values (p=0.029) in response to CRE, 
whereas intrauterine-growth restricted neonates with antenatal evidence of cerebral blood flow 
redistribution showed more negative variations of %DcFTOE (p=0.042). A significant positive 
correlation was observed between %DCO and GA (p=0.036), and significantly higher %DCO were 
also found in neonates with abnormal antenatal Doppler, with or without brain sparing evidence 
(p=0.039 and p=0.036, respectively). 
 
Table 6.4. Results of three generalized estimating equation models predicting percentage changes of 
cerebral tissue oxygenation index (%DcTOI), cerebral fraction of oxygen extraction (%DcFTOE) and 
cardiac output (%DCO), respectively. b are regression coefficients that can be interpreted as in a 
linear regression model. The confidence interval reflects the error of the estimate of the regression 
coefficient; when the confidence interval includes zero, the association between the dependent and 
the independent variable is not significant. When the independent variable is categorical, one group 
is used as the reference category (ref). Abbreviations: CI, confidence interval; GA, gestational age; 
AREDF, umbilical absent or reversed end-diastolic flow; CPAP, continuous positive airway 
pressure; SVIA, self-ventilating in air; ID, isolated desaturation; DB, desaturation with bradycardia; 
IB, isolated bradycardia 
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 %DcTOI (n=1426) %DcFTOE (n=1426) %DCO (n=1426) 
Variable b (95%CI) P-value  b (95%CI) P-value b (95%CI) P-value 
GA, weeks -0.415 (-0.990, 0.160) 0.157 0.423 (-0.297, 1.143) 0.250 0.900 (0.061, 1.739) 0.036 
Antenatal Doppler status 
AREDF, brain sparing 
AREDF, no brain sparing 
Normal  
 
-0.459 (-3.257, 2.338) 







-3.669 (-7.201, -0.137) 







4.017 (0.269, 7.765) 






Antenatal steroids,  
Complete course  
Incomplete/not given 
 



















Restrictive or closed 
 











































6.503 (4.665, 8.340) 








-4.858 (-9.972, 0.257) 






-20.869 (-26.457, -15.281) 









Figure 6.4. Percentage change (%D) of cerebral tissue oxygenation index (cTOI), cerebral fraction of tissue oxygen extraction (cFTOE), stroke 
volume (SV), cardiac output (CO), index of cardiac contractility (ICON) and systemic vascular resistance (SVR) during bradycardic events 
characterized by a HR nadir < or ≥80 bpm. The central line in the boxplot is the median, the margins of the box are the 25th and the 75th percentiles 




To the best of our knowledge, this is the first data providing a combined non-invasive investigation 
of cardiac and cerebral haemodynamics in response to CRE in preterm infants during the transitional 
period. Our findings indicate that different types of CRE elicit variable cardiovascular and 
cerebrovascular fluctuations. These in turn, are significantly influenced not only by the event type, 
but also by specific neonatal characteristics, such as abnormal umbilical Doppler or the presence of 
a hsPDA.  
CRE characterized by a combined drop in SpO2 and HR had the highest impact on cerebral 
oxygenation; this is consistent with previous findings describing a significant reduction of this 
parameter during DB when compared to isolated events [288,289].  
In 1985, Perlman and Volpe [303] carried out a Doppler evaluation of blood flow velocity fluctuations 
in the anterior cerebral arteries during apnoeic episodes accompanied by bradycardia in preterm 
infants aged 2 to 45 days. During a bradycardia, especially if the HR fell below 80 bpm, they observed 
a significant decrease in cerebral blood flow velocity and associated reduction in BP. A causal 
relationship between the two findings was postulated, raising important questions on the efficacy of 
the physiological mechanisms of cerebral autoregulation during these events, characterized by a 
sudden onset and a relatively short duration.  
Later on, Pichler et al. [304] performed a combined evaluation of cerebral oxygenation and cerebral 
blood volume during a small number of apnoeic episodes, characterized by desaturation with or 
without bradycardia (HR <80 bpm). In the presence of bradycardia, a greater reduction of cerebral 
oxygenation and of cerebral blood volume occurred compared to desaturation alone. The authors 
hypothesized that a decrease in cerebral blood flow occurs during bradycardic episodes, highlighting 
the importance of associated cardio-vascular changes on cerebral haemodynamics.  
This research provides simultaneous evaluation of cerebral and cardiovascular haemodynamic 
changes in response to CRE in preterm infants during the transitional period. We observed a 
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significant reduction in CO during bradycardic episodes, with lower values if the bradycardia was 
accompanied by desaturation. CO is the product of HR and SV. With a fall in HR, there was a 
compensatory increase in SV. The inverse correlation between HR and the left-ventricular ejection 
time, which is a main determinant for SV [305], can explain this finding. While HR decreased, SV 
significantly increased during IB and DB, compared to ID. However, according to our results, the 
effect of HR drop predominated over the increase in SV resulting in a net decrease in CO during 
bradycardic events. Moreover, the occurrence of bradycardia and desaturation together was 
associated with a significant reduction of cardiac contractility, which could play a role in the deeper 
reduction of CO observed during DB.  
The effect of bradycardia on myocardial function has been previously evaluated by de Waal et al. on 
a small number of episodes by means of functional echocardiography [295]. In line with the present 
findings, the authors reported an increased SV but a lower total CO during bradycardic events; they 
also observed a deficit in left atrial contractility. Bradycardic episodes, with or without desaturation, 
were also associated also with a significant increase in sVR. This might represent a physiological 
attempt to compensate the reduction in CO occurring with the bradycardia by increasing the systemic 
vascular tone. However, as there was no continuous invasive BP monitoring when collecting this 
data, this finding should be interpreted with caution. 
In the present cohort, the presence of a hsPDA led to a greater fall in cTOI and increase in cFTOE 
during CRE, independently of their type. A significantly lower cerebral oxygenation has been 
previously reported by several NIRS studies in preterm infants with a hsPDA compared to those with 
a non-significant PDA or with a closed duct [306–309], reflecting reduced cerebral blood flow due 
to the significant left-to-right transductal shunting [310]. These findings suggest that, in infants with 
a hsPDA, CRE are more likely to result in a greater degree of cerebral hypoxia, which has been 
recently proposed as a possible risk factor for IVH development over the first days of life [176,294]. 
Moreover, both hsPDA [311] and intermittent hypoxia [290,312] have been associated with a higher 
 160 
risk of periventricular leukomalacia. We speculate that particular attention should be made in infants 
with a hsPDA experiencing repeated CRE. However, the evaluation of a possible association with 
IVH/PVL was not feasible in the present study, as only few infants had low-grade IVH during the 
study period and none went on to develop PVL. 
Antenatal Doppler impairment was associated with different haemodynamic responses to CRE, with 
particular reference to cFTOE and CO. Infants with antenatal evidence of brain sparing showed a 
lower increase of cFTOE in response to CRE, irrespective of the type of event, whereas a smaller CO 
reduction during CRE was observed in the presence of antenatal AREDF, with or without blood flow 
redistribution. Identifying fetuses with placental-related intrauterine growth restriction, characterized 
by the antenatal Doppler evidence of AREDF in the umbilical artery and/or in the ductus venosus, is 
very important. This condition is associated with chronic fetal hypoxia, which ultimately leads to a 
circulatory redistribution aimed at favouring brain perfusion [313]. Our findings suggest that the 
physiological adaptations occurring antenatally in response to the persistently reduced blood and 
oxygen delivery through the placenta, and to the subsequent compensatory cardiovascular 
remodelling [314], aimed at guaranteeing an adequate blood perfusion and oxygenation of the brain, 
may persist over the 3 days after birth [270]. The high prevalence of AREDF in the study cohort, 
which is due to the characteristics of the local preterm population as our hospital is a tertiary referral 
centre for placental-related pregnancy complications, including placental-related IUGR, allowed to 
evaluate the effects of this condition also in relation to the antenatal patterns of blood flow 
redistribution. 
According to the present results, lower GAs resulted in a greater drop in CO during CRE associated 
with bradycardia. It has been shown that preterm infants have an immature myocardial tissue, with 
fewer contractile elements, higher water content, greater surface-to-volume ratio, and a reliance on 
L-type calcium channels that utilize extracellular calcium as a source of the second messenger driving 
cardiomyocyte contraction [208]. A GA-dependent impairment of myocardial function has been 
 161 
demonstrated by functional echocardiographic studies [216,315], and  a positive correlation between 
GA and baseline CO has also been documented using electrical cardiometry in healthy and stable 
preterm neonates [150,196]. Hence, the immature cardiac function associated with lower GAs may 
explain the greater impact of CO that we observed in more premature infants during CRE.  
To date, increasing evidence correlates vital parameters during the first golden minutes after birth 
with postnatal adaptation [316]. As illustrated in Table 6.1, most of the study infants showed an 
adequate early postnatal adaptation, and 1 in 3 did not require positive pressure ventilation in the 
delivery room. Consistent with the mentioned evidence, these infants maintained an overall stable 
condition during the transitional period and a low number of complications possibly triggered by poor 
neonatal adaption were observed. 
An important limitation of the present study is the lack of invasive continuous BP monitoring (i.e., 
through an indwelling arterial catheter). However, this was an observational study based on relatively 
stable preterm infants, and in our routine practice arterial lines are not placed in infants without a 
significant haemodynamic instability (e.g., hypotension requiring inotropes).  
Furthermore, the small number of infants with extremely low gestational ages (e.g., <28 weeks’ 
gestation) or with adverse postnatal adaptation also needs to be acknowledged among the study 
limitations. This is mainly due to the exclusion of invasively ventilated neonates, in order to rule out 
several factors related to mechanical ventilation (e.g., ventilation settings, respiratory rate, 
endotracheal suctioning, tube obstruction or dislodgement) which may have influenced not only CRE 
features but also cardiovascular and cerebrovascular parameters. As a consequence, however, the 
infants included were generally well-adapted and developed very few complications during transition. 
Although this cohort may constitute a reference range for cerebral and cardiovascular haemodynamic 
parameters, larger studies including ventilated and haemodynamically unstable neonates, may 
elucidate the role of BP and the integrity of the physiological mechanisms of cerebral autoregulation 
during intermittent hypoxia and bradycardia in sicker preterm infants.   
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7.  CONCLUSIONS AND FUTURE WORK 
The transition from intrauterine to extrauterine life is a critical phase of physiological adaptation in 
preterm infants. Due to their functional and anatomical immaturity, this population is prone to 
enhanced haemodynamic instability during the transitional period, which put them at risk of 
developing significant clinical complications. The validation of comprehensive haemodynamic 
monitoring, aimed at the assessment of cardiovascular function and end-organ perfusion throughout 
this challenging phase, would not only improve knowledge of transitional physiology and 
pathophysiology following preterm birth, but would also support the development of a tailored 
therapeutic management. 
In the present research, integrated, continuous and non-invasive monitoring of cardiovascular and 
cerebrovascular haemodynamics throughout the first 72 hours of life was performed on 64 preterm 
infants. The obtained results support the technical feasibility of this monitoring approach even at 
extremely low gestational ages (e.g., 24 weeks). Together with NIRS and pulse oximetry, the 
comprehensive monitoring adopted in this research project also included electrical velocimetry. This 
technique, which has been introduced in neonatal settings only in recent years, demonstrated a good 
agreement for cardiac output estimation when compared with functional echocardiography, which is 
the most widely used technique for non-invasive cardiac output assessment in the preterm population; 
however, a slight overestimation was observed in infants with a haemodynamically significant PDA, 
consistent with the currently available literature. 
A non-invasive marker for cerebrovascular reactivity, based on the correlation between cerebral 
oxygenation and heart rate, was also evaluated in this dissertation, providing encouraging results in 
support of its inclusion in the haemodynamic monitoring during postnatal transition. 
In Chapter 4, the time trends of cardiovascular and cerebrovascular haemodynamics during the 
transitional period have been evaluated, demonstrating the occurrence of a progressive improvement 
in the overall cardiovascular function, especially within the first 48 hours of life, and in 
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cerebrovascular reactivity. Moreover, the influence of a haemodynamically significant PDA on the 
observed trends has been demonstrated, supporting the pathophysiological relevance of this 
condition. The association between cardiovascular and cerebrovascular parameters and a pool of 
antenatal, perinatal and postnatal factors that overall contribute to characterize the early exposome of 
preterm infants has also been investigated. This analysis revealed specific interactions between these 
factors and the haemodynamic parameters and allowed to outline characteristic haemodynamic 
profiles in association with the following neonatal features: gestational age, antenatal Doppler status 
(with particular reference to the presence or absence of the brain sparing phenomenon), and ductal 
status. These results underpin how multifaceted the transitional haemodynamic status is in such a 
heterogenic population as preterm infants and provide valuable hints in support of the development 
of an individualized haemodynamic management of preterm infants during this delicate phase. 
In chapter 5, the relationship existing between CO and its two main determinants, namely HR and 
SV, was evaluated, revealing that the correlation between CO and HR is not linear and is significantly 
influenced by HR ranges themselves, the ductal status and ongoing cardiovascular drugs; hence, 
knowledge of where a neonate lies within this curve, may be useful for CO optimization. Moreover, 
a strong relationship between SV and CO has been demonstrated, especially after the first 24 hours 
of life, thus supporting evidence according to which SV is a predominant CO determinant even in 
preterm infants and, as such, should be primarily taken into account in the haemodynamic 
management of this population.  
In chapter 6, the cardiovascular and cerebrovascular responses to brief and acute cardio-respiratory 
events, which are particularly common in preterm infants during the transitional period, were 
examined. According to the obtained results, the haemodynamic impact of these events on both 
cardiovascular and cerebral sides is modulated not only by the event characteristics themselves, but 
also by individual neonatal features that coincided within the three characteristics underlying the 
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haemodynamic profiles described in Chapter 4: gestational age, antenatal Doppler status and ductal 
status. 
The present research indicates that cardiovascular and cerebrovascular haemodynamics undergo 
significant changes over the first 72 hours of life and are significantly influenced by specific antenatal, 
perinatal or postnatal factors – inclusive of cardiovascular treatments –  that contribute to outline 
characteristic haemodynamic profiles, whose knowledge may support the development of 
individualized strategies for the haemodynamic management of high-risk preterm neonates. 
In particular, the following key findings have emerged from the present research:  
 
1) The haemodynamic status of preterm infants varies upon several underlying or ongoing 
conditions: in particular, GA, antenatal Doppler characteristics and the state of the PDA 
impart significant differences in cardiovascular and cerebrovascular physiology during the 
transitional phase. Hence, these factors and their possible dynamic interactions should be 
taken into account in the clinical and therapeutic management of the preterm population, 
which cannot therefore be considered as a haemodynamically homogenous group. Moreover, 
the emerged haemodynamic profiles should also be considered as a way of stratifying preterm 
neonates when designing future studies or developing therapeutic protocols. 
 
2) The contribution of SV and HR in determining CO vary over the first 3 days of life and in 
relation to specific clinical and therapeutic factors. The importance of SV on CO 
determination, the enhanced susceptibility of the preterm myocardium to afterload observed 
in the first 24 hours and the impact of different HR ranges should not be underestimated, but 




3) Although cardio-respiratory events are very frequent among preterm infants, their 
cardiovascular and cerebrovascular impact should not be ignored. Since some events are less 
benign than others, it is important to classify them correctly. Moreover, knowledge of the 
clinical factors associated with deeper haemodynamic fluctuations in response to these events 
(e.g., low GA, hsPDA) it is important to identify infants that may be more susceptible to the 
effects of repeated hypoxia-ischemia-reperfusion cycles. 
 
While the increased representation of intrauterine growth-restricted infants with fully available data 
on antenatal Doppler represents a point of strength of the present study, the unavailability of a 
simultaneous invasive blood pressure monitoring needs to be acknowledged as a research limitation. 
In fact, if available, it would have allowed not only to examine the continuous trajectories of MABP 
over time, but also to compare the observed TOHRx values against alternative indices of cerebral 
autoregulation loss, derived from methods of autoregulation assessment based on continuous blood 
pressure monitoring. 
The small number of preterm infants who developed IVH, especially of high grades, within the first 
72 hours, represents an additional limitation to the present research, as it did not allow to perform a 
targeted analysis of cardiovascular and cerebrovascular transitional features in relation to the 
development of this complication, which thus represents a key target for future research. 
Based on the present data, additional research objectives that deserve to be addressed in targeted 
investigations have been identified. The first is whether early cardiovascular and cerebrovascular 
patterns may effectively predict spontaneous ductal closure, or the responsiveness to pharmacological 
treatment. The second would aim to investigate whether (and when) the particular haemodynamic 
patterns observed in infants with antenatal impairment of umbilical Doppler resolve, or persist over 
time. Third, in settings where continuous BP data are available, the investigation of MABP changes 
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during to CRE may add valuable information to contextualize the cardiovascular and cerebrovascular 
responses to these events described in Chapter 6. 
Finally, targeted research aimed at evaluating the relationship between cardiovascular and 
cerebrovascular parameters, lung pressures and volumes in invasively ventilated preterm infants has 
been developed in the context of this research project, and is currently ongoing, with the aim to assess 
more in deep the haemodynamic effects of mechanical ventilation in sick preterm infants. 
 
The body of work presented in this thesis demonstrates the feasibility and validity of multiparameter 
monitoring in neonatal clinical settings to provide useful information on the cardiovascular and 
cerebrovascular circulation of very preterm infants during the transitional phase. Continuous 
monitoring of transitional circulation combining EV and NIRS enables real-time assessment of the 
response to therapies, CRE and other interventions both at a cardiovascular and cerebral level. From 
a haemodynamic perspective, the present data indicate the importance of stratifying this population 
particularly based on their antenatal physiology, GA and postnatal ductal status in both clinical 
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